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A B S T R A C T
Background
Cigarette smoking is one of the leading causes of preventable death world wide. There is good evidence that brief interventions from
health professionals can increase smoking cessation attempts. A number of trials have examined whether skills training for health
professionals can lead them to have greater success in helping their patients who smoke.
Objectives
To determine the effectiveness of training health care professionals in the delivery of smoking cessation interventions to their patients,
and to assess the additional effects of training characteristics such as intervention content, delivery method and intensity.
Search methods
The Cochrane Tobacco Addiction Group’s Specialised Register, electronic databases and the bibliographies of identified studies were
searched and raw data was requested from study authors where needed. Searches were updated in March 2012.
Selection criteria
Randomized trials in which the intervention was training of health care professionals in smoking cessation. Trials were considered if
they reported outcomes for patient smoking at least six months after the intervention. Process outcomes needed to be reported, however
trials that reported effects only on process outcomes and not smoking behaviour were excluded.
Data collection and analysis
Information relating to the characteristics of each included study for interventions, participants, outcomes and methods were extracted
by two independent reviewers. Studies were combined in a meta-analysis where possible and reported in narrative synthesis in text and
table.
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Main results
Of seventeen included studies, thirteen found no evidence of an effect for continuous smoking abstinence following the intervention.
Meta-analysis of 14 studies for point prevalence of smoking produced a statistically and clinically significant effect in favour of the
intervention (OR 1.36, 95% CI 1.20 to 1.55, p= 0.004). Meta-analysis of eight studies that reported continuous abstinence was also
statistically significant (OR 1.60, 95% CI 1.26 to 2.03, p= 0.03).
Healthcare professionals who had received training were more likely to perform tasks of smoking cessation than untrained controls,
including: asking patients to set a quit date (p< 0.0001), make follow-up appointments (p< 0.00001), counselling of smokers (p<
0.00001), provision of self-help material (p< 0.0001) and prescription of a quit date (p< 0.00001). No evidence of an effect was
observed for the provision of nicotine gum/replacement therapy.
Authors’ conclusions
Training health professionals to provide smoking cessation interventions had a measurable effect on the point prevalence of smoking,
continuous abstinence and professional performance. The one exception was the provision of nicotine gum or replacement therapy,
which did not differ between groups.
P L A I N L A N G U A G E S U M M A R Y
Can training health professionals to ask people if they smoke increase offers of advice and help patients quit?
Training programs are used to encourage health professionals to ask their patients if they smoke, and then offer advice to help them
quit. The review of 17 trials found that these training programs help health professionals to identify smokers and increase the number
of people who quit smoking. The programs also increase the number of people offered advice and support for quitting by health
professionals.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Training health professionals for smoking cessation
Patient or population: Smokers treated by health professionals
Intervention: Training
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Training health profes-
sionals
Point prevalence of
smoking cessation
self-report and some bio-
logically validated
Follow-up: 6 to 14
months
78 per 1000 107 per 1000
(88 to 131)
OR 1.41
(1.13 to 1.77)
13459
(14 studies)
⊕⊕⊕©
moderate1,2
Continuous smoking ab-
stinence
self-report and some bio-
logically validated
Follow-up: 6 to 14
months
27 per 1000 42 per 1000
(28 to 62)
OR 1.60
(1.26 to 2.03)
9443
(8 studies)
⊕⊕⊕©
moderate1,2
Number of smokers
counselled
self-report
Follow-up: 6 to 48
months
465 per 1000 664 per 1000
(578 to 739)
OR 2.28
(1.58 to 3.27)
8531
(14 studies)
⊕⊕©©
low1,3
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Patients asked to make
a follow-up appointment
self-report
Follow-up: 6 to 12
months
166 per 1000 400 per 1000
(233 to 593)
OR 3.34
(1.52 to 7.30)
3114
(7 studies)
⊕©©©
very low1,2,3
Number of smokers re-
ceiving self-help mate-
rial
self-report
Follow-up: 6 to 48
months
134 per 1000 351 per 1000
(227 to 500)
OR 3.51
(1.90 to 6.47)
4925
(9 studies)
⊕©©©
very low1,2,3
Number of smokers re-
ceiving nicotine gum/re-
placement therapy
self-report
Follow-up: 12 to 48
months
312 per 1000 416 per 1000
(283 to 563)
OR 1.57
(0.87 to 2.84)
5073
(9 studies)
⊕⊕©©
low1,3
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; OR: Odds ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Unclear methods of sequence generation and allocation concealment in the majority of studies and all studies had inadequate blinding
of participants
2 Wide confidence intervals around the estimate of effect
3 Significantly large amounts of heterogeneity were observed (I² >90%)
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B A C K G R O U N D
Description of the condition
Every year approximately 5.4 million people die from tobacco-
related diseases, translating to 1 in every 10 deaths among adults
world wide (Mathers 2006; WHO 2008). Approximately 80% of
those deaths are from people living in less developed countries and
by 2030 this figure will increase to more than 8 million per year
if no action is taken (Mathers 2006). If current trends continue
on this trajectory, an estimated 500 million people alive today will
be killed by tobacco. In the 27 countries that form the European
Union, over 25% of cancer deaths and 15% of all deaths can be
attributed to smoking (European Commission 2004). Smoked to-
bacco is known to cause up to 90% of all lung cancers and is a sig-
nificant risk factor for strokes and fatal heart attacks. In addition,
tobacco use is linked to the development and treatment of many
oral diseases (Bergstrom 2000; Balaji 2008; Petersen 2009) includ-
ing oral cancer, delayed wound healing and peridentitis contribut-
ing to loss of teeth and edentulism (Tomar 2000; Mohammad
2006; Gordon 2009).
Description of the intervention
Health professionals are at the forefront of tobacco epidemics as
they consult millions of people and can encourage them to quit
smoking (WHO 2005; Zwar 2009). In developed countries, more
than 80% of the population will see a primary care physician at
least once a year, with doctors perceived to be influential sources
of information on smoking cessation (Mullins 1999; Richmond
1999; Zwar 2009). It has been reported that most dentists and
dental hygienists believe the lack of skills and training is a sig-
nificant barrier to effectively providing tobacco cessation inter-
ventions into routine care (Gelskey 2002; Warnakulasuriya 2002;
Gordon 2009; Rosseel 2009).
Providing training in smoking cessation care is one possible
method for increasing the number and quality of delivered in-
terventions by primary care health professionals, and a variety of
training methods are available (Anderson 2004; Twardella 2004;
Stead 2009). To date, individual studies have shown an effect of
training on physician’s activities, but there have been doubts about
the extent to which this translates into changes in patient be-
haviour and actual smoking abstinence (Kottke 1989; Cummings
1989a; Cummings 1989b). Training health professionals to de-
liver smoking cessation messages has been known to increase the
frequency with which interventions are offered to patients in the
clinical context (Thorogood 2006).
How the intervention might work
Provision of advice and support to smokers by healthcare profes-
sionals in primary care settings has been shown to be themost cost-
effective preventive service and has a small but significant effect on
cessation rates (Maciosek 2006; Solberg 2006; Stead 2008). Even
though these rates appear low from the perspective of many clini-
cians, they could translate into a substantial public health benefit
if consistently provided, as approximately 70-80% of adults have
contact with a health care practitioner, usually in primary care, at
least once each year (Mullins 1999; Richmond 1999; Hung 2009;
Zwar 2009). It is therefore disappointing that despite ongoing de-
velopments in this field worldwide, the number of patients who
report receiving advice on smoking cessation from health profes-
sionals is still low (CDC 2007).
Why it is important to do this review
On a worldwide scale, tobacco use currently costs hundreds of
billions of dollars each year (WHO 2008). Data on the global
impact of tobacco is incomplete, however it is known to be high,
with annual tobacco related health care costs being US$81 billion
for the USA, US$7 billion for Germany and US$1 billion for
Australia (Guindon 2008).
The first systematic review on this topic was published over a
decade ago and showed that training health professionals to pro-
vide smoking cessation interventions had a positive effect on pro-
fessional performance.However, there was no strong evidence that
it changed smoking behavior of patients (Lancaster 2008). Since
then, a number of new trials have examined whether specific skills
training for health professionals leads them to overcome frequently
mentioned barriers and to have greater success in helping their
patients to quit smoking.
We therefore systematically identified and reviewed the evidence
fromnewpublished randomized controlled trials that have studied
the effects of training and supporting health care professionals in
providing smoking cessation advice. Furthermore, we assessed the
effects of training characteristics, such as the content, setting, and
intensity.
O B J E C T I V E S
The aim of this review was to assess the effectiveness of training
health care professionals to deliver smoking cessation interventions
to their patients, and to assess the effects of training characteristics
(such as contents, setting, delivery and intensity).
M E T H O D S
Criteria for considering studies for this review
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Types of studies
We considered only randomized controlled trials.
Types of participants
We considered trials in which the unit of randomization was a
healthcare practitioner or practice, and that reported the effects
on patients who were smokers.
Types of interventions
We considered interventions in which health care professionals
were trained in methods to promote smoking cessation among
their patients. To be included in the review studies had to have
allocated healthcare professionals to at least two groups (includ-
ing one which received some form of training) by a formal ran-
domization process. Studies that used historical controls were ex-
cluded. We included studies that compared a trained group to an
untrained control group, and studies that examined the effective-
ness of adding prompts and reminders to training.
Types of outcome measures
Primary outcomes
The primary outcome measure was abstinence from smoking six
months or more after the start of the intervention, assessed as:
• point prevalence (defined as not smoking at a set period
(e.g., seven days) prior to the follow-up), and
• continuous abstinence (defined as not smoking for an
extended/prolonged period at follow-up)
The definition of point prevalence and continuous abstinence
for each study can be found in the ’Outcomes’ section of the
Characteristics of included studies table.
The strictest available criteria to define abstinence were used. In
studies where biochemical validation of cessation was available,
only those participants who met the criteria for biochemically
confirmed abstinence were regarded as being abstinent. Those lost
to follow-up were regarded as being continuing smokers.
Secondary outcomes
Secondary ‘patient level’ outcome measures included process vari-
ables such as the number of smokers who were:
• asked to set a date for stopping (quit date)
• given a follow-up appointment
• counselled
• given self-help materials
• offered nicotine gum/replacement therapy
• prescribed a quit date, and
• cost effectiveness for interventions.
Secondary ‘physician level’ outcome measures include the number
of referrals made (to local smoking cessation services).
To be included in the review, studies had to assess changes in
the long term smoking behaviour of patients. Studies which only
assessed the effect of training on the consultation process were
excluded.
Search methods for identification of studies
We identified potentially relevant study reports from theCochrane
Tobacco Addiction Group Specialised Register. This Register
includes reports of trials and other evaluations of interven-
tions for smoking cessation and prevention, based on regular
highly sensitive searches of multiple electronic databases including
MEDLINE, EMBASE, PsycINFO and CENTRAL, and hand-
searches of conference abstracts. For details of search strategies
and dates see the Cochrane Tobacco Addiction Group Module in
the Cochrane Library. The most recent search of the Register was
in March 2012. Records were identified from the Register as po-
tentially relevant if they included the free text terms ‘training’ or
‘trained’ or the MeSH keywords ‘Education, Premedical’ or ‘Ed-
ucation, Professional’ or ‘Inservice Training’ or ‘Physician’s Prac-
tice Patterns’ or ‘Dentist’s Practice Patterns’ or ‘Delivery of Health
Care’ or ‘Comprehensive Health Care’ or ‘Critical Pathways’ or
‘Disease Management’ or the EMBASE indexing terms ‘clinical
education’ or ‘continuing education provider’ or ‘continuing ed-
ucation’ or ‘medical education’ as indexing terms. We conducted
an additional search of MEDLINE (via OVID, to 2012 Feb week
5) exploding the same MeSH keywords in combination with the
terms for smoking cessation and controlled trials used in the regu-
lar search ofMEDLINE for the Specialised Register. See Appendix
1 for this strategy. Records included definite and probable reports
of randomized trials, and reviews.
Data collection and analysis
Selection of studies
Two reviewers (KC, MV) prescreened all study reports identified
from the Specialised Register (limited to papers published after
1999 for this update). Articles were rejected if the title and/or
abstract did not meet the inclusion/exclusion criteria. In instances
where the study could not be categorically rejected, the full text
was obtained and screened. Reference lists of screened articles were
scanned for other potentially relevant articles.
Two reviewers then independently assessed the relevant studies for
inclusion (KC andMV), with discrepancies resolved by consensus.
Studies which were excluded though relevant to the review topic
are listed in the Characteristics of excluded studies table, with the
reason for their exclusion described.
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Data extraction and management
Acombinationof two reviewers independently extracted data from
published reports (KC, MV, and MB). Disagreements were re-
solved by referral to a third party. No attempt was made to blind
any of these reviewers to either the results of the primary studies
or the intervention the subjects received.
The data extraction process identified information on the follow-
ing design characteristics:
• Country and setting of study
• Description of training delivery method, duration, content
• Number of therapists (intervention, control, post
randomization dropouts)
• Number of patient participants (intervention, control,
losses to follow-up in each condition), method of identification/
enrolment
• Number of patients per therapist (range and/or average)
• Description of intervention and control conditions
• Definition of abstinence for smoking cessation outcome(s),
duration of follow-up, method of biochemical validation if used
• Secondary outcomes reported
Data was extracted and entered into Review Manager for the fol-
lowing outcome variables, where reported:
• Point prevalence abstinence at longest follow-up (preferred
outcome for meta-analysis is continuous or sustained abstinence)
• Continuous or sustained smoking abstinence at longest
follow-up
• Cost effectiveness analysis for intervention
We also extracted data on process outcomes where reported. These
included patient reported or documented delivery of interven-
tions, such as: setting a quit date, making a follow-up appoint-
ment, number of smokers counselled, provision of self-help ma-
terials, prescription of nicotine replacement therapy and/or pre-
scription of a quit date.
Assessment of risk of bias in included studies
Two reviewers independently assessed the full text versions for of
all included papers for risk of bias using the Cochrane Handbook
guidelines, using a domain-based evaluation (Higgins 2009). In
addition, extra criteria developed by the Cochrane EPOC Group
(EPOC 2009) were used to address potential sources of bias re-
lated to clustering effects. These domains included sequence gen-
eration, allocation concealment, blinding for participants, blind-
ing for outcome assessors, incomplete outcome data, selective re-
porting, imbalance of outcome measures at baseline, comparabil-
ity of intervention and control group characteristics at baseline,
protection against contamination, selective recruitment of partic-
ipants and any other sources of potential biases. The risk of bias
was assessed for each domain as ’high risk’, ’low risk’, and ’un-
clear risk’ (using the guidelines from Table 8.5.c of the Cochrane
Handbook, Higgins 2009). Two of three reviewers (KC, MV or
MB) independently assessed the included studies for risk of bias.
Conflicts were resolved by consensus or by referring to a third
party if disagreement persisted.
Unit of analysis issues
The trials included in the review used cluster randomization. Out-
comes relate to individual patients whilst allocation to the inter-
vention is by provider or practice, and ignoring this may introduce
unit of analysis errors. Using statistical methods which assume for
example that all patients’ chances of quitting are independent ig-
nores the possible similarity between outcomes for patients seen
by the same provider. This may underestimate standard errors and
give misleadingly narrow confidence intervals, leading to the pos-
sibility of a type 1 error (Altman 1997). All trials were expected to
be cluster randomized studies, with analysis performed at the level
of individuals whilst accounting for the clustering in the data. This
was performed by using a random effects model for pooled meta-
analysis as recommended in the Cochrane Handbook (Chapter
16.3.3, Higgins 2009) and checked by a statistician (AE). For
those studies which did not adjust for clustering the actual sample
size was replaced with the effective sample size (ESS), calculated
using a rho= 0.02 as per Campbell 2000. Trials may use a variety
of statistical methods to investigate or compensate for clustering;
we have recorded whether studies used these and whether the sig-
nificance of any effect was altered. In instances where the studies
appeared homogenous via a combination of the statistical I² test
in addition to homogeneity expressed in the visual inspection of
a Funnel plot we meta-analysed using a fixed effect model. How-
ever in the presence of significant heterogeneity (as defined below
under ‘Data Synthesis’) the random effects model was used.
In the case of multi-arm trials each pair-wise comparison was in-
cluded separately, but with shared intervention groups divided out
approximately evenly among the comparators. However, if the in-
tervention groups were deemed similar enough to be pooled, the
groupswere combinedusing appropriate formulas in theCochrane
Handbook (Table 7.7.a for continuous data and Chapter 16.5.4
for dichotomous data, Higgins 2009).
Dealing with missing data
Missing participant data were evaluated on an available case anal-
ysis basis as described in Chapter 16.2.2 of the Cochrane Hand-
book (Higgins 2009). Missing standard deviations were addressed
by imputing data from the studies within the same meta-analysis
or from a different meta-analysis as long as these use the same
measurement scale, have the same degree of measurement error
and the same time periods (between baseline and final value mea-
surement, as per Chapter 16.1.3.2 of the Cochrane Handbook,
Higgins 2009). Where statistics essential for analysis were miss-
ing (e.g. group means and standard deviations for both groups are
not reported) and could not be calculated from other data, we at-
tempted to contact the authors to obtain data. Loss of participants
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that occurred prior to performance of baseline measurements was
assumed to have no effect on the eventual outcome data of the
study. Losses after the baseline measurement were taken were as-
sessed and discussed. Studies that had more than 30% attrition
(i.e., deaths and withdrawals) were reported in text only and ex-
cluded from the meta-analysis.
We made an attempt to contact all authors for verification of
methodological quality, classification of the intervention(s) and
outcomes data. We attempted to contact the second author if we
were unsuccessful in contacting the first author.
Assessment of heterogeneity
The review was expected to have some heterogeneity due to fac-
tors such as differing characteristics of clinics, practices and med-
ical surgeries, differences in intervention characteristics and vary-
ing measurement tools used to assess outcomes. The Chi² and I²
statistic (Higgins 2009) were used to quantify inconsistency across
studies. The presence of significant heterogeneity was further ex-
plored through subgroup analyses. These were conducted for:
1. ‘treatment type’ (e.g., counselling alone, counselling plus
nicotine replacement therapy, counselling plus request for
additional appointments, etc.)
2. ‘treatment intensity’ (number of sessions)
3. ‘treatment intensity’ (total exposure)
4. ‘mode of delivery’ (e.g., face-to-face, group sessions or both)
5. ‘behavioural change techniques’ (e.g., prompting, providing
feedback, use of behavioural change theories)
6. ‘type of professional being trained’ (e.g., dentist, doctor,
health care worker etc.)
7. ‘length of follow-up’ (i.e., >6 to <9 months, >9 to <12
months, >12 to <24 months), and
8. ‘risk of bias’ (i.e., high risk of bias for: < 2 domains, 3 - 5
domains, 6 - 8 domains or > 9 domains).
The likelihood of false positive results among subgroup analyses
increase with the number of potential effect modifiers being inves-
tigated (Higgins 2009). As such we have adjusted these analyses
using a Holm-Bonferroni method (Holm 1979) using α= 0.05.
Assessment of reporting biases
With the inclusion of more than ten included studies, potential
reporting biases were assessed using a funnel plot. Asymmetry in
the plot could be attributed to publication bias, but may well be
due to true heterogeneity, poor methodological design or artefact.
Contour lines corresponding to perceived milestones of statistical
significance (p= 0.01, 0.05, 0.1 etc.) were applied to funnel plots,
which may help to differentiate between asymmetry due to pub-
lication bias from that due to other factors (Higgins 2009).
Data synthesis
1. For dichotomous outcomes the fixed effect model with an odds
ratio (OR) was calculated with 95% confidence interval (CI),
which was synthesised using inverse variance. However for out-
comes with greater than 10 included studies a test for heterogene-
ity was conducted using a combination of two methods. If hetero-
geneity was found (defined as the I² test >60% and visual inspec-
tion of the funnel plot indicating no clustering of large or small
studies) the random effects model was used in place of the fixed
effect model, as suggested by the Cochrane Handbook (Section
9.5.2 and 9.5.3, Higgins 2009). Reasons for heterogeneity are fur-
ther explored in the discussion. When studies appeared homoge-
nous, the meta-analysis was redone using the fixed effect model.
2. For continuous outcomes, a fixed effect model with a weighted
mean difference (WMD) or standardised mean difference (SMD)
with 95% confidence intervals were calculated as appropriate.
However, in the presence of significant heterogeneity (as defined
above) the random effects model was used in place of the fixed
effect model.
Sensitivity analysis
Sensitivity analysis was conducted on studies with an unclear or
high risk of bias for sequence generation and/or allocation con-
cealment.
We include the Tobacco Addiction Group glossary of tobacco-
specific terms (Appendix 2).
R E S U L T S
Description of studies
See the Characteristics of included studies and Characteristics of
excluded studies tables.
Results of the search
Of 381 articles screened, 17 studies met all of the inclusion criteria
(see Figure 1 for PRISMA diagram). Detailed information relating
to each included study is reported in theCharacteristics of included
studies table (for information relating to the 65 excluded studies
see Characteristics of excluded studies).
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Figure 1. Study flow diagram
Included studies
Design
All 17 included studies used a randomized controlled trial design
with clustering and eleven studies also adopted nesting of par-
ticipants within practices/hospitals (Wilson 1988; Cohen (Dent)
1989; Cohen (Doc) 1989; Cummings (Priv) 1989; Kottke 1989;
Lennox 1998; Strecher 1991; Hymowitz 2007; Twardella 2007;
Unrod 2007; Gordon 2010). One study (Twardella 2007) incor-
porated a 2x2 factorial design with randomization to: training plus
incentive, training plus medication, training plus incentive and
medication or usual care.
Sample sizes
In total 28,531 patients were assessed at baseline (following ran-
domization) with 21,031 remaining in the studies at final follow-
up. Authors report a total of 1,434 individual health professionals
recruited at baseline (across a known 260 practices) with follow-
up available for 1,204. Sample sizes for individual studies were
medium to large, with the smallest number of patients (random-
ized at baseline) found in the Wang 1994 study (n= 93) and the
largest in the Kottke 1989 study. The smallest sample at follow-
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up remained with the Wang 1994 study (n= 82), and the largest
remained with the Kottke 1989 study (n= 5266) . At the health
professional level, the Hymowitz 2007 study had the largest num-
ber of residents randomized at baseline (n= 275) and follow-up
(n= 235) and likewise, Wang 1994 had the smallest number of
residents at baseline and follow-up (n= 27 for both). Seven studies
also reported baseline cluster sizes at the practice level: Lennox
1998 (n= 16); Sinclair 1998 (n= 62); Swartz 2002 (n= 50); Joseph
2004 (n= 20); Hymowitz 2007 (n= 16); Twardella 2007 (n= 82);
and Gordon 2010 (n= 14).
Setting
Elevenof the 17 studieswere conducted in theUSA, one inCanada
(Wilson 1988), one in Taiwan (Wang 1994), one in Scotland
(Sinclair 1998), one in the United Kingdom (Lennox 1998), one
in Switzerland (Cornuz 2002) and one in Germany (Twardella
2007). Two studies were performed in a dentistry setting (Cohen
(Dent) 1989; Gordon 2010), whilst the remaining 15 were con-
ducted within primary care clinics, HMO (Health Maintenance
Organisation) medical centres (Cummings 1989; Swartz 2002),
VAMC’s (Veterans Affairs Medicial Centres) (Joseph 2004) and
one in a pharmacy setting (Sinclair 1998).
Participants
At the health professional level, two studies were performed with
dentists (Cohen (Dent) 1989; Gordon 2010), six studies included
only primary care physicians (Wilson 1988; Cohen (Doc) 1989;
Cummings (Priv) 1989; Kottke 1989 Twardella 2007; Unrod
2007), two studies were conducted with residents (Cornuz 2002
and paediatric residents in Hymowitz 2007), three studies incor-
porated a combination of primary care physicians and internists
(Cummings 1989; Strecher 1991; Wang 1994), one study used
pharmacists (Sinclair 1998), whilst the remaining three studies
used a combination of health professionals including physicians,
nurse practitioners, physician assistants, psychologists, pharma-
cists and other health visitors (Lennox 1998; Swartz 2002; Joseph
2004).
The individual patients in 16 of the 17 included studies were those
visiting their health professional during the recruitment phase of
each study. They were recruited during standard GP, dentist or
outpatient visits, emergency department visits or from waiting
rooms. The Hymowitz 2007 study was the only one to perform
the training in a paediatric setting, targeting the parents/guardians
of children visiting 16 primary care clinics.
Interventions
Treatment type
Six studies provided patients with a counselling plus nicotine re-
placement therapy intervention arm (Wilson 1988; Cohen (Dent)
1989; Cohen (Doc) 1989; Sinclair 1998; Joseph 2004; Twardella
2007). The two Cohen et al studies had a second intervention arm
of counselling plus a reminder for physicians to ask about smoking
(chart prompt), and a third intervention arm combining the coun-
selling, nicotine replacement therapy and chart prompt (Cohen
(Dent) 1989; Cohen (Doc) 1989). Another study (Twardella
2007) also had three intervention arms: counselling plus nicotine
replacement therapy; counselling plus a monetary incentive to the
physician following study completion per successful smoke-free
participant (EURO130); and a counselling plus nicotine replace-
ment therapy plus incentive arm. The Wilson 1988 study had
two intervention arms in addition to usual care: counselling and
nicotine gum (as mentioned above) and a second arm of nicotine
gum plus usual care (i.e., physicians were not trained in coun-
selling). Three studies included multiple intervention methods to
curtail smoking including counselling, nicotine replacement ther-
apy, request for additional follow-up appointments and provision
of self-help materials (Cummings (Priv) 1989; Cummings 1989;
Gordon 2010), whilst one study combined three of those four
(counselling, nicotine replacement therapy, and self-help materi-
als, Cornuz 2002). Five studies used counselling alone (Strecher
1991; Wang 1994; Lennox 1998; Swartz 2002; Unrod 2007) and
two studies used counselling with the addition of self-help mate-
rials (Kottke 1989; Hymowitz 2007).
Treatment intensity
The level of training intensity for health professionals ranged from
one 40-minute session in the Unrod 2007 study, to ’four or five’
day long sessions in the Joseph 2004 study. Nine studies had a
training session for one day or less: Wilson 1988 (four hours),
Cohen (Dent) 1989 (one hour), Cohen (Doc) 1989 (one hour),
Kottke 1989 (6 hours), Lennox 1998 (one day), Sinclair 1998 (two
hours), Twardella 2007 (two hours), Unrod 2007 (40 minutes)
and Gordon 2010 (three hours). Four studies had two separate ses-
sions: Strecher 1991 (two, one hour sessions scheduled two weeks
apart), Wang 1994 (two sessions of unknown duration), Cornuz
2002 (two, four hour training sessions scheduled two weeks apart)
and Swartz 2002 (two, 20 minute training sessions and another
session of unknown duration, where residents were able to practice
counselling techniques with standardised patients). Four studies
had three ormore sessions:Cummings (Priv) 1989 andCummings
1989 both had three, one hour sessions over a four to five week
period, Hymowitz 2007 had four, one hour sessions, four times
a year and Joseph 2004 had four to five, day long sessions within
six months.
Mode of intervention delivery
Three different modes of intervention delivery were used being
groups sessions, one-on-one or a combination of the two. Two
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studies only used one-on-one sessions (Joseph 2004;Unrod 2007),
eleven studies delivered the intervention in a group setting only
(Wilson 1988; Cummings 1989; Kottke 1989; Strecher 1991;
Wang 1994; Lennox 1998; Sinclair 1998; Swartz 2002;Hymowitz
2007; Twardella 2007; Gordon 2010) with an eighth study us-
ing group delivery as the primary mode, however doctors who
were unable to attend received a private session in their office
(Cummings (Priv) 1989). Finally three studies used both modes
of intervention delivery (Cohen (Dent) 1989; Cohen (Doc) 1989;
Cornuz 2002), with health professionals in the two Cohen et al
studies provided the option of a group or individual session.
Theoretical model - behavioural change technique
Nine studies used behavioural change theories to underpin the
intervention techniques. These included the ’stages of change’
(also known as the trans-theoretical)model (Kottke 1989; Strecher
1991; Wang 1994; Lennox 1998; Sinclair 1998; Cornuz 2002;
Twardella 2007) and the ’5A’ (Ask, Assess, Advise, Assist and
Arrange) approach (Unrod 2007; Gordon 2010). Three studies
incorporated prompting or reminders to ask about tobacco use
(Cohen (Dent) 1989; Cohen (Doc) 1989; Hymowitz 2007) and
four provided feedback to the health providers, for example num-
ber of patients counselled (Cornuz 2002; Swartz 2002; Joseph
2004; Unrod 2007).
Type of professional being trained:
Two studies only focused on dentists (Cohen (Dent) 1989;
Gordon 2010), one focused on pharmacists (Sinclair 1998), and
the remaining fourteen studies all involved doctors. Five of these
fourteen studies included doctors still undergoing training, either
residents (Strecher 1991; Wang 1994; Cornuz 2002; Hymowitz
2007) or a combination of physicians and internists (Cummings
1989). Three other studies included training to other health care
workers as well as doctors: Lennox 1998 also involved nurses and
other health visitors; Swartz 2002 also trained nurse practitioners,
physicians assistants and other health professionals; and, in addi-
tion to doctors, Joseph 2004 included nurses, psychologists and
pharmacists.
Length of follow-up
Eight studies reported follow-up periods between six and nine-
months post intervention (Cohen (Dent) 1989; Cohen (Doc)
1989; Strecher 1991; Wang 1994; Lennox 1998; Sinclair 1998;
Unrod 2007; Gordon 2010), eleven studies presented 12 month
follow-up data (Wilson 1988; Cohen (Dent) 1989; Cohen (Doc)
1989; Cummings 1989; Kottke 1989; Wang 1994; Cornuz 2002;
Swartz 2002; Joseph 2004; Twardella 2007; Gordon 2010) and
two studies assessed extended follow-up periods of 14 months
(Lennox 1998) and four years (Hymowitz 2007). However, only
two-year post intervention data was available for Hymowitz 2007
at the time of writing.
Outcomes
Smoking abstinence was assessed in all included studies through
self-report of either continuous abstinence (no smoking for an
extended period of time) or point prevalence (for example, no
smoking for seven days prior to the time of outcome collec-
tion). Of the eight studies that reported continuous abstinence, six
(Cummings (Priv) 1989; Cummings 1989;Gordon 2010; Lennox
1998; Sinclair 1998; Wilson 1988) also reported a point preva-
lence measure of abstinence. Ten of the included studies used
biochemical validation through either exhaled carbon monoxide
(Cohen (Dent) 1989; Cohen (Doc) 1989; Strecher 1991; Cornuz
2002), serum cotinine (Kottke 1989; Twardella 2007), saliva co-
tinine (Wilson 1988; Unrod 2007) or a combination of exhaled
carbon monoxide and serum cotinine (Cummings (Priv) 1989;
Cummings 1989). A number of secondary outcomes measures
were reported by some studies including: patients asked to set a
quit date; patients asked to make a follow-up appointment; num-
ber of smokers counselled; number of smokers receiving self-help
material; number of smokers receiving nicotine gum/replacement
therapy; and number of smokers prescribed a quit date.
Two studies reported n-values as a total across both intervention
and control arms (Cohen (Dent) 1989; Cohen (Doc) 1989) and
six studies reported n-values as percentages, which had to be trans-
formed into whole numbers (Wilson 1988; Cornuz 2002; Swartz
2002; Joseph 2004; Hymowitz 2007; Unrod 2007). As such there
is likely to be some small variance between actual n-values and
those reported in these analyses, but this is not significant. Seven
studies had multiple intervention arms, which were considered
similar enough to be pooled together, two in the Wilson 1988,
Kottke 1989 and Wang 1994 studies and three intervention arms
in the Cohen (Dent) 1989, Cohen (Doc) 1989, Strecher 1991
and Twardella 2007 studies. One study did not report the n-value
for subjects at randomization, and hence this was calculated based
on the number eligible for study and the number at follow-up
(Strecher 1991). The Kottke 1989 study reported all outcome data
as continuous variables, as such it was unable to be pooled in the
meta-analyses. Smoking related outcomes in the Hymowitz 2007
study were unable to be pooled as only change scores from baseline
were presented.
Excluded studies
Sixty-five studies (71 articles) were excluded for the following rea-
sons: 21 included consultation process only, 18 did not include
a control group, 13 failed to measure smoking related outcome
data, 12 were considered to be inadequately randomized and one
only reported on smokeless tobacco use. See the Characteristics of
excluded studies table for more detailed information relating to
each excluded study.
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Risk of bias in included studies
Methodological details for the 17 included studies are provided in
the ’risk of bias table’ at the end of the Characteristics of included
studies tables. Key methodological features are also summarised
in Figure 2.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias judgement presented as
percentages across all included studies
Random sequence generation (selection bias)
Five studies reported adequate methods of sequence generation
(Cummings 1989; Cornuz 2002; Hymowitz 2007; Twardella
2007; Unrod 2007), two had inadequate methods (Kottke 1989;
Strecher 1991) whilst the remaining ten did not provide enough
information to assess risk of bias for sequence generation and were
hence judged to be at unclear risk in this category. Adequate meth-
ods included the use of a random number generator or coin toss,
whilst unclearmethodswere described as being ’random’ in design,
however methods were not described. The Kottke 1989 study re-
quired some physicians to be re-assigned due to inappropriate al-
location methods during assignment. For the Strecher 1991 study
appropriate randomization did not occur as residents were ran-
domly assigned by clinic half-day session to one of four groups,
which risks introducing bias. All 17 trials used cluster randomiza-
tion, with five studies inadequately accounting for potential clus-
tering effects in the data, requiring manual clustering adjustments
(Wilson 1988; Cummings (Priv) 1989; Cummings 1989; Kottke
1989; Wang 1994). Only two studies (Kottke 1989; Hymowitz
2007) reported outcome data at the level of randomization. No
authors reported that differences in themethod of analysis affected
the results.
Allocation concealment (selection bias)
Allocation concealment was unclear in all 17 included studies as
authors did not describe methods of allocation concealment. Au-
thors of the Lennox 1998 study report that physicians were ran-
domly and blindly allocated to control or intervention groups,
however the methods were not described. Another study men-
tioned that an independent research assistant concealed the result
of randomization until two weeks before the intervention, when
residents were provided with details about training sessions, how-
ever, methods of concealment were again not reported (Cornuz
2002).
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Blinding (performance bias and detection bias) of
participants
Only one study reported adequately blinding participants to the
intervention (Cornuz 2002), as residents were not informed about
the aim of the trial and were advised only that a survey on car-
diovascular risk factors and prevention would be conducted. Au-
thors announced that a training program in clinical prevention
that included sessions on smoking cessation and management of
dyslipidaemia was being conducted. Authors also report that pa-
tients were blinded to the aim of the study and group allocation
of their physician. Due to the nature of the intervention, blinding
of participants was not possible for the remaining 16 studies. An
attempt was made to blind physicians in the Unrod 2007 study,
with physicians learning their group assignment only after signing
the informed consent, however they were not blinded during the
study intervention period and follow-up.
Blinding (performance bias and detection bias) of
outcome assessors
Three studies reportedmethods blinding of outcome assessors that
we judged at low risk of bias. Authors of Cummings (Priv) 1989
stated that ’outcome assessors were blinded’, authors of the Joseph
2004 study report interviewers collecting patient outcomes were
blinded to subject treatment status and authors in the Strecher
1991 study report that telephone interviewers, who were blinded
to residents’ and patients’ group assignments, obtained the patient
reports. The remaining 14 studies did not report any attempts to
blind outcome assessors and as such are unclear for this category.
Incomplete outcome data (attrition bias)
Incomplete outcome data was adequately addressed in three stud-
ies (Cummings (Priv) 1989; Cummings 1989; Gordon 2010) and
unclear in the remaining 14 studies. The Cummings (Priv) 1989
and Cummings 1989 studies reported that missing data was ac-
counted for in analyses, whilst the Gordon 2010 study reported
the use of multiple imputation procedures to account for missing
data with participants lost to attrition discussed in the text. All
unclear studies failed tomention if there was any missing outcome
data and if so, how this was addressed when reporting results.
Selective reporting (reporting bias)
Selective reporting was evident in three studies (Hymowitz 2007;
Unrod 2007; Gordon 2010), unclear in three studies (Kottke
1989; Strecher 1991; Wang 1994) and not detected in the re-
maining 11. Although all pre-specified outcomes were addressed
in the four year follow-up for the Hymowitz 2007 study, the au-
thors mention that outcome data for year one was omitted in or-
der to provide a ’cleaner look’ at the progress of the data. In the
Unrod 2007 study, smoking abstinence from baseline to follow-
up (an outcome that would be expected to have been assessed in
this study) was not reported. The Gordon 2010 authors report
that secondary participant outcomes were examined with no sig-
nificant differences on any variables, and that therefore they were
not presented in the publication. Also, receipt of intervention was
reported in text as percentages, however no information regarding
this outcome was reported for the control.
Imbalance of outcome measures at baseline
One study did not report data for baseline smoking and made
no mention of statistical analyses to potentially adjust for any im-
balances (Wang 1994), as such the risk of bias category was as-
sessed as unclear. All remaining studies adequately addressed im-
balances of outcome measures at baseline. Thirteen studies ac-
counted for baseline imbalances through analysis of covariance,
regression analyses or other analysis techniques, whilst three stud-
ies reported outcomes at baseline to be similar across groups and as
such did not require adjustment (Cummings (Priv) 1989; Lennox
1998; Sinclair 1998).
Comparability of intervention and control group
characteristics at baseline
Five studies had unclear comparability between intervention and
control groups at baseline (Wilson 1988; Cohen (Dent) 1989;
Cohen (Doc) 1989; Cummings 1989; Twardella 2007) and the re-
maining twelve studies adequately addressed any differences found
between groups via appropriate analysis methods.
Protection against contamination
Two studies reported contamination. In Gordon 2010, authors
reported contamination due to a tax increase on cigarettes in New
York, which resulted in a drop in smoking prevalence from 18.4%
in 2006 to 15.8% in 2008. Authors believed that this tax increase
contributed to the unusually high rate of smoking cessation in
the usual care patients, thereby affecting the relative impact of the
intervention. Authors of the second study, Strecher 1991, men-
tion that “all four groups worked closely with one another at each
site”, leading to the possibility of contamination, however they also
state that “...the effects appeared to be slight.” Nine studies had
unclear risk of bias for contamination with insufficient informa-
tion to permit a judgement of yes or no, whilst the remaining six
studies (Wilson 1988; Cummings (Priv) 1989; Cummings 1989;
Kottke 1989; Lennox 1998; Cornuz 2002) reported no potential
contamination during the study period.
Selective recruitment of participants
Although no studies were identified as having selectively recruited
participants, this could not be completely ruled out for eleven
studies, which were determined to have an unclear risk of bias for
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this outcome (Wilson 1988; Cohen (Dent) 1989; Cohen (Doc)
1989; Cummings (Priv) 1989; Kottke 1989; Strecher 1991;Wang
1994; Sinclair 1998; Swartz 2002;Twardella 2007;Gordon 2010).
The sampling frames in these studies were unclear and as such,
generalisability is of a potential concern. The remaining six studies
adequately reported recruitment methods and were determined as
having a low risk of bias.
Other bias
No other biases were identified for the 17 included studies.
Effects of interventions
See: Summary of findings for the main comparison Training
health professionals for smoking cessation
Intervention effectiveness was assessed in all seventeen included
studies through smoking prevalence, as well as through multi-
ple secondary outcomes (see Summary of findings for the main
comparison). All datawere analysed as per the pre-definedmethod-
ology outlined in the Methods section. For a summary of inter-
vention effectiveness for each of these outcomes see Table 1.
Overall summary of smoking behaviour
Four out of 13 studies detected significant intervention effective-
ness in training health professionals to influence point prevalence
of smoking in their patients at primary follow-up (Cohen (Doc)
1989; Cornuz 2002; Twardella 2007; Gordon 2010). Out of the
eight studies reporting continuous abstinence at primary follow-
up, only one reported a statistically significant effect in favour of
the intervention (Gordon 2010). Fifteen of the 17 included stud-
ies (the exceptions being Kottke 1989 and Hymowitz 2007) could
be included in a meta-analysis for the primary outcome of smok-
ing (Analysis 1.1). Using a fixed effect model there was a statisti-
cally and clinically significant effect in favour of the intervention
for point prevalence abstinence (OR 1.36, 95% CI 1.20 to 1.55,
14 trials, I² = 57%) and continuous abstinence (OR 1.60, 95%
CI 1.26 to 2.03, 8 trials, I² = 59%) (Figure 3). Using only the
stricter outcome of continuous abstinence for studies reporting
both types of cessation, a pooled estimate for all 15 trials gave a
similar estimate (OR 1.60, 95% CI 1.35 to 1.89, I² = 55%, data
not displayed). Since the heterogeneity in this analysis approached
the level at which we proposed a random-effects model we did a
sensitivity analysis; the point estimates were similar and the wider
confidence intervals continued to exclude no effect. The trial con-
tributing most evidently to the heterogeneity, particularly for the
continuous outcome, was Lennox 1998 in which the point esti-
mates for both abstinence outcomes favoured the control group.
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Figure 3. Forest plot of comparison: 1 The effect of training health professionals on patient smoking
cessation
Two studies could not be included in the meta-analyses. In the
Kottke 1989 study at one year follow-up almost half of the partic-
ipants in each group who were smoking at baseline reported quit
attempts for at least 24 hours during the previous year, with amean
duration of cessation of two months. No differences between the
three groups were identified. For the Hymowitz 2007 study there
was an increase in the special training condition of reported quit-
ting during the past year of 3.8% (an 8.5% increase over baseline
levels), however the change from baseline failed to achieve statisti-
cal significance. Among parents associated with standard training,
the change was only 0.8%.
As per pre-specified methodology, a funnel plot examined the pri-
mary outcome of smoking cessation using contour lines to assess
the presence of reporting biases. No publication biases were iden-
tified (Figure 4).
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Figure 4. Funnel plot of comparison: 1 The effect of training health professionals on patient smoking
cessation
Overall summary of secondary outcomes
Asked to set a quit date for stopping (quit date)
Nine studies reported the effect of training health professionals
on the number of patients being asked to set a quit date, eight
of which could be included in the meta-analysis producing a sig-
nificant result (random effects OR 4.98, 95% CI 2.29 to 10.86,
Analysis 1.2). Only three of the seven studies crossed the line of
no effect (Strecher 1991; Cornuz 2002; Swartz 2002) but there
was a very high level of heterogeneity (I² = 90%) suggesting that
not all interventions had the same impact on this outcome. Sub-
group analyses suggest that some of the heterogeneity might be
due to whether or not the patient intervention included an offer
of NRT. The two studies (Strecher 1991; Swartz 2002) that re-
ported this outcome and did not include NRT showed no differ-
ence between groups. The other studies showed more consistent
evidence that intervention increased numbers although the size of
effect remained variable (Analysis 2.1). Contrary to what might
have been expected, the studies where training took only a single
session had higher effect sizes (Cohen (Dent) 1989; Cohen (Doc)
1989; Wilson 1988, Analysis 3.1) compared to the five studies
using multiple sessions. Duration of training was similar for the
three sub-groups being examined (Analysis 4.1) as was interven-
tion delivery via one-on-one compared to group sessions (Analysis
5.1). There was a large amount of variability between the use of
prompting and provision of feedback, however this difference was
not significant (Analysis 6.1). Intervention delivery by a doctor
(six studies) or dentist (one study) produced a larger effect size
compared to delivery by a healthcare worker (Swartz 2002), which
may also explain some of the heterogeneity (Analysis 7.1). When
comparing follow-up periods, studies reporting between six and
nine months (Cohen (Dent) 1989; Cohen (Doc) 1989; Strecher
1991) and between nine and 12 months (seven studies) produced
similar effect sizes and large amounts of variability (Analysis 8.1).
Studies judged to be at lower risk of bias were more likely to show
evidence of an effect (seven studies) compared to studies with be-
tween three and five categories rated at high risk of bias (Strecher
1991), however the between group analysis did not suggest that
this was a source of heterogeneity (Analysis 9.1).
Given a follow-up appointment
There was a significant increase in the intervention arm for pa-
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tients being asked to make a follow-up appointment, as reported
in seven studies available for meta-analysis (random effects OR
3.34, 95% CI 1.51 to 7.37, Analysis 1.3), although significant
heterogeneity was observed (I² =92%). When comparing inter-
ventions using NRT with those that used counselling alone, an I²
of 96% was observed, meaning any results from a pooled analysis
would be too unreliable. As such only a visual analysis of odds
ratios and confidence intervals are presented, showing similar vari-
ability between sub-groups (Analysis 2.2). Subgroup analyses for
treatment intensity suggest that some of the heterogeneity might
be due to whether or not the training sessions were single or mul-
tiple. Two studies that employed single sessions (Wilson 1988;
Unrod 2007) were more likely to show an effect (although vari-
ability was observed), compared to five studies using multiple ses-
sions, which produced a smaller effect estimate with less variability
(Analysis 3.2). When comparing the duration of the training, sig-
nificant heterogeneity was once again observed between groups,
with studies presenting large amounts of variability, resulting in
a pooled estimate being unreliable for comparison (Analysis 4.2).
There was little difference between delivery by one-on-one com-
pared to group sessions (Analysis 5.2), and due to significant het-
erogeneity (I² =96%) the pooled comparison of prompting and
provision of feedback was not possible, although a visual display
shows variability is mostly due to the Unrod 2007 study (Analysis
6.2). Similar to other outcomes, delivery of the intervention by a
doctor (assessed in seven studies) meant that more patients were
likely to have a follow-up appointment compared to intervention
delivery by a healthcare worker (one study), however the Swartz
2002 study was present in both sub-groups as the intervention in-
cluded delivery by both a doctor and healthcare worker, as such a
statistical between group comparison was not performed (Analysis
7.2). Reporting of results at different follow-up periods were sim-
ilar between sub-groups, although the five studies with follow-up
between nine and 12 months had similar distributions with the
exception of the Wilson 1988 study, which significantly favoured
the intervention and had wide confidence intervals (Analysis 8.2).
No between group differences were observed for quality of the
studies (Analysis 9.2).
Counselled
Fourteen of the fifteen studies reporting on the number of smokers
counselled were meta-analysed (Analysis 1.4). Overall, a statisti-
cally and clinically significant effect in favour of the intervention
was observed (OR 2.28, 95% CI 1.58 to 3.27, p< 0.00001), as-
sessed using the random effects model due to significant hetero-
geneity (I²= 93%). An investigation into the causes of heterogene-
ity found no differences between counselling with and without
nicotine replacement therapy (Analysis 2.3), however implemen-
tation via multiple sessions or single sessions did produce between
group differences, with a larger effect size for single session de-
livery (Analysis 3.3). Duration of intervention delivery also pro-
duced significant differences with total exposure of between 40
minutes and two hours producing a larger effect size compared to
durations of between two and four hours and greater than four
hours (Analysis 4.3). Mode of intervention delivery (one-on-one
compared to group sessions) produced very similar effect sizes
(Analysis 5.3), as did the provision of feedback and prompting to
aid intervention delivery by the health professional (Analysis 6.3).
The type of health professional being trained may contribute to
the heterogeneity with the one study evaluating dentists (Cohen
(Dent) 1989) producing a larger effect size compared to those with
doctors and other health professionals which showed a more con-
servative effect with narrow confidence intervals (Analysis 7.3).
When examining follow-up periods, there was a slightly larger ef-
fect and more variability in the studies reporting results between
six and nine months compared to results between nine and twelve
months and 12 and 24 months (Analysis 8.3). No sub-group dif-
ferences were observed when analysing studies based on risks of
bias (Analysis 9.3).
Given self-help materials
The number of smokers receiving self-help material increased sig-
nificantly in favour of the intervention for the nine studies able
to be included in the meta-analysis (OR 3.52, 95% CI 1.90 to
6.52, p< 0.0001, Analysis 1.5). Provision of cessation materials in
the Hymowitz 2007 study, which could not be included in the
meta-analysis, did increase significantly across both groups over
the four year study period when compared to baseline values (in-
tervention 28.8%, control 17.6%) however, this interaction was
not statistically different between groups. The other study unable
to bemeta-analysed (Kottke 1989) also produced a statistically sig-
nificant effect (p< 0.001). Signficant heterogeneity was observed
in the meta-analysis (I²= 91%) which was explored through sub-
group analyses. The type of treatment did not show a significant
difference between groups, although the counselling plus nicotine
replacement therapy group did have a larger effect size compared
to counselling alone (Analysis 2.4). Likewise, no differences were
observed for single compared tomultiple session delivery (Analysis
3.4) or duration of delivery (Analysis 4.4), although the Cornuz
2002 study with a total exposure over four hours did produce a
very large effect with wide confidence intervals. No differences
were observed for the mode of intervention delivery (Analysis 5.4)
or provision of prompting or feedback to aid health profession-
als in the provision of self-help materials (Analysis 6.4). The one
study (Swartz 2002) which included healthcare workers for inter-
vention delivery produced less of an effect compared to the pooled
result of studies using doctors (Analysis 7.4). No difference be-
tween sub-groups was observed for length of follow-up (Analysis
8.3) although studies identified as having less risk of bias did have
a larger effect size compared to those with larger amounts of bias
(Analysis 9.4).
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Offered nicotine gum/replacement therapy
Nine studies were pooled to assess the number of smokers receiving
nicotine gum/replacement therapy (Analysis 1.6). The meta-anal-
ysis did not produce evidence of an effect (OR 1.57, 95% CI 0.87
to 2.84, p= NS), but significant heterogeneity was detected (I²=
91%). The Hymowitz 2007 study also assessed this outcome with
few parents in either condition reporting that residents prescribed
nicotine replacement therapy (intervention 7.6%, control 5.9%).
An exploration into the possible sources of heterogeneity found
no difference between interventions containing counselling with
or without nicotine replacement therapy (Analysis 2.5), however
surprising results were observed with much larger effect sizes for
single session intervention delivery compared to multiple session
(Analysis 3.5), which could account for some of the heterogeneity.
No differences were observed between sub-groups for treatment
intensity (Analysis 4.5), mode of intervention delivery (Analysis
5.5), use of feedback or prompting (Analysis 6.5), type of profes-
sional being trained (Analysis 7.5) or length of follow-up (Analysis
8.5). However studies with less risk of bias did produce larger ef-
fect sizes compared to studies with three to five sources of bias
identified, which could also contribute to some of the observed
heterogeneity (Analysis 9.5).
Prescribed a quit date
Only three studies reported on smokers being prescribed a quit
date (Wilson 1988; Cummings 1989; Strecher 1991). Pooling
these together produced a statistically and clinically significant ef-
fect in favour of the intervention (OR 14.18, 95% CI 6.57 to
30.61, p< 0.00001, Analysis 1.7), with minimal observed hetero-
geneity. As such, sub-group analyses were not necessary for this
outcome.
Cost effectiveness of interventions
Cost effectiveness data was presented in one study (Cornuz 2002),
with the incremental cost of the intervention reported to amount
to (U.S.) $2.58 per consultation by a smoker. When considering
’cost per life-year saved’, this translated to (U.S.) $25.40 for men
and $35.20 for women, with one-way sensitivity analyses yielding
a range of $4.00 to $107.10 in men and $9.70 to $148.60 in
women. The Joseph 2004 study reported that the dollar spent per
1000 primary care patients did increase in the intervention sites
and decrease in control sites, however this was not significant.
Number of referrals made
No studies reported on the number of referrals made to local
smoking cessation services.
Statistical analyses and cluster adjustments
All 17 studies used a cluster randomized design for practical rea-
sons, with the unit of randomization being the health care practi-
tioner or practice. However, in 15 of the 17 studies patients were
the unit of analysis. Hymowitz 2007 and Kottke 1989 were the
exceptions, reporting outcomes at the level of randomization (the
doctor/resident). The majority of studies that reported outcomes
at the level of patient accounted for potential clustering effects
within their reported results, with four studies (three in the late
1980’s Wilson 1988; Cummings (Priv) 1989; Cummings 1989
and one in the mid-1990’s Wang 1994) being the exceptions. The
two Cummings et al studies did perform clustering analyses, how-
ever they were not included in the published results as they were
seen to have had no effect on the final outcome. As such, the data
for these studies were manually adjusted for potential clustering
effects as per the pre-specified methodology outlined in the Unit
of analysis issues section of this review.
Sub-group analyses
Multiple sub-group analyses have been considered as per the pre-
definedmethodology to further explore heterogeneity.When con-
sidering these outcomes the level of statistical significance should
be considered at p< 0.01, to account for potential false positive
results (as per the Bonferroni adjustment described Assessment
of heterogeneity), which increase with the number of potential
effect modifiers being investigated. Total study confidence inter-
vals were assessed at the 99% level for all sub-group analyses. Sig-
nificant heterogeneity was determined through a combination of
the I² statistic (I² >60%), Chi² statistic and visual inspection of
the Forest plots, and was present for all outcomes with the ex-
ception of ’Smoking cessation at longest follow-up’ and ’Number
of smokers prescribed a quit date’ where significant heterogeneity
was not identified. In the presence of heterogeneity based on the
I² statistic of > 96%, the pooled estimate has been removed, as the
outcomes are considered too different to be combined in meta-
analysis. Likewise, when a comparison contained the same study
in different sub-groups, the pooled estimate was not used.
D I S C U S S I O N
Summary of main results
Seventeen completed studies (total 28,531 subjects) assessed the
benefits of interventions to train health professionals to pro-
vide smoking cessation initiatives to their patients. Whilst some
methodological variations occurred between studies in relation to
intervention, delivery mode, type of health professional and du-
ration, they were all aimed at training health professionals to help
their patients stop smoking. The primary outcome of smoking ces-
sation was presented in pooled meta-analyses as point prevalence
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(14 studies) and continuous abstinence (eight studies). A statisti-
cally and clinically significant effect in favour of the intervention
was observed for both of these outcomes at final follow-up (see
Summary of findings for themain comparison). All secondary out-
comes (with one exception) produced a statistically and clinically
significant effect in favour of the intervention at final follow-up.
These outcomes include asking patients to set a quit date, asking
patients to make follow-up appointments, counselling of smok-
ers, provision of self-help material and prescription of a quit date.
No evidence of an effect was observed for the secondary outcome
of providing patients with nicotine gum/replacement therapy. No
studies were able to be meta-analysed to assess the cost effective-
ness of interventions.
Overall completeness and applicability of
evidence
In the context of current practice, this review should be used to
provide readerswith anoutline ofwhat interventions have a proven
effect, and where resources need to be directed for future investiga-
tions. Studies which incorporated multiple intervention compo-
nents such as provision of nicotine replacement therapy, requests
for follow-up appointments and provision of self-help material
were more likely to be successful than those with interventions
of counselling alone. Surprisingly, health professionals who were
trained using only a single session and in a group setting were
just as likely if not more likely to have patients quit smoking as
those being trained with multiple delivery sessions and one-on-
one training (i.e., face to face with the trainer). Similarly, the dura-
tion of training for the health professional of between 40 minutes
to two hours was just as effective, and in some cases more so, than
a duration of greater than two hours. Studies with multiple follow-
up periods and closer monitoring of outcomes by investigators
(including the provision of feedback) were more successful than
those of lesser intensity. Smoking cessation interventions delivered
by a doctor or dentist were more likely to produce successful quit
attempts than those delivered by other health care workers.
To ensure methodological rigour, future studies should aim to
incorporate the following into the study design:
• Report patient level outcomes (e.g., smoking cessation) as
well as health professional outcomes (e.g., physician report of
number of smokers counselled) rather than providing details
only relating to the consultation process
• Adequate methods of randomization and allocation
concealment
• Report smoking related outcome data both pre and post
intervention
• Incorporate a control group which adequately matches the
demographic characteristics of the intervention population.
Quality of the evidence
Study quality was a potential issue in this review with many of
the studies being of unclear methodological design. It is extremely
difficult to blind participants in relation to what intervention they
will be receiving, as there are two levels to consider: the health pro-
fessional and the patient. All 17 included studies had unclear al-
location concealment whilst only five studies adequately reported
methods of random sequence generation, two had a high risk of
bias with the remaining ten studies being unclear. Overall, the
body of evidence identified permits a moderately robust conclu-
sion regarding the objectives of this review, with 17 included stud-
ies (28,531 participants).
Evidence presented in the summary of findings table was down-
graded to take into account:
• limitations in design: methods of randomization, allocation
concealment and/or blinding were not described or inadequate
for the majority of studies assessing the particular outcome (-1)
• Inconsistencies: significant heterogeneity (-1)
• Imprecision: only few participants in few studies available
to assess the outcome (-1)
Potential biases in the review process
A potential bias in the review process is exclusion of studies exam-
ining interventions that train health professionals in smoking ces-
sation that are of questionable methodological design. This review
does sacrifice inclusion of some relevant information, however the
trade off is a meta-analysis of higher quality evidence on which
future investigations can be based. Some of the pertinent informa-
tion from these studies is discussed below under Agreements and
disagreements with other studies or reviews though results should
be interpreted with caution. Another limitation to the review is
the under-reporting of the intervention for included studies. This
means that some studies may have indeed included additional in-
tervention components that, had we known they existed, would
have led us to classify the study differently within the sub-groups.
One key strength of the review process to address potential biases
is the use of two experienced and independent review authors who
assessed the studies for risk of bias, although this can do little to
account for biases which occur in the methodological designs of
the included studies.
Agreements and disagreements with other
studies or reviews
A compilation of systematic reviews and surveys of key informants
were published as a special edition in the journal ’Drug and Al-
cohol Review’ in 2009, relating to the education and training of
health professionals and students in tobacco, alcohol and other
drugs (Richmond 2009a). The first published survey of 21 key in-
formants from eight countries found a high level of consistency in
19Training health professionals in smoking cessation (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
the content of the smoking cessation interventions, with 72% of
programs using the 5A (Ask, Assess, Advise, Assist, Arange)model,
64% using the stages of change (trans-theoretical) model, 84%
including pharmacotherapies, with 84% having some reference to
clinical practice guidelines (Zwar 2009). Only five of the seven-
teen included studies in our review had reference to any particular
behavioural change technique, however it is quite likely that the
majority of studies are based around some kind of theoretical be-
havioural change context, which is not reported in the publication.
These results are similar to the those reported inRichmond 2009b.
The authors identified a lack of interest (with other continuing ed-
ucation topics considered to be a higher priority) and lack of fund-
ing for interventions to be the major barriers for the uptake and
sustainability of training programs (Zwar 2009). Some possible
solutions were provided to address these barriers including raising
awareness of the importance of smoking cessation for the health of
patients and incorporating education on smoking cessation into
vocational courses for specialties. Another systematic review of
postgraduate smoking cessation training for physicians in 28 Eu-
ropean countries found nine studies which met all of the inclusion
criteria containing a total of 170 postgraduate training programs
(Kralikova 2009). The key implications reported by the authors
were that postgraduate training in smoking cessation may not be
reaching physicians and was not rigorously evaluated. To combat
this problem multiple authors suggest that future research needs
to incorporate methods of disseminating effective educational ac-
tivities with the intention of increasing participation (Kralikova
2009; Muramoto 2009). It is also imperative that health profes-
sional organisations advocate for the systematic implementation
of comprehensive tobacco cessation training programs to increase
the number of patients receiving tobacco cessation interventions
(Botelho 2009). Another study using direct observation of physi-
cian-patient encounters found similar results and concluded that
strategies are needed to assist physicians to incorporate systematic
approaches that will standardise smoking cessation care (Ellerbeck
2001). In this investigation, discussions around tobaccoweremore
common in practices that utilised standard forms for recording
smoking status and during new patient visits. Interestingly, the
authors also found that discussions around tobacco use occurred
less often among physicians in practice for more than 10 years
and with older patients (Ellerbeck 2001), which is similar to an
observational study by Bertakis 2007 investigating the factors as-
sociated with physician discussion of tobacco use with patients.
Considerable resistance was also observed in a cohort of physi-
cians receiving academic detailing to promote tobacco-use cessa-
tion counselling in dental offices. Dental staff members (includ-
ing receptionists, office managers, dental assistants and dental hy-
gienists) were reluctant to participate in the interventions due to
increased paperwork, having to deal with uncooperative patients,
and the perception that only a few patients use tobacco anyway
and that counselling does not work (Albert 2004). However, the
resistance observed did decrease as follow-up visits progressed and
staff became more comfortable with the intervention and the pro-
cedures involved. This evidence suggests that through the provi-
sion of first-hand experience prior to guiding patients through the
same process, physiciansmay feel more comfortable in implement-
ing smoking cessation interventions into standard practice, which
has the potential to be highly cost-effective. One of the included
studies by Cornuz 2002 reported that training residents in smok-
ing cessation counselling is very cost-effective and may be more
efficient than the majority of currently accepted tobacco control
interventions. This has also been supported by more recent sys-
tematic reviews and investigations (Maciosek 2006; Solberg 2006;
Stead 2008). As such, the provision of counselling, advice and/or
offers of assistance to the patient has the potential to significantly
increase the number of quit attempts, which subsequently has the
potential to reduce health related costs as well as morbidity and
mortality associated with ongoing chronic tobacco use.
The previous version of this Cochrane review (New Reference)
included eight studies with six finding no effect of intervention.
The authors also stated that effects of training on process out-
comes increased if prompts and reminders were used, however they
concluded that there was no strong evidence that training health
professionals to provide smoking cessation interventions changed
smoking behaviour. With the addition of nine studies (more than
half the initial number of inclusions), the findings of this review
have now changed to support the training health professionals in
smoking cessation interventions.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Overall, a moderately large amount of methodologically rigorous
evidence has been presented to support the effectiveness of train-
ing health professionals in smoking cessation. The following pro-
gram characteristics could be considered for individuals involved
in future clinical practice initiatives:
• Combination of multiple intervention components
including the provision of counselling, offer of follow-up
appointments, setting or being prescribed a quit date and
provision of self-help material
• A one-off group training session for health professionals of
between one to two hours duration, providing there is adequate
follow-up and monitoring of progress. This will need to include
provision of follow-up feedback to health professionals and
resources such as patient self-help materials, with consideration
given to other intervention components as mentioned above.
• Consider organisational factors to ensure that smoking
cessation messages are reliably delivered. Training can be
expensive, and simply providing programs for health care
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professionals, without addressing the constraints imposed by the
conditions in which they practise, is unlikely to be a wise use of
health care resources.
Implications for research
Multi-component investigations incorporating new pharmacolog-
ical interventions for smoking cessation (such as varenicline tar-
trate and bupropion) or other cessation aids (such as electronic
cigarettes) alongside physician training should be considered to
determine if any additional benefit in long-term abstinence can be
obtained. Future research needs to ensure that adequate method-
ological rigour is met with considerations relating to:
• Sequence generation and allocation concealment
• Demographics and comparability of the control comparison
• Reporting of smoking related outcome data
• Collection of data both pre and post intervention
implementation.
So as to enable interventions to be replicated in clinical practice,
it is also important that authors of future trial reports describe the
content of the training in sufficient detail, for example detailing
the educational methods, strategies and theories used to train the
professionals.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cohen (Dent) 1989
Methods Country: USA, Indianapolis area
Design: Randomized controlled trial; Nested; Clustered
Objective: To improve the effectiveness of dentists helping their patients quit smoking
Methods of analysis: A generalized linear model was used to analyse the results of the
quit-smoking rates and a scale-factor was used to reflect the expected extra variance in
quit rates caused by between-dentist variability; Chi² statistic based on changes in the
deviance function for a series of nested models was used to test for main effect and
interactions; Two-way analyses of variance were calculated on the weighted data for the
amount of time spent in counselling patients about their smoking
Clustering adjustmentmade:Yes -Generalised linearmodel allowed a scale-factor to reflect
the extra variance expected to be inflated due to variability between dentists
Significance of cluster adjustment: Not reported
Participants Therapist description:Dentists
Eligible for study: n= 54
Randomized: n= 50
Completed:Gum n= 9, reminder n= 10, gum & reminder n= 12, control n= 13 (total n=
44)
Age: Not reported
Gender:Not reported
Patient description: n= 1027 patients from American private dental practices
Eligible for study: n= 1027
Randomized: n= 1027
Completed: n= 647
Age:Mean = 37.1 (SD + 10.4) (total population only)
Gender:Males= 43.2% males (total population only)
Interventions Setting: American private dental practices
Training of those delivering the intervention to the health professional:Not reported
Intervention description: Three intervention groups: Training & nicotine gum, training
& reminder (chart prompt), combined training with prompt & nicotine gum
Control description:Training alone (advice, quit date, follow-up check);Dentists provided
a booklet containing the four-step care protocol and were encouraged to counsel their
patients who were smokers
Duration of intervention:One hour
Intervention delivered by: General dentist
Intensity: One lecture
Outcomes Pre-specified outcome data: Point prevalence of cessation at 12 months; Number advised
to quit; Number asked about setting a quit date
Follow-up period: Twelve months total: 6 months (defined as the smoking status deter-
mined at any visit that occurred at least 3 months after the initial appointment but not
more than 9 months); 12 months (defined as the smoking status determined at any visit
that occurred at least 9 months and 1 day and up to 15 months after the initial visit)
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Cohen (Dent) 1989 (Continued)
Notes Process measures: Outcomes reported in Cohen 1987; Patients not having a visit during
the 6 or 12 month periods were assumed to be smokers
Validation: Expired carbon monoxide
The three intervention groups were combined for meta-analyses to produce the
single ’Intervention’ sample
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomization mentioned though meth-
ods not described: “...dentists and their en-
tire panel of patients who smoked cigarettes
were randomly assigned to one of four con-
ditions.”
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the interventionblind-
ing of participants was not possible for this
study
Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk Nomention of attempted blinding for out-
come assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Patients not having a visit during the 6
or 12 month periods were assumed to be
smokers; No further information provided
regarding missing or incomplete outcome
data
Selective reporting (reporting bias) Low risk All expected outcomes, including those
that were pre-specified were reported
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Low risk Analysis of covariance occurred
Comparability of intervention and control
group characteristics at baseline
Unclear risk Insufficient information reported to permit
judgement of yes or no; “… participating
dentists varied widely in age, types of prac-
tices, previous use of tobacco effects …”
Protection against contamination Unclear risk Insufficient information to permit judge-
ment of yes or no
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Selective recruitment of participants Unclear risk n-values across different intervention
groups not reported
Cohen (Doc) 1989
Methods Country: USA
Design: Randomized controlled trial; Nested; Clustered
Objective: Evaluation of a RCT of interventions designed to improve effectiveness of
physicians and dentists in helping their patients quit smoking
Methods of analysis: Analysis of variance performed on percentages; Stepwise multiple
regression analyses performed using the weighted number of minutes as the criterion
to determine the extent to which the amount of counselling time was a function of the
health professionals’ initial attitudes and habits; Chi² analysis used to test main effects
and interactions; Generalised linear interactive modelling (GLIM) software used
Clustering adjustmentmade:Yes -Generalised linearmodel allowed a scale-factor to reflect
the extra variance expected to be inflated due to variability between physicians
Significance of cluster adjustment: Not reported
Participants Therapist description: n= 112 primary care physicians (including n= 97 physicians in
training)
Eligible for study: Not reported
Randomized: Total= 97 internal medicine residents and 15 faculty general internists
Completed: Total= 97 internal medicine residents and 15 faculty general internists
Age: Not reported
Gender:Not reported
Patient description: n= 1420 patients receiving primary care, not selected by motivation
to quit
Eligible for study: Participation refusal rate was 9.7% of all eligible patients contacted
Randomized: n= 1420
Completed: n= 1091 medical patients
Age: 18 to 64 years; Mean = 46.2 + 11.6 years
Gender:Male= 37%
Interventions Setting: General medicine (primary care) clinic of a city-county teaching hospital in the
USA
Training of those delivering the intervention to the health professional: Registered internist
Intervention description: Three intervention groups: Training & nicotine gum, training
& reminder (chart prompt), combined training with prompt & nicotine gum
Control description: Training alone (advice, quit date, follow-up check); Physicians pro-
vided a booklet containing the four-step care protocol and were encouraged to counsel
their patients who were smokers
Duration of intervention:One-hour lecture or personalised instruction
Intervention delivered by: David M Smith, registered internist
Intensity: One, one hour lecture maximum
Outcomes Pre-specified outcome data: Point prevalence of abstinence at 12 months; Patients who did
not have an appointment in the period regarded as smokers; Rates also reported giving
returnees as denominator; Number advised to quit; Number asked about setting a quit
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date; Had their doctor talked to them about smoking
Follow-up period: Six and 12 months (12 months defined as patients visited 9 and 15
months after the initial visit)
Notes Process measures: Outcomes reported in Cohen 1987; Patients not having a visit during
the 6 or 12 month periods were assumed to be smokers
Validation: Expired carbon monoxide
The three intervention groups were combined for meta-analyses to produce the
single ’Intervention’ sample
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomization mentioned however meth-
ods not described
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the interventionblind-
ing of participants was not possible for this
study
Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk Nomention of attempted blinding for out-
come assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Patients not visiting the physicians during
the 6 and 12 month visits were assumed
smokers; No further information provided
regarding missing or incomplete outcome
data
Selective reporting (reporting bias) Low risk All expected outcomes, including those
that were pre-specified were reported
Other bias Low risk No other potential risks of bias identified
Imbalance of outcome measures at baseline Low risk Analysis of covariance occurred
Comparability of intervention and control
group characteristics at baseline
Unclear risk Insufficient information reported to permit
judgement of yes or no
Protection against contamination Unclear risk Insufficient information reported to permit
judgement of yes or no
Selective recruitment of participants Unclear risk Insufficient information reported to permit
judgement of yes or no
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Cornuz 2002
Methods Country: Geneva and Lausanne, Switzerland, Europe
Design: Randomized controlled trial; Clustered
Objective: To assess the efficacy of an educational program based on behavioural theory,
active learning methods, and practice with standardized patients in helping patients
abstain from smoking and changing physicians’ counselling practices
Methods of analysis: To compare baseline characteristics of patients and physicians’ prac-
tices between groups, the authors used the Chi² or Fisher exact tests for categorical data
and the t-test or Wilcoxon rank-sum test for continuous data; To test the effectiveness
of the training on the outcomes, the authors performed a logistic regression with gener-
alized estimating equation to stratify by clinic and adjust for clustering on residents; In-
tention-to-treat analysis was performed for abstinence from smoking, in which smokers
lost at follow-up were considered to be continuing smokers; Because smoking abstinence
was validated in a sub sample of the study participants, the authors used simulation to
perform sensitivity analysis of the likelihood of smoking cessation
Clustering adjustment made: Yes - to test the effectiveness of the training on the outcomes,
the authors performed a logistic regressionwith generalized estimating equation to stratify
by clinic and adjust for clustering on residents
Significance of cluster adjustment: Not reported
Participants Therapist description: Resident physicians; All residents were at the end of postgraduate
training in general internal medicine or family medicine
Eligible for study: n= 35
Randomized: Intervention n= 17; Control n= 18
Completed: Intervention n= 17; Control n= 18
Age:Median 31 years
Gender: 18 females and 17 males
Patient description: Patients aged 16 to 75 years who consulted one of the outpatient
clinics for a follow-up or an emergency visit
Eligible for study: n= 1456
Randomized: Intervention n= 115; Control n= 136
Completed: Intervention n= 77; Control n= 100
Age: Range 16 to 75 years; Mean + SD: Intervention 35.1 + 14 years; Control 36.9 + 15
years
Gender: Intervention = 63% male; Control= 57% male
Interventions Setting:Two general internal medicine clinics of the university hospitals of Lausanne and
Geneva, Switzerland; Both sites are public service clinics that provide adult ambulatory
care to approximately 25,000 outpatient visits per year
Training of those delivering the intervention to the health professional: Teachers are two
authors, who are experienced physicians active in both clinical practice and teaching;
Bothwere previously trained in smoking cessation counselling through aMaster of Public
Health course and are considered national experts in smoking cessation
Intervention description:The trainingprogram is based on5principles: 1) recent evidence-
based content on tobacco use and cessation, 2) behavioural theory (stage-of-change
model), 3) pharmacological therapy, 4) educational methods focusing on active skills
training, and 5) tobacco control context; Session 1: Video-clips observations, interactive
workshops and role plays; Session 2: practice with standardized patients; At the end of the
first session, participants received a set of documents (reference manual, two algorithms
of counselling strategies and pharmacological therapy, record sheet for consultations with
smokers, brochures for patients and patient instructions for NRT)
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Control description: Training in management of dyslipidaemia with equal contact time
to the intervention; This course taught residents about the Swiss guidelines on screening
for and diagnosis/management of high blood levels of cholesterol; Residents that were
trained in smoking cessation attended the lesson on dyslipidaemia 4 months later, and
vice versa
Duration of intervention: Two, 4 hour sessions scheduled 2 weeks apart
Intervention delivered by: Not specified though face-to-face workshops took place
Intensity: Two, half-day sessions; Total contact time 8 hours
Outcomes Pre-specified outcome data: Self-reported abstinence from smoking, 1 week point preva-
lence of abstinence, score of overall quality of counselling based on use of 14 counselling
strategies, patient willingness to quit, daily cigarette consumption, socio-demographic
data, cardiovascular risk factors, smoking history, nicotine dependence, smoking inter-
vention
Follow-up period: Twelve months
Notes Process measures: None reported
Validation: Exhaled carbon monoxide testing at one clinic
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk An independent research assistant per-
formed computer randomization stratified
by clinic
Allocation concealment (selection bias) Unclear risk An independent research assistant con-
cealed the result of randomization until 2
weeks before the intervention, when res-
idents were provided with details about
training sessions - howevermethods not de-
scribed
Blinding (performance bias and detection
bias)
of participants
Low risk “Residents were blinded to the aim of the
trial and were informed only that a survey
on cardiovascular risk factors and preven-
tionwould be conducted”; “We announced
only that a training program in clinical pre-
vention that included sessions on smok-
ing cessation and management of dyslip-
idaemia was being conducted”; “Patients
were also blinded to the aim of the study
and group allocation of their physician”
Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk A research assistant was blinded to group
allocation for measurement of exhaled car-
bon monoxide; Authors also mention that
allocation of residents and patient assign-
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ment was blinded to research staff that col-
lected data; No mention of attempts to
blind outcome assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Intention-to-treat analysis used;No further
information provided regarding missing or
incomplete outcome data
Selective reporting (reporting bias) Low risk All expected outcomes, including those
that were pre-specified were reported
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Low risk Baseline outcome data are reported and
similar
Comparability of intervention and control
group characteristics at baseline
Low risk The authors mention no differences at
baseline between intervention and control
residents or patients
Protection against contamination Low risk “Residents who first trained in smoking
cessation attended the session on dyslipi-
daemia 4 months later, and vice versa. The
second session took place after the 3month
patient recruitment period had ended” -
Contamination unlikely
Selective recruitment of participants Low risk “...to identify smokers and avoid revealing
group assignments, we interviewed all pa-
tients, regardless their smoking status”
Cummings (Priv) 1989
Methods Country: USA
Design: Randomized controlled trial; Nested; Clustered
Objective: To test if physicians who are trained to use the ’Quit for Life’ (QFL) program
are more effective in helping patients to quit smoking
Methods of analysis: Chi² test for proportions and t-tests for means; Multiple logistic
regression (for proportions) and ordinary least-squares (for means) and calculated adjust-
ment rates from the partial slopes associated with a dummy variable; Individual patients
were the unit of analysis
Clustering adjustment made:No adjustment to presented data but separate analyses tested
clustering effects
Significance of cluster adjustment:Clustering effects were tested in separate analyses; These
adjustments had no discernible effect on significance levels and did not alter the conclu-
sion
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Participants Therapist description: Primary care physicians in private practice
Eligible for study: n= 844
Randomized: Intervention n= 31; Control n= 28
Completed: Intervention n= 20; Control n= 18
Age: Not reported
Gender: Intervention females n= 4; Control females n= 2
Patient description: n= 916 smoking patients not selected by motivation to quit
Eligible for study: Not reported
Randomized: Intervention n= 470; Control n= 446
Completed: Intervention n= 360; Control n= 364
Age: Intervention mean = 43 years; Control mean = 45 years
Gender: Intervention mean = 53%; Control mean = 61%
Interventions Setting: Private primary care internal medicine and family practice (primary care) in San
Francisco, USA; Local hospitals at times that fit with the schedules of the participating
physicians; Four who were unable to attend the second sessions received the training
privately in their office
Training of those delivering the intervention to the health professional:Not described
Intervention description: Training (personalised advice, quit date, one follow-up visit, self
help materials and nicotine gum)
Control description: Normal care (no training)
Duration of intervention: Three, one hour seminars
Intervention delivered by: Internist or psychologist
Intensity: Three, one hour seminars, second seminar one or two weeks after the first,
third seminar four to twelve weeks later
Outcomes Pre-specified outcome data: Demographic characteristics; Smoking history; How much
do you want to quit smoking; How confident are you that you will not be smoking one
year from now; Pressure to quit from family and friends; Was smoking discussed; Did
you receive a self-help booklet; Did you receive a follow-up appointment about smoking
Follow-up period: Twelve months
Notes Process measures: None reported
Validation: Expired carbon monoxide and serum cotinine
Manual adjustment for potential clustering effects performed in the meta-analyses
for primary outcome data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Authors state patients were randomly as-
signed however methods not described
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the interventionblind-
ing of participants was not possible for this
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study
Blinding (performance bias and detection
bias)
of outcome assessors
Low risk Authors state outcome assessors were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Participants assumed smokers if lost to fol-
low-up or abstinence unable to be bio-
chemically verified; Missing outcome data
accounted for in analyses
Selective reporting (reporting bias) Low risk All expected outcomes, including those
that were pre-specified were reported
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Low risk Imbalances adjusted for using logistic re-
gression
Comparability of intervention and control
group characteristics at baseline
Low risk Imbalances adjusted for using logistic re-
gression
Protection against contamination Low risk Members of the same group practice were
assigned to the same condition tominimise
cross-over
Selective recruitment of participants Unclear risk More control participants were recruited
by practice staff than intervention subjects;
Methods of recruitment not clearly de-
scribed
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Methods Country: San Francisco, California, USA
Design: Randomized controlled trial; Clustered
Objective:To test whether physicians who receive a continuing education program about
how to counsel smokers to quit would counsel smokers more effectively and have higher
rates of long-term smoking cessation among their patients that smoke
Methods of analysis: Chi² for proportions and t-tests for means were used for significance
measures; Binomial test for difference between paired proportions used to calculate con-
fidence intervals for changes in attitudes and self-reported counselling practices of physi-
cians in the experimental group before and after training; To analyse differences between
the groups in patient reports about physicians counselling and rates of abstinence, large-
sample difference-of-proportions and difference-of-means tests were used; To determine
significance of intervention among those patients who had the greatest desire to quit, an
interaction was tested between assignment to the experimental or control group and the
smoker’s rating of his or her desire to quit; Multiple logistic regression analysis used to
determine significance for specific counselling strategies by experimental group physi-
cians for abstinence levels
Clustering adjustment made:No - The individual patient was the unit of analysis for these
results; However, patients were clustered by physician and physicians were clustered by
work station; “...Therefore for simplicity, we present the results with the patient as the
unit of analysis”
Significance of cluster adjustment: Not reported
Participants Therapist description: Physicians
Eligible for study: n= 189 internists
Randomized: n= 81; Control n= 41; Intervention n= 40
Completed: n= 81; Control n= 41; Intervention n= 40
Age: Not reported
Gender: Control: 27% female; Intervention 30% female
Patient description:
Eligible for study: n= 2056; Control n= 1032; Intervention n= 1024
Randomized: n= 2056; Control n= 1032; Intervention n= 1024
Completed: n= 2012; Control n= 1008; Intervention n= 1004
Age: Control 45 years; Intervention 46 years
Gender: Control 53% female; Intervention 58% female
Interventions Setting: Four Health Maintenance Organisation (HMO) medical centres in northern
California
Training: Three, one hour group tutorials
Training of those delivering the intervention to the health professional: Not stated but de-
livered by internist or psychologist
Intervention description: Training (personalised advice, quit date, one follow-up visit, self
help materials and nicotine gum)
Control description: Normal care (no training)
Duration of intervention: Three sessions over a five to fourteen week period
Intervention delivered by: Internist or psychologist
Intensity: Three, one hour sessions
Outcomes Pre-specified outcome data: long-term abstinence from smoking (≥ 9 months); Number
of smokers counselled; Asked to set a quit date; Asked to make a follow-up appoint-
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ment; Number receiving self help materials; Number receiving nicotine gum; Number
of smokers prescribed a quit date
Follow-up period: Point prevalence abstinence at 12 months
Notes Process measures: None reported
Validation: Expired carbon monoxide and serum cotinine
Manual adjustment for potential clustering effects performed in the meta-analyses
for primary outcome data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random allocation of physicians (by com-
puter) to intervention or control groups
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the interventionblind-
ing of participants was not possible for this
study
Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk Authors report a blinded assessment of
principal outcomes; Methods for blinding
participants or outcome assessors were not
mentioned
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data obtained for 78% of surviving pa-
tients of experimental physicians and 76%
of surviving controls
Selective reporting (reporting bias) Low risk All expected outcomes, including those
that were pre-specified were reported
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Low risk Participants assumed smokers if lost-to-fol-
low-up or abstinence unable to be bio-
chemically verified; Missing outcome data
accounted for in analyses
Comparability of intervention and control
group characteristics at baseline
Unclear risk Except for sex, the characteristics of smok-
ers in the experimental and control groups
were similar
Protection against contamination Low risk “...To minimize exchange of informa-
tion, materials, and cross-over of patients
between two groups of physicians, we
grouped physicians into 22 units corre-
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sponding to existing medical stations, each
with distinct space and separate office staff
”
Selective recruitment of participants Low risk n-values are similar across groups; Also, all
smokers who made a visit to any doctor
participating in the study were eligible for
participating in the study
Gordon 2010
Methods Country: USA
Design: Randomized controlled trial; Nested; Clustered
Objective:With consideration to the oral health effects associated with chronic tobacco
use, the dental visit provides a “teachable moment” during which the dental team can
relate oral health and systemic problems to tobacco use and provide evidence-based brief
interventions to patients who use tobacco in lower socio-economic areas
Methods of analysis: Analysis of variance with clinics as a random, nested factor within
condition and patients nested within clinic for both outcomes, for all participants, and
within each racial/ethnic group; Logistic regression used for baseline measures of tobacco
use with condition included as a covariate
Clustering adjustment made: Yes: intra cluster correlation and analysis of variance with
nesting
Significance of cluster adjustment: Not reported
Participants Therapist description: Federally funded public health dental clinics in lower socio-eco-
nomic areas
Eligible for study: Not reported
Randomized: Intervention n= 7 practices; Control n= 7 practices
Completed: Intervention n= 7 practices; Control n= 7 practices
Age: Not reported
Gender:Not reported
Patient description: Dental patients aged 18 years and older who were seen for a non-
emergency visit to the clinic and were self-identified current tobacco users (within the
past 7 days)
Eligible for study: n= 2751 completed informed consent and baseline survey
Randomized: Intervention n= 1434; Control n= 1203
Completed: Six weeks Intervention n= 1214; Control n= 1026; 7.5 months Intervention
n= 990; Control n= 885
Age: Total sample only: Mean = 40.5 + 12.6 years
Gender: Total sample only: Female= 45.8% n= 1508
Interventions Setting: Baseline survey completed in the clinic and were mailed follow-up surveys at 6
weeks and 7.5 months (lower socio-economic areas)
Training of those delivering the intervention to the health professional:Not reported
Intervention description: ’5A approach’ (Ask, Advise, Assess, Assist and Arrange): Ask -
ask all patients about their tobacco use at every visit; Advise - relating the oral effects
of tobacco use to the patients’ oral health status and advising patients to quit tobacco;
Assess - setting a quit date, discussing pharmacotherapy, providing free self-helpmaterials
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and free nicotine replacement therapy; Arrange - arranging for follow-up by mail or
phone for patients setting a quit date; Each intervention practice was provided with a
supply of nicotine patches and lozenges, as well as printed patient self-help materials
and information on the local tobacco quit line, which providers were asked to give to all
tobacco-using patients
Control description:Usual care - delayed intervention control; Following the study period
control clinics received the in-serviceworkshop and received all the interventionmaterials
Duration of intervention:One workshop
Intervention delivered by: Dentists, dental hygienists and dental assistants
Intensity: One, 3 hour workshop
Outcomes Pre-specified outcome data: Tobacco cessation, reduction in tobacco use, number of quit
attempts, change in readiness to quit, number of cigarettes smoked per day, level of
nicotine dependence
Follow-up period: 7.5 months (6 months post-enrolment plus a 6 week grace period)
Notes Process measures: Intervention subjects only - 66.5% reported receiving the reading mate-
rials and the majority of patients reported reading them (96.7%); 16.9% reported using
nicotine replacement therapy and 10.9% reported receiving quit line counselling
Validation: No biochemical validation
n-values re-calculated for meta-analysis to permit intention-to-treat analysis for
primary outcome data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomization mentioned however meth-
ods not described
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the interventionblind-
ing of participants was not possible for this
study
Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk No mention of attempted blinding of out-
come assessors
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missingdata accounted for viamultiple im-
putation procedures; Attrition in partici-
pants discussed in text
Selective reporting (reporting bias) High risk Secondary participant outcomes were ex-
amined however authors found no signif-
icant differences on any of these variables,
consequently no data was presented in the
publication; Receipt of intervention sec-
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ondary outcome measures were reported as
percentages in text, however no informa-
tion was presented for the control popula-
tion
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Low risk Imbalances at baseline were identified,
however they were controlled using analy-
sis of variance
Comparability of intervention and control
group characteristics at baseline
Low risk Logistic regression used to examine the ef-
fect of baseline measures on tobacco use
with condition as a covariate in the model
Protection against contamination High risk Authors mention a tax increase on
cigarettes in New York (2008), such that
the tax on a pack of cigarettes was $5.
00; The smoking prevalence in New York
City dropped from 18.4% (2006) to 15.
8% (2008); Authors state this likely con-
tributed to the unusually high rate of quit-
ting among usual care patients observed in
this study, thereby affecting the relative im-
pact of the intervention
Selective recruitment of participants Unclear risk Insufficient information to permit judg-
ment of yes or no
Hymowitz 2007
Methods Country: USA
Design: Randomized controlled trial; Nested; Clustered
Objective: The primary aim of the study was to compare the effects of the two training
conditions on resident tobacco intervention as measured by annual resident tobacco
survey and OSCEs, baseline, and end-of-study patient and parent/guardian tobacco
surveys, and a survey of program graduates who enter paediatric practice
Methods of analysis: Due to training site being the unit of randomization, analyses were
based on aggregated data rather than on individuals; Likert scales were calculated as
means; Two-stage mixed model relationship was used for waves of residents at baseline
and 2 year follow-up
Clustering adjustment made:No - However data were analysed based on aggregated data
to account for unit of analysis issues; Authors state that this will provide “…an unbiased
estimate of the intervention effect and standard error” (also know as a ‘mean analysis’)
Significance of cluster adjustment: Not reported
Participants Therapist description: Paediatric residents undergoing training in the New York/New
Jersey metropolitan area
Eligible for study: n= 16 residency training programs; n= 2069 Residents
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Randomized:n=16 residency trainingprograms; 3rd year residents n= 140 in intervention
arm; n= 135 in control arm
Completed: n= 14 residency training programs; 3rd year residents n= 136 in intervention
arm; n= 99 in control arm
Age: Approximately 33 years of age for overall population; Intervention mean = 32.3 +
5.1 years; Control mean = 33.7 + 5.7 years
Gender: Intervention female= 69.1%; Control female= 59.3%
Patient description: Parent/Guardian: Parents of the patients visiting the primary care
clinics
Eligible for study: n= 1770
Randomized: Intervention n= 849; Control n= 776
Completed: Intervention n= 724; Control n= 617
Age: Overall= 29.88 + 8.65 years
Gender: Female= 85.8%
Patient description: Children: Patients (children) visiting the primary care clinics
Eligible for study: n= 550
Randomized: Intervention n= 255; Control n= 300
Completed: Intervention n= 255; Control n= 300
Age: Intervention 14.89 + 1.84 years; Control 15 + 2.16 years
Gender: Intervention female= 55.3%; Control female= 60%
Interventions Setting:New York/New Jersey metropolitan area; Continuity clinic (primary care clinic)
served as the venue for resident tobacco-intervention activities
Training of those delivering the intervention to the health professional:Not specified
Intervention description: Special training - ‘Solutions for Smoking’ was the main teaching
tool; Also provided with assistance with clinics (e.g., take-home educational and be-
havioural-change materials available in the waiting areas, anti-tobacco posters, marking
charts of smokers etc); Packets of educational and behavioural materials designed for
mothers of newborns, adolescent smokers, parents who smoke etc.; Seminar series pro-
vided opportunities to distribute program materials, highlight key concepts and aspects
of the background material, and utilise role-playing to help residents acquire interview-
ing, counselling and tobacco-intervention skills; PowerPoint presentations were used
during these seminars on environmental tobacco smoke, smoking cessation and preven-
tion of smoking onset and solutions for smoking audio/visual vignettes to demonstrate
and model state-of-the-art counselling and intervention skills
Control description: Standard training - Background reading material that included
the clinical practice guideline ’Treating Tobacco Use and Dependence’ and ’American
Academy of Pediatrics Statement on Tobacco’; A manual entitled ’Clinical Interventions
to Prevent Tobacco Use by Children and Adolescents’; A journal article on approaches to
tobacco prevention and control in clinic and office settings; Standard training sites did
not receive assistance with clinic mobilisation or have access to companion intervention
material; They did receive pamphlets and related material to facilitate intervention on
tobacco; Seminar also conducted the same as the intervention group with the exception
of vignettes to demonstrate counselling and intervention skills
Duration of intervention:One hour seminars, four times per year
Intervention delivered by: Unclear, though the manuscript mentions ‘training directors’;
Seminars delivered by senior investigators from the New Jersey Medical School
Intensity: One hour seminars, four times per year
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Outcomes Pre-specified outcome data: Primary outcome measures included changes in resident to-
bacco intervention activities and skills in the area of environmental tobacco smoke, to-
bacco-use prevention and tobacco-use cessation; Demographic information, knowledge
and attitudes about tobacco prevention and control, tobacco-intervention activities dur-
ing the past year, use of specific tobacco-intervention skills and strategies, and beliefs
about the efficacy of tobacco intervention in patients and parents
Follow-up period: Four years in total; Outcome data for participants only published for
2 year follow-up
Notes Process measures: Sixty percent of residents in the special training condition reported
review of ‘Solutions for Smoking’, although a higher proportion attended the seminar
series (80%) and had access to companion intervention material in the clinic
Validation: No biochemical validation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomization was performed according
to coin toss
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the interventionblind-
ing of participants was not possible for this
study
Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk No mention of attempts to blind outcome
assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk One sitewithdrew from the study following
the events of 9/11/2001 and another with-
drew later; No further information pro-
vided regarding missing or incomplete out-
come data
Selective reporting (reporting bias) High risk All pre specified outcomes were addressed
in the 4 year outcome findings; However,
the authors mention that outcome data for
year 1 were omitted in order to provide a
‘cleaner look’ at the progress of the study
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Low risk All within-condition analyses controlled
for residents’ gender, smoking status and
ethnic status
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Comparability of intervention and control
group characteristics at baseline
Low risk The two conditions differed with respect
to racial composition, however analyses
adjusted to account for residents’ gender,
smoking status and ethnic status
Protection against contamination Unclear risk The control and intervention residents all
arrived at the medical school and attended
the one hour seminar together at the same
time
Selective recruitment of participants Low risk n-values reported and similar across groups
Joseph 2004
Methods Country: USA
Design: Randomized controlled trial; Clustered
Objective: To test the effect of modest intensity, practical systems changes that might
increase the delivery of smoking cessation treatment within VAMCs (Veterans’ Medical
Centres); Authors hypothesized that an intervention addressing common barriers to
delivery of smoking cessation treatment at the organisation level (as opposed to provider
or patient level) might be an effective strategy to improve compliance with guideline
recommendations; The trial was designed to test the effectiveness of this intervention
Methods of analysis:McNemar odds on change to assess differences in the change between
intervention groups; Pearson Chi² statistic to compute the significant of the resulting
odds ratio between the intervention and control group; Differences in smoking cessation
rates were determined via the Pearson Goodness-of-Fit Chi² statistic; Change scores
were used for continuous variables and the relative difference in change was measured
using the Wilcoxon rank sum test; Logistic regression was used for binary outcomes;
SAS glimmix macro was used to incorporate the design effect and allow for the binary
outcome
Clustering adjustment made: Yes - SAS glimmix macros used to incorporate the design
effects
Significance of cluster adjustment: Not reported
Participants Therapist description: Physicians, nurses, psychologists and pharmacists were present at
the training meeting
Eligible for study: n= 164 VAMCs (Veteran Medical Centres) nationwide
Randomized: Intervention n= 10; Control n= 10
Completed: Intervention n= 10; Control n= 10
Age: Not reported
Gender:Not reported
Patient description: A random selection of patients who had seen their primary care
provider (at VAMCs) within 6 weeks were phoned for baseline surveys; Current smokers
were identified and underwent 1 year follow-up also via phone
Eligible for study: Cohort n= 5793; Eligible n= 5367
Randomized: Intervention n= 2112; Control n= 2142
Completed: Intervention n= 641; Control n= 783
Age: Baseline - Intervention 64.6 years; Control 63.1 years; Follow-up - Intervention 64.
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9 years; Control 63.8 years
Gender:Baseline (male) - Intervention 96.1%; Control 95.3%; Follow-up - Intervention
95.8%; Control 98.0%
Interventions Setting: Veterans Affairs Medical Centers (VAMCs)
Training of those delivering the intervention to the health professional: Registered nurse
who was trained in smoking cessation methods and had considerable administrative
experience within Veteran Affairs
Intervention description: Intervention sites received 5 copies of the AHCPR Smoking
Cessation Guideline for distribution; Plus a multi-component intervention designed to
increase implementation of 3 specific Guideline recommendations: 1) documentation
of tobacco use status in the medical record 2) delivery of intervention to all smokers and
3) liberal use of smoking cessation medications; The organisational support included a
training meeting, site visits and a study interventionist at the coordinating site in Min-
neapolis; Removal of formulary restrictions were encouraged for smoking cessation aids
as were the requirements for attendance at a cessation class to access pharmacotherapies;
Bupropion SR was suggested as an addition to formulary; However approaches were
individualised for each site
Control description:Control sites also received 5 copies of the AHCPRSmokingCessation
Guideline for distribution
Duration of intervention: Authors state intervention lasted through a 6 month period,
however level of exposure for participants not specified
Intervention delivered by:Registered nurse face-to-face through 2 to 3 site visits within the
first 6 months to communicate with directors of primary care, pharmacy service chiefs,
smoking cessation coordinators and primary care nurses, as well as the 2 day training
meeting
Intensity: One, 2 day training meeting held in Minneapolis for the site-based principal
investigator; 2 to 3 day visit to each site by the interventionist within the first 6 months
Outcomes Pre-specified outcome data:General health, smoking history/status, nicotine dependence,
services provided at the last primary care visit, mood, alcohol use and demographics,
provision of counselling, referred to a smoking cessation clinic, provided advice or med-
ications and cessation discussed (documented in medical records)
Follow-up period: Twelve months
Notes Process measures: None reported
Validation: No biochemical validation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomization mentioned, however
methods not described
Allocation concealment (selection bias) Unclear risk Methods not described
46Training health professionals in smoking cessation (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Joseph 2004 (Continued)
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the interventionblind-
ing of participants was not possible for this
study
Blinding (performance bias and detection
bias)
of outcome assessors
Low risk Interviewers were blinded to subjects’ site
treatment status
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition appears to be higher in the inter-
vention arm than the control arm based on
n-values; No further information provided
regarding missing or incomplete outcome
data
Selective reporting (reporting bias) Low risk All expected outcomes, including those
that were pre-specified were reported
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Low risk A logistics regression analysis was used to
account for imbalances in outcome mea-
sures at baseline
Comparability of intervention and control
group characteristics at baseline
Low risk No significant differences between subject
characteristics were identified
Protection against contamination Unclear risk Insufficient information to permit judge-
ment of yes or no
Selective recruitment of participants Low risk Baseline n-values appear similar, methods
for recruitment of participants are the same
across groups
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Methods Country: USA
Design: Randomized controlled trial; Clustered
Objective: “...the task of Doctors Helping Smokers was to be the development and testing
of a program to help physicians incorporate currently identified smoking cessation inter-
vention into their practice routine.” Hypothesis: that physicians trained in a workshop
would be more effective in helping their smoking patients quit than would similar vol-
unteer physicians who received only patient education materials or a group of physicians
that received no assistance
Methods of analysis: Data presented as proportions were analysed with the Chi² analysis;
Data reported as means and SDs were analysed with analysis of variance; Life-table
analysis used to examine relapse patterns of the patients who attempted to quit smoking
Clustering adjustment made: Physicians unit of analysis; Multivariate regression used to
adjust for confounding effects of differences among the groups of doctors and their
patients
Significance of cluster adjustment: Not reported
Participants Therapist description: n= 109 family practitioners
Eligible for study; n-value: 1110; n= 109 physicians returned postcards
Randomized; n-value: Workshop group n= 27; No-assistance group n= 17; Materials
group n= 22
Completed; n-value:Workshop group n= 27; No-assistance group n= 17; Materials group
n= 22
Age:Workshop group 37.9 + 9.7; No-assistance group 39.5 + 7.7; Materials group 44.3
+11.7
Gender: Workshop group female=22.2%; No-assistance group female=9.1%; Materials
group female=11.8%
Patient description: n= 1653 primary care smoking patients not selected by motivation
to quit
Eligible for study; n-value: Not reported
Randomized; n-value: 6053 total (89.4% of patients whose names were submitted by the
physicians)
Completed; n-value: 87% of the n= 6053 were available for follow-up; 86.8%, 87.5%
and 86.8% for the workshop, materials and no-assistance groups respectively
Age: 18 to 70 years; Mean= slightly over 40
Gender: 2/3 female
Interventions Setting: Private family practice (primary care) in Minnesota, USA; Workshop site not
described though likely centralised
Training of those delivering the intervention to the health professional:Not described
Intervention description: Two intervention groups: Materials group - physicians given
self-help manuals to distribute; Workshop group - self-help manuals plus 6 hour group
workshop
Control description: Normal care
Duration of intervention: Workshop group: 6-hour workshop given on two occasions.
Workshop started in themorning with two presentations of 30-minutes about the effects
of smoking, chronic disease and organisation for smoking cessation interventions; 1-
hour presentation on doctor-patient intervention skills; 1-hour introduction to smoking
cessation techniques; Two 1-hour small-group workshop sessions on counselling sessions
and planning for smoking cessation interventions and 30-minutes for summary and
discussion; Materials group: 100 copies of Quit-and-Win, a smoking cessation manual
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Intervention delivered by: Not described
Intensity: Workshop: 6-hr workshop given on 2 occasions; Materials group: None; No
assistance: None
Outcomes Pre-specified outcome data: Physicians: Characteristics, knowledge, skills, confidence and
beliefs about smoking cessation in relation to their performance during the trial
Patients: demographics, smoking habits, health status, details about visit with physician,
prevalence of smoking in their social environment and support received from spouse
or others who were emotionally important to them; Four questions about extent to
which they felt in control of their life, the confidence they felt about handling personal
problems, extent that “things were going [their] way,” and the extent to which difficulties
were piling up; Serum cotinine levels
Follow-up period: 12months
Notes Process measures: None
Validation: Serum cotinine
Not able to be meta-analysed due to unit of analysis being the practitioners instead
of the individuals
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Some physicians were re-assigned to groups
due to inappropriate allocation methods
during assignment
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the intervention it is
not possible to blind participants
Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk Nomention of attempted blinding for out-
come assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Participants lost-to-follow-up were as-
sumed smokers; No information on how
missing data fromquestionnaires were han-
dled
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment of yes or no
Other bias Low risk No other potential threats to validity iden-
tified
Imbalance of outcome measures at baseline Low risk Analysis of covariance conducted
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Comparability of intervention and control
group characteristics at baseline
Low risk Characteristics of physicians reported and
comparable; Multivariate regression anal-
ysis conducted to adjust for confounding
factors
Protection against contamination Low risk Physicians within the same practice were all
within the same arm of the study
Selective recruitment of participants Unclear risk Insufficient reporting to permit judgement
of yes or no
Lennox 1998
Methods Country: United Kingdom
Design: Randomized controlled trial; Nested; Clustered
Objective: To assess the impact of the training intervention on both health professionals
and smoking subjects
Methods of analysis: Comparison of binary outcomes were analysed using the Chi² test;
Logistic and multiple regression analyses were carried out where appropriate for these
outcomemeasures; Comparisons of continuous outcomes were analysed using t-tests and
multiple linear regression; Confounders were adjusted including age, sex and deprivation
score for the regression analysis as well as for indicators for the intervention group
Clustering adjustment made: Yes - GLMM (Generalised linear mixed model) approach
used for regression techniques which added the general practice as a random factor nested
within the treatment groups to the other fixed-effect factors
Significance of cluster adjustment: Regression techniques used to explore clustering effects
for variables significant in individual level analyses; No significant difference in point
prevalence of abstinence after adjustment
Participants Therapist description: n= 16 general practices with training for doctors, nurses and health
visitors
Eligible for study: n= 26 practices
Randomized: n= 16 practices
Completed: n= 16 practices
Age: Not reported
Gender:Not reported
Patient description: Smoking patients of the practices identified from questionnaires to
random sample
Eligible for study: Not reported
Randomized: Number of patients surveyed: Intervention n= 6631; Control n= 6631;
Number of patients responding: Intervention n= 5022; Control n= 5217; Number of
smokers identified: Intervention n= 1381; Control n= 1207
Completed: Eight months - Intervention n= 941; Control n= 864; 14 months - Inter-
vention n= 898; Control n= 795
Age: Not reported
Gender:Not reported
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Interventions Setting: Primary care medical practices in Aberdeen, UK
Training of those delivering the intervention to the health professional: Two authors con-
ducted the training, one a senior health promotion officer experienced in group work
with primary health care teams and the other a GP
Intervention description:One day training workshop based on stages of change model
Control description: Usual care control group
Duration of intervention: Six identical one day training workshops were held within a
three week period based on stages of change model
Intervention delivered by:Two authors, one a senior health promotion officer experienced
in group work with primary health care teams and the other a GP
Intensity: One day training workshop
Outcomes Pre-specified outcome data:Changes in attitudes, self-reported behaviour, change in readi-
ness to change, cessation attempt made, point prevalence, continuous abstinence
Follow-up period: 8 and 14 months post workshop for patient questionnaires
Notes Process measures: Some subjects did not attend their practice during the study and there-
fore were not exposed to the effects of the training
Validation: No biochemical validation
n-values re-calculated for meta-analysis to permit intention-to-treat analysis for
primary outcome data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Physicians were randomly allocated to con-
trol or intervention however method not
described; Patients were randomly selected
via a computer-generated randomization
program for every 1 in 6 drawn from the
patient lists
Allocation concealment (selection bias) Unclear risk Physicians were randomly and blindly al-
located to control or intervention however
methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the interventionblind-
ing of participants was not possible for this
study
Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk Nomention of attempted blinding for out-
come assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No further information provided regarding
missing or incomplete outcome data
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Selective reporting (reporting bias) Low risk All expected outcomes, including those
that were pre-specified were reported
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Low risk No significant differences between groups
Comparability of intervention and control
group characteristics at baseline
Low risk No significant differences between groups
however intervention subjects less affluent
than controls which was adjusted for in re-
gression analyses
Protection against contamination Low risk Practices containing staff who attended pi-
lot workshops or staff whom worked for
more than one participating practice were
excluded
Selective recruitment of participants Low risk Patients were randomly selected from prac-
tices using a computer-generated random-
ization program; n-values are similar across
groups
Sinclair 1998
Methods Country: Scotland
Design: Randomized controlled trial
Objective: To evaluate a training workshop for community pharmacy personnel to im-
prove their counselling in smoking cessation based on the stage-of-change model
Methods of analysis: To demonstrate the differences between intervention and control
groups, parametric tests (t-tests for quantitative variables) and non-parametric tests
(Mann-Whitney tests for quantitative variables) were used. Multiple logistic regression
was carried out for the binary outcomes of point prevalence at one month, and continu-
ous abstinence at four and nine months, and to assess the effect of potential confounders
Clustering adjustment made: Yes; authors mention that the effect of cluster randomization
was assessed by firstly calculating the degree of intra-cluster correlation for each of the
binary outcomes of abstinence. Secondly, regression techniques, adding the pharmacy as
a random factor nested within the treatment groups to the other fixed effect factors, were
considered leading to a generalised linear mixed model. The authors mention that intra-
cluster correlations for the outcomes at each time point were calculated. The estimated
values were less than 0.0001 and therefore negligible
Significance of cluster adjustment: No; authors mention that trends in outcome were not
affected by potential confounders or adjustment for clustering
Setting: Residents and physicians in family medicine, Taiwan
Training: Two lessons
Participants Therapist description:
Eligible for study; n-value: n= 76 pharmacies
Randomized; n-value: Intervention n= 32 pharmacies; Control n= 30 pharmacies
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Completed; n-value: Intervention n= 32 pharmacies (specify: n= 94 (54 assistants, 40
pharmacists); Control n= 29 pharmacies
Age: Not described
Gender: Intervention: 54 female assistants; 25 female pharmacists; Control: not described
Patient description:
Eligible for study; n-value: n= 775 smokers
Randomized; n-value: Intervention n= 224; Control n= 268
Completed; n-value: Intervention n= 159; Control n= 188
Age: Intervention 41.7 (17-74); Control 41.5 (17-77)
Gender: Intervention 61.2% men; Control 62.7% men
Interventions Setting: Eight workshops were scheduled with a choice of dates, times and location
(Aberdeen or Elgin - the major population centres which are located 70 miles apart at
apposite ends of the study area)
Training of those delivering the intervention to the health professional:Not described
Intervention description: Training in stages of change approach to smoking cessation
Control description: Usual care
Duration of intervention: Two-hour workshop
Intervention delivered by: Not described
Intensity: One workshop
Outcomes Pre-specified outcome data: Self-reported point prevalence smoking cessation rates at one
month; Self-reported continuous abstinence from zero to four months and from zero to
nine months; The pharmacy support process (registration, counselling and client record)
Follow-up period: 1, 4, 9 months; Point prevalence of abstinence at 12 months
No process outcomes
Notes Validation: none
n-values re-calculated for meta-analysis to permit intention-to-treat analysis for
primary outcome data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Pharmacy recruits were stratified by type
… and ranked according to the pharma-
cists’ level of motivation…They were then
randomized to either the intervention or
control group by sequential allocation”
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Authors state “Pharmacists and pharmacy
assistants were aware of group by virtue of
intervention design”
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Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk Methods for blinding participants for out-
come assessors were not mentioned
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information to permit judge-
ment of yes or no
Selective reporting (reporting bias) Low risk All outcomes were reported
Other bias Low risk No other sources of bias were identified
Imbalance of outcome measures at baseline Low risk The potential confounders of age, sex, so-
cio-economic status, and nicotine depen-
dence showed no difference between inter-
vention and controls
Comparability of intervention and control
group characteristics at baseline
Low risk There was no significant difference be-
tween the characteristics of the interven-
tion and control customers
Protection against contamination Unclear risk To minimise inter-group contamination,
both leaflets requested customers to return
to that same pharmacy for any further ad-
vise and for subsequent purchase(s) of anti-
smoking products
Selective recruitment of participants Unclear risk During the 12-month customer recruit-
ment period, all smokerswho sought advice
on stopping smoking or those who bought
an OTC anti-smoking product in prepa-
ration for a new attempt to stop smoking
were eligible for inclusion
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Methods Country: USA
Design: Randomized Controlled Trial; Factorial design; Nested; Cluster
Objective: The study evaluated the effectiveness of training and prompting under real-
istic conditions, including: the use of simple and generalisable interventions; training
conducted by existing faculty; and evaluation at several sites with residents from three
primary care specialties
Methods of analysis: Contingency tables with Chi² tests, t-tests, and analysis of variance
(ANCOVA) were used to investigate the pre-test equivalencies of the four groups and all
outcomes for selected other variables; ANCOVA compared the effects of the two inter-
ventions, alone and in combination, whilst controlling for pre-test scores and physician
speciality
Clustering adjustment made: No
Significance of cluster adjustment:N/A (Physician speciality adjusted for but not individual
physician clustering effects)
Participants Therapist description: 250 residents in internal medicine, family practice and paediatrics
Eligible for study; n= 261
Randomized; n= 250; Tut (Tutilage) and Pro (Prompt) n= 66; Tut only n= 66; Pro only
n= 60; Control n= 58
Completed; n= 234; Tut and Pro n= 62; Tut only n= 63; Pro only n= 55; Control n= 54
Age: Not reported
Gender:Not reported
Patient description: 937 patients from American primary care medical practice
Eligible for study; n= 937; Tut and Pro n= 250; Tut only n= 243; Pro only n= 228; Control
n= 225
Randomized; n= 843
Completed; n= 659; Tut and Pro n= 184; Tut only n= 156; Pro only n= 162; Control n=
157
Age: 17 to 75 years; Mean age = 45 years
Gender: 63% female
Interventions Setting: American primary care residency programs (physicians in training)
Training of those delivering the intervention to the health professional:Not specified though
one of the authors in each instance conducted the tutorial
Intervention description:Three intervention groups: Tutilage only (minimal contact coun-
selling); Prompt only (chart-reminder and advice sheet); Tutilage and Prompt
Control description: Normal care
Duration of intervention: Only held once, two sessions in total - the first included slide
presentations the second group discussions
Intervention delivered by:One of the authors, usually a clinic director or a facultymember
conducted the tutorial
Intensity: Tutorial: two sessions - initial one-hour long, second session two weeks later
Outcomes Pre-specified outcome data: Self-administered questionnaires requesting self-reports on
smoking-cessation counselling frequency, content, attitude and training; Patients were
asked about smoking habits and physicians advice to stop smoking
Follow-up period: 6-months
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Notes Process measures: None
Validation: Expired CO; Biochemical verification was obtained where possible
The three intervention groups were combined for meta-analyses to produce the
single ’Intervention’ sample; n-values re-calculated for meta-analysis to permit in-
tention-to-treat analysis for primary outcome data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Authors state ”After the pre-test, residents
were randomly assigned by clinic half-day
session to one of four groups”
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the intervention it was
not possible to blind participants
Blinding (performance bias and detection
bias)
of outcome assessors
Low risk Authors state “...telephone interviewers,
who were blinded to residents’ and pa-
tients’ group assignments, obtained patient
reports...”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No mention of data containing any miss-
ing variables;Missing outcome data not de-
scribed
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment of yes or no
Other bias Low risk No other sources of bias were identified
Imbalance of outcome measures at baseline Low risk All groupswere reported as similar for base-
line outcomes; Analysis of variance also
conducted
Comparability of intervention and control
group characteristics at baseline
Low risk All groupswere reported as similar for base-
line characteristics; Analyses to test pre-test
equivalence were conducted
Protection against contamination High risk Authors state contamination occurred as all
four groups worked closely with one an-
other at each site though they also state that
“...the effects appeared to be slight.”
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Selective recruitment of participants Unclear risk Insufficient information to permit judge-
ment of yes or no
Swartz 2002
Methods Country: USA
Design: Randomized controlled trial; Clustered
Objective: Primary goal of this study was to determine if in-person feedback intervention,
compared to mailed feedback, would lead to a higher use of tobacco treatments by
patients who smoke
Method of Analysis:Odds ratios, 95% confidence intervals and p-values were calculated to
evaluate intervention effects on patient and provider behaviour; Unadjusted models and
models adjusted for age, insurance at baseline, practice speciality and region of the state
were calculated using logistic regression; All analyses were completed with SAS statistical
software
Clustering adjustments made: Yes - survey logistic procedures
Significance of clustering: Not reported
Participants Therapist description: Primary care providers with practices of at least 75% internal
medicine or family medicine clinicians providers combined with Medicaid and HMO
panel size of at least 200 adults; n= 176 were physicians, n= 26 nurse practitioners, n=
20 physician assistants, n= 3 unknown classification
Eligible for study: n= 150 practices; n= 230 providers within the 50 practices recruited
were eligible
Randomized: n= 50 practices; n= 225 providers
Completed: n= 50 practices; n= 179 providers
Age: Not reported
Gender:Not reported
Patient description : Patients were adults receiving primary care by a study practice aged
18 years and older who were seen within the prior year
Eligible for study: n= 17318 identified as receiving primary care by a study practice; n=
11547 eligible
Randomized: n= 7461 completed baseline survey; n= 1238 patients identified as smokers
at baseline
Completed: n= 807 reporting provider visit in the year proceeding follow-up; n= 516
smokers with baseline and follow-up surveys reporting one serious quit attempt
Age: Intervention mean age= 41.9 years; Control mean age= 42.9 years
Gender: Intervention male= 26.4%; Control male= 23.2%
Interventions Setting:Maine Medicaid and Maine HMO, USA
Training of those delivering the intervention to the health professional:Not reported
Intervention description: Experimental study practices received two educational office
sessions, with data feedback presented during the first visit; Second visit reinforced the
guidelines and discussed office systems to improve tobacco treatment
Control description: Control practices received information and feedback data by mail
Duration of intervention: For the intervention: Two educational office sessions, the second
occurred five months after the first
Intervention delivered by:One nurse practitioner well-versed inmotivational interviewing
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and tobacco guidelines
Intensity: Twenty minute slide presentation followed by feedback and discussions for the
first visit; Second visit discussions time not stated
Outcomes Pre-specified outcome data: Reports of provider asking about tobacco, advice to quit,
spending time talking about smoking or quitting, discussing tobacco treatment medica-
tions, and discussing counselling services or programs; Smokers were asked about seri-
ous attempts at quitting for 24 hours or longer, use of medication or counselling to aid
quitting, and use of any tobacco in the previous week (7 day point prevalence)
Follow-up Period: Fifteen to 18months later which corresponded to 12months following
the practice intervention
Notes Process measures: None reported
Validation: No biochemical validation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomization mentioned however meth-
ods not described
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the interventionblind-
ing of participants was not possible for this
study
Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk No mention of attempted blinding of out-
come assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No further information provided regarding
missing or incomplete outcome data
Selective reporting (reporting bias) Low risk All expected outcomes, including those
that were pre-specified were reported
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Low risk Differences in intervention effect were ad-
justed for baseline outcomes
Comparability of intervention and control
group characteristics at baseline
Low risk Data were adjusted for age, gender and in-
surance to account for patient differences
Protection against contamination Unclear risk Insufficient information to permit judge-
ment of yes or no
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Selective recruitment of participants Unclear risk Methods of recruitment not described
Twardella 2007
Methods Country: Germany
Design: Randomized controlled trial; Nested; Clustered; Factorial design 2x2
Objective: The aim of this study was to examine whether and to what extent structural
changes could enhance promotion of smoking cessation in general practice. In particular,
we aimed to investigate the effect of the following strategies on smoking cessation rates:
(1) specific training of general practitioners in methods of promoting smoking cessation
and a financial incentive to general practitioners for each recruited patient who success-
fully quits and (2) specific training of general practitioners in promotion of smoking
cessation and the cost-free prescription of drugs proved effective in supporting smoking
cessation
Methods of analysis: Primary end-point data were assessed on an intention-to-treat basis;
Smoking abstinence at 12 months was assessed using a mixed logistic regression model
accounting for cluster randomization including a random effect for medical practice in
the model; Baseline imbalances between intervention arms were adjusted using multi-
variate analyses; The effect of drug use during follow-up, as recorded by general practi-
tioners, was evaluated in a bivariate mixed logistic regression model
Clustering adjustment made: Yes - mixed logistic regression model, using PROC
NLMIXED in “SAS V8.1” (including a random effect for medical practice)
Significance of cluster adjustment: Not reported
Participants Therapist description:General practitioners in the Rhine-Neckar region located in south-
west Germany
Eligible for study: n= 174 met the inclusion criteria
Randomized: Total= 94 general practitioners from n= 82 practices; Usual care: n= 21
therapists (20 practices); Training + incentive: n= 24 therapists (21 practices); Training
+ medication: n= 23 therapists (21 practices); Training, incentive + medication: n= 26
therapists (20 practices)
Completed: n= 59 practices; Usual care: n= 14 practices; Training + incentive: n= 16
practices; Training + medication: n= 11 practices; Training, incentive + medication: n=
18 practices
Age: Not reported
Gender:Not Reported
Patient description:Patients visiting the practices andwho smoked at least 10 cigarettes per
day and agedbetween36 to75 years, were recruited by participating general practitioners,
irrespective of intention to quit smoking and conditional on written informed consent
Eligible for study: n= 587
Randomized: n= 587; Usual care: n= 76; Training + incentive: n= 146; Training + med-
ication: n= 144; Training, incentive + medication: n= 221
Completed: n= 488; Usual care: n= 61; Training + incentive: n= 123; Training + medica-
tion: n= 121; Training, incentive + medication: n= 183
Age: Range 36 to 75 years;<45 years: Usual care n= 30; Training + incentive n= 55;
Training + medication n= 59; Training, incentive + medication n= 95; 45 to 54 years:
Usual care n= 24; Training + incentive n= 63; Training + medication n= 44; Training,
incentive + medication n= 86; > 55 years: Usual care n= 22; Training + incentive n= 28;
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Training + medication n= 41; Training, incentive + medication n= 40
Gender: Female: Usual care n= 38; Training + incentive n= 74; Training + medication
n= 71; Training, incentive + medication n= 121
Interventions Setting: Not reported
Training of those delivering the intervention to the health professional:Not reported
Intervention description:Three intervention groups: Training + incentive - Two hour cost-
free group tutorial for general practitioners in methods of promoting smoking cessation
including stages of change model, approaches for counselling in general practice and
potential of pharmacological support; Financial remuneration of EURO130 after study
completion per smoke-free participant; Training + medication - Same group tutorial
as above plus general practitioners could offer cost-free prescription of drugs proved
effective in supporting smoking cessation; Training, incentive + medication - All of the
above
Control description: Usual care
Duration of intervention: A single 2 hour tutorial available at two session times
Intervention delivered by: Not reported
Intensity: Two-hour workshop
Outcomes Pre-specified outcome data: Primary outcome measure - Self-reported point prevalence of
smoking abstinence obtained at 12 months follow-up
Second outcome measure - Continuous smoking abstinence for at least 6 months (183
days) at 12 months follow-up; Frequency of the use of methods to support smoking
cessation among patients during the follow-up period as reported by general practitioners
Follow-up period: Twelve months
Notes Process measures: None reported
Validation: Serum cotinine
Other: Definition of abstinence - Participants were categorised as ‘at least 6 months
abstinent’ if they were smoke free at 12 months follow-up, validated by serum cotinine,
and, according to self-report, had stopped smoking at least 6 months before the date of
follow-up
The three intervention groups were combined for meta-analyses to produce the
single ’Intervention’ sample
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomization performed centrally at the
German Centre for Research on Aging us-
ing PROC PLAN in SAS
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the interventionblind-
ing of participants was not possible for this
study
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Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk Authors report serum cotinine levels deter-
mined in a blinded fashion, though meth-
ods not described; Nomention of blinding
for assessors of the other outcomes
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Two participants died during follow-up
and five participants could not be located;
Three participants in whom smoking ab-
stinence could not be validated as a result
of current use of nicotine replacement ther-
apy were excluded; No further information
provided regarding missing or incomplete
outcome data
Selective reporting (reporting bias) Low risk All expected outcomes, including those
that were pre-specified were reported
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Low risk Patients did substantially differ at baseline
regarding the stage of change for smoking
cessation; A multivariate analysis was con-
ducted in which the authors adjusted for
all baseline factors that were unequally dis-
tributed between intervention arms, as as-
sessed by Mantel-Haenszel Chi² statistic
Comparability of intervention and control
group characteristics at baseline
Unclear risk “We found no significant differences be-
tween the four groups of GPs with respect
to the number of GPs per practice (p= 0.
13), location (p= 0.62), sex (p= 0.38), age
(p= 0.19) or smoking status (p= 0.21)”; 13
GPs withdrew and 13 GPs had no refer-
rals of eligible patients, leaving a total of 68
GPs, unequally divided across the different
arms
Protection against contamination Unclear risk Insufficient information to permit judge-
ment of yes or no
Selective recruitment of participants Unclear risk Authors state that a possibility exists for se-
lective recruitment, however statistical ad-
justments for this at follow-up still produce
a significant result; n-values are different
between the three intervention groups in
comparison to the usual care arm
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Methods Country: USA
Design: Randomized controlled trial; Nested; Clustered
Objective: To bolster the rate at which physicians delivered smoking cessation services
and to increase patients’ quit rates
Methods of analysis:Descriptive statistics for characterisation of sample at baseline; Pear-
son’s Chi² test and independent sample t-test to measure differences between groups;
Hierarchic generalised linear model analysis of variance controlling for baseline variables
used tomeasure physician performance; Abstinence analysed via generalised linearmodel
Clustering adjustment made: Yes - Mixed linear modelling with physician as clustering
variable used for smoking related outcomes
Significance of cluster adjustment: Not reported
Participants Therapist description:Primary care physicians recruited from the four largestmetropolitan
boroughs, Bronx, Brooklyn, Manhattan and Queens
Eligible for study: n= 579
Randomized: Intervention n= 35; Control n= 35
Completed: Intervention n= 35; Control n= 35
Age:Mean = 51.1 + 8.1 years (total population only)
Gender:Males= 74% (total population only)
Patient description: Patients in primary care physician waiting rooms who were identified
as smokers
Eligible for study: n= 5826
Randomized: Intervention n= 270; Control n= 248
Completed: Intervention n= 237; Control n= 228
Age: Intervention mean= 43.5 + 14.7 years; Control mean= 42.8 + 14.2 years
Gender: Intervention 58% male; Control 64% male
Interventions Setting: Training conducted during a 40 minute visit to the physicians office
Training of those delivering the intervention to the health professional:Not reported
Intervention description: Physician training in brief smoking cessation counselling based
on the 5As Clinical Practice Guideline algorithm; Patients and physicians provided with
a one page report containing smoking-related information and recommendations based
on the information provided during the patient assessment
Control description: Physicians in the control condition were not given any training and
were instructed to continue their usual smoking cessation practices; Patients completed
the same assessments but did not receive the report (being the one page report charac-
terising patients smoking habits)
Duration of intervention:One session only
Intervention delivered by: Health educator
Intensity: One, 40 minute session
Outcomes Pre-specified outcome data: Patients asked - Did your doctor... ask whether you smoke,
ask whether you are ready to quit, advise you to quit smoking, help you to quit smoking,
help you set goals about quitting, give you written materials about quitting, refer you to
a quit smoking program, talk to you about quit-smoking medications, make a follow-
up appointment to discuss smoking
Primary outcome measure - 7 day point prevalence abstinence; Longest quit attempt (in
days); Total number of 25 hour quit attempts, stage-of-change progression
Follow-up period: Six months
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Notes Process measures: None reported
Validation: For sub-group of participants - Saliva-cotinine test; 14 of 16 samples con-
firmed abstinence (88%)
n-values re-calculated for meta-analysis to permit intention-to-treat analysis for
primary outcome data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number generator
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Physicians learned their group assignment
after signing the informed consent; Due to
the nature of the intervention blinding of
participants was not possible for this study
Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk No mention of attempts to blind outcome
assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 62 subjects were withdrawn due to com-
puter malfunction, scheduling and time
constraints; No further information pro-
vided regarding missing or incomplete out-
come data
Selective reporting (reporting bias) High risk Smoking abstinence from baseline to fol-
low-up has not been reported, which is an
outcome that would be expected to have
been assessed for such a study
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Low risk Patient intervention and control groups
differed on the amount of daily smoking
with the intervention group having more
smokers with >25 year smoking history
which was subsequently controlled in all
smoking outcome analyses
Comparability of intervention and control
group characteristics at baseline
Low risk Both physician and patient characteris-
tics were reported and no differences were
found
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Protection against contamination Unclear risk Geographic location of intervention and
control physicians not described
Selective recruitment of participants Low risk Project staff offered participation to all
identified smokers
Wang 1994
Methods Country: Taiwan
Design: Randomized Controlled Trial
Objective: To assess the stages-of-change model in cigarette smoking and practice guide-
lines for practicing cigarette smoking cessation counselling in a short training program,
designed to make physicians more willing to help their patients to quit smoking and
increase success rates
Methods of analysis: All data were analysed using either the Chi² or Fisher’s exact tests
Clustering adjustment made: No
Significance of cluster adjustment: Not applicable
Participants Therapist description: Residents and physicians in family medicine
Eligible for study; n-value not reported
Randomized; n-value: Group one: lessons n= 9, Group two: posters n= 9, Group three:
usual care n= 9
Completed; n-value: Group one: lessons n= 9, Group two: posters n= 9, Group three:
usual care n= 9
Age: Not reported
Gender:Not reported
Patient description:
Eligible for study; n-value not reported
Randomized; n-value: n= 93, Group one: n= 39, Group two: n= 26, Group three: n= 28
Completed; n-value: n= 82, Group one: n= 35, Group two: n= 24, Group three: n= 23
Age: Group one: <40 n= 14, 40-59 n= 17, > 60 n= 8; Group two: <40 n= 14, 40-59 n=
8, > 60 n= 4; Group three: <40 n= 7, 40-59 n= 12, > 60 n= 9
Gender:Group one: male n= 38 female n= 1; Group two: male n= 24 female n= 2; Group
three: male n= 27 female n= 1
Therapists: 27 physicians
Patients: 93 patients
Interventions Setting: Not reported
Training of those delivering the intervention to the health professional:Not reported
Intervention description: Two intervention groups: Training - stages of change model and
practice guidelines; Poster - used as a reminder to give advice
Control description: Usual care
Duration of intervention:Group one: two lessons; Group two: provided with poster only;
Group three: no intervention
Intervention delivered by: Not reported
Intensity: Group one: two lessons; Group two: provided with poster only; Group three:
no intervention
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Outcomes Pre-specified outcome data:Demographic data, cigarette-smoking habits and health beliefs
Follow-up period: 6-months; Point prevalence of abstinence at 12 months
No process outcomes
Notes Validation: None
Process measures: None reported
Manual adjustment for potential clustering effects performed in the meta-analyses
for primary outcome data; The two intervention groups were combined for meta-
analyses to produce the single ’Intervention’ sample; n-values re-calculated formeta-
analysis to permit intention-to-treat analysis for primary outcome data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Physicians were randomized “…to one of
three groups by number of years in practice.
” No other information provided
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the intervention it was
not possible to blind participants
Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk Nomention of blinding for outcome asses-
sors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No mention of missing outcome data or
how any missing variables were handled
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment of yes or no
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Unclear risk Data not reported for baseline smoking;No
mention of analyses of covariance
Comparability of intervention and control
group characteristics at baseline
Low risk Authors reported no significant differences
between patient demographic characteris-
tics
Protection against contamination Unclear risk Insufficient information to permit judge-
ment of yes or no
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Selective recruitment of participants Unclear risk Methods of recruitment not described; n-
values are different between groups
Wilson 1988
Methods Country: Canada
Design: Randomized controlled trial; Nested; Clustered
Objective: To investigate the effects of a smoking cessation workshop on physician prac-
tices and on patients’ smoking behaviour
Methods of analysis: Analysis of covariance - Obtained by averaging patient values within
the practice; Analysis of differences between groups - If there was no difference between
the usual care and gum only groups (untrained cohorts) these would be combined and
compared with the gum plus (trained cohort); Regression analysis performed on practice
unit, adjusting for the effects of predictor variables and treatment
Clustering adjustment made: No - None reported
Significance of cluster adjustment: Not reported
Participants Therapist description: Physicians
Eligible for study: n= 460 Family physicians
Randomized: n= 90 Physicians
Completed: n= 83 Physicians; Usual care n= 27; Gum only n= 29; Gum plus n= 27
Age: Usual care:Mean = 41.64 years; Gum only: Mean = 41.77 years; Gum plus: Mean
= 40.57 years
Gender: Usual care: Male 92.6%; Gum only: Male 93.1%; Gum plus: Male 81.5%
Patient description:
Eligible for study:Not stated as n-value; Participation consent rates were: Usual care 91%;
Gum only 83%; Gum plus 76%
Randomized: Not reported
Completed: Usual care n= 601; Gum only n= 726; Gum plus n= 606 (total n= 1933)
Age: <25 years: Usual care 22%; Gum only 19%; Gum plus 17%; 25 to 44 years: Usual
care 50%; Gum only 54%; Gum plus 56%; ≥ 45 years: Usual care 27%; Gum only
27%; Gum plus 27%
Gender:Male: Usual care 39%; Gum only 42%; Gum plus 33%
Interventions Setting: Clinical practice setting - Participation during routine physician consultation;
Based in Ontario, Hamilton
Training of those delivering the intervention to the health professional:Not described; CME
Protocol
Intervention description: Two intervention groups: Gum only - Physicians instructed to
approach patients in their usual manner about quitting smoking and to offer nicotine
gum as an aid to quitting; Gum Plus Training - Gum in addition to training
Control description: Usual care
Duration of intervention:One, 4 hour training workshop to Gum plus physician cohort
Intervention delivered by: Not described
Intensity: Control - Not explicitly reported; Gum only - Not explicitly reported; Gum
plus - One, 4 hour workshop for physicians; For patients - Use of gum, 1 to 6 follow-
up visits and quit dates
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Outcomes Pre-specified outcome data: Three-month self reported sustained abstinence prior to bio-
chemically validated cessation at 12 months; Smoking behaviour, cessation attempts and
nicotine gum use measured by telephone interviews; Physicians performance measured
by patient flow sheets and patient telephone exit interviews
Follow-up period: Point prevalence of abstinence at 12 months
Notes Process measures: None reported
Validation: Salivary cotinine
The two intervention groupswere combined formeta-analyses to produce the single
’Intervention’ sample;Manual adjustment for potential clustering effects performed
in the meta-analyses for primary outcome data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomization mentioned as ’allocated by
practice to one of the three treatment
groups’ however methods not described
Allocation concealment (selection bias) Unclear risk Methods not described
Blinding (performance bias and detection
bias)
of participants
High risk Due to the nature of the interventionblind-
ing of participants was not possible for this
study
Blinding (performance bias and detection
bias)
of outcome assessors
Unclear risk Nomention of attempted blinding for out-
come assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk A total of 87 patients (4.5%) who may
have been non-smokers were classified as
cigarette smokers for the purpose of the
analysis; No further information provided
regarding missing or incomplete outcome
data
Selective reporting (reporting bias) Low risk All expected outcomes, including those
that were pre-specified were reported
Other bias Low risk No other biases identified
Imbalance of outcome measures at baseline Low risk Adequately described in text and adjusted
for using analysis of variance
Comparability of intervention and control
group characteristics at baseline
Unclear risk Carried out a comparison of demographic
characteristics of the cohorts; Baseline char-
acteristics not fully reported
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Protection against contamination Low risk Clinical practice level randomization suit-
able for this type of study; No indication of
contamination from external sources dur-
ing study period; All participants were fam-
ily physicians within a 40mile radius of the
McMaster University in Hamilton, On-
tario
Selective recruitment of participants Unclear risk Physician n-values across different groups
not reported; Participation consent rates
were 91%, 83% and 76%, respectively, in
the usual care, gum only, and gum plus
groups
HMO: Health Maintenance Organization; OTC: over the counter
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Albert 2006 No patient smoking related outcomes reported separately for intervention and control groups
Allen 1998 Unit of randomization was patients not health care providers; No patient level outcome data reported
Andrews 1999 No smoking related outcomes reported as interventions for smokeless tobacco only
Andrews 2001 Consultation process only - No smoking related outcomes reported
Ballbe 2008 Sample not randomly allocated - consultation process only
Bernstein 2009 Sample not randomly allocated - consultation process only
Bobo 1997 Consultation process only
Campbell 1997 Consultation process only - No smoking related outcomes reported
Caplan 2011 No control group
Carney 1995 Consultation process only - No smoking related outcomes reported
Cockburn 1992 Study compared academic detailing, courier delivery and directmailing of a new smoking cessation program for
use in primary care; Did not include any measure of the extent to which physicians changed their counselling,
or the number of smokers who stopped smoking in the 3 groups
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Depue 2002 No control group
Dietrich 1992 Consultation process only - No smoking related outcomes reported
Dunkley 1997 Sample not randomly allocated - midwives selected into intervention and control groups
Etter 2000 No smoking related outcomes reported
Etter 2006 No smoking related outcomes reported
Giuntini 2001 No smoking related outcomes reported
Goldberg 1994 Training not randomized
Gordon 2005a Sample not randomly allocated - historical control only
Gordon 2005b Investigation of smokeless tobacco cessation only
Graham 2011 Consultation process only - No smoking related outcomes reported
Guo 2010 No control group
Haresaku 2010 No control group and no patient related smoking outcomes reported
Keller 2000 Consultation process only - No smoking related outcomes reported
Kerr 2011 Consultation process only - No smoking related outcomes reported
Leong 2008 No smoking related outcomes reported - only patient movement across stages of change model
Lindsay 1997 Consultation process only - No smoking related outcomes reported
Little 2009 Consultation process only - No smoking related outcomes reported
Manfredi 2011 No control group
Martin 2010 Consultation process only - No smoking related outcomes reported
Matten 2011 No control group
McEwen 2002 Consultation process only - No smoking related outcomes reported
McEwen 2006 Consultation process only - No long-term smoking related outcomes reported
McIntosh 2004 Consultation process only - No smoking related outcomes reported
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McRobbie 2008 Consultation process only - No long-term smoking related outcomes reported
Meyer 2008 Sample not randomly allocated - unit of randomization weeks 1, 2, and 3 within the ’randomly selected’
practices
Moore 2005 Consultation process only - No smoking related outcomes reported
Morgan 1996 Both groups of physicians received training; Delayed intervention group asked to give usual care
Moss 2009 No control group
Ockene 1991 Physicians not randomly allocated to training; Patients were randomly allocated to different types of physician
counselling with or without nicotine gum
Patwardhan 2010 Consultation process only - No smoking related outcomes reported
Pereira 2006 No patient related smoking outcome data available
Prokhorov 2010 No outcome data available on matched cohort - follow-up data only presented for cross-sectional sample of
patients
Pronk 2006 No control group and no patient outcome data presented
Rankin 2010 Sample not randomly allocated and no patient outcome data presented
Richmond 1998 No control group: All physicians trained to provide Smokescreen intervention; Intervention consisted of
telephone calls to ask about use of program; Patient smoking outcomes not given separately for intervention
groups
Roche 1996 No control group: Comparison of different methods of training, with no patient quit rate outcomes
Royce 1995 No control group
Russos 1999 Consultation process only - No smoking related outcomes reported
Schmelz 2010 No control group and no patient related smoking outcomes reported
Schnoll 2003 Level of randomization not healthcare practitioner or practice; Level of randomization is patient
Secker Walker 1992 The study involved training residents in obstetrics and family practice to give advice about stopping smoking
during pre-natal care; However, training was not the variable that was randomized
Sheffer 2009 No control group and no patient related smoking outcomes reported
Sheffer 2011 No control group
Sohn 2010 No control group and no patient related smoking outcomes reported
70Training health professionals in smoking cessation (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Steinemann 2005 Consultation process only - No smoking related outcomes reported
Stolz 2012 No true control group and no patient related smoking outcomes reported
Targhetta 2011 Sample not randomly allocated
Von Garnier 2010 Historical control group only
Walsh 2010 No patient smoking related outcomes reported
Ward 1996 No smoking related outcome data
Wisborg 1998 Sample not randomly allocated - Midwives working on Thursdays were considered to be the intervention
group
Young 2002 Consultation process only - No smoking related outcomes reported
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D A T A A N D A N A L Y S E S
Comparison 1. The effect of training health professionals on patient smoking cessation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Smoking cessation at longest
follow-up
15 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Point prevalence 14 13459 Odds Ratio (M-H, Fixed, 95% CI) 1.36 [1.20, 1.55]
1.2 Continuous abstinence 8 9443 Odds Ratio (M-H, Fixed, 95% CI) 1.60 [1.26, 2.03]
2 Patient asked to set a quit date 8 4332 Odds Ratio (M-H, Random, 95% CI) 4.98 [2.29, 10.86]
3 Patient asked to make a
follow-up appointment
7 3114 Odds Ratio (M-H, Random, 95% CI) 3.34 [1.51, 7.37]
4 Number of smokers counselled 14 8531 Odds Ratio (M-H, Random, 95% CI) 2.28 [1.58, 3.27]
5 Number of smokers receiving
self-help material
9 4925 Odds Ratio (M-H, Random, 95% CI) 3.52 [1.90, 6.52]
6 Number of smokers receiving
nicotine gum/replacement
therapy
9 5073 Odds Ratio (M-H, Random, 95% CI) 1.57 [0.87, 2.84]
7 Number of smokers prescribed a
quit date
3 1172 Odds Ratio (M-H, Fixed, 95% CI) 14.18 [6.57, 30.61]
Comparison 2. Sub-group: treatment type
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient asked to set a quit date 8 4332 Odds Ratio (M-H, Random, 95% CI) 4.98 [1.79, 13.88]
1.1 Counselling plus NRT 6 3322 Odds Ratio (M-H, Random, 95% CI) 7.45 [3.30, 16.85]
1.2 Counselling alone 2 1010 Odds Ratio (M-H, Random, 95% CI) 1.22 [0.78, 1.92]
2 Patient asked to make a
follow-up appointment
7 Odds Ratio (M-H, Random, 95% CI) Totals not selected
2.1 Counselling plus NRT 4 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.2 Counselling alone 3 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3 Number of smokers counselled 14 8531 Odds Ratio (M-H, Random, 95% CI) 2.28 [1.41, 3.67]
3.1 Counselling plus NRT 9 5768 Odds Ratio (M-H, Random, 95% CI) 2.66 [1.33, 5.32]
3.2 Counselling alone 5 2763 Odds Ratio (M-H, Random, 95% CI) 1.71 [1.09, 2.68]
4 Number of smokers receiving
self-help material
9 4925 Odds Ratio (M-H, Random, 95% CI) 3.52 [1.56, 7.91]
4.1 Counselling plus NRT 5 3165 Odds Ratio (M-H, Random, 95% CI) 5.50 [2.45, 12.36]
4.2 Counselling alone 4 1760 Odds Ratio (M-H, Random, 95% CI) 1.91 [0.56, 6.48]
5 Number of smokers receiving
nicotine gum/replacement
therapy
9 5073 Odds Ratio (M-H, Random, 95% CI) 1.57 [0.72, 3.42]
5.1 Counselling plus NRT 6 4122 Odds Ratio (M-H, Random, 95% CI) 1.78 [0.65, 4.91]
5.2 Counselling alone 3 951 Odds Ratio (M-H, Random, 95% CI) 1.00 [0.66, 1.50]
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Comparison 3. Sub-group: treatment intensity - Number of sessions
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient asked to set a quit date 8 4332 Odds Ratio (M-H, Random, 95% CI) 4.98 [1.79, 13.88]
1.1 Single session 3 1969 Odds Ratio (M-H, Random, 95% CI) 14.45 [3.98, 52.48]
1.2 Multiple sessions 5 2363 Odds Ratio (M-H, Random, 95% CI) 2.79 [1.03, 7.55]
2 Patient asked to make a
follow-up appointment
7 3114 Odds Ratio (M-H, Random, 95% CI) 3.34 [1.18, 9.46]
2.1 Single session 2 751 Odds Ratio (M-H, Random, 95% CI) 13.33 [2.95, 60.24]
2.2 Multiple sessions 5 2363 Odds Ratio (M-H, Random, 95% CI) 1.88 [0.94, 3.74]
3 Number of smokers counselled 14 8531 Odds Ratio (M-H, Random, 95% CI) 2.28 [1.41, 3.67]
3.1 Single session 7 4213 Odds Ratio (M-H, Random, 95% CI) 3.39 [1.56, 7.37]
3.2 Multiple sessions 7 4318 Odds Ratio (M-H, Random, 95% CI) 1.50 [1.14, 1.98]
4 Number of smokers receiving
self-help material
9 4925 Odds Ratio (M-H, Random, 95% CI) 3.52 [1.56, 7.91]
4.1 Single session 3 1182 Odds Ratio (M-H, Random, 95% CI) 6.93 [1.42, 33.76]
4.2 Multiple sessions 6 3743 Odds Ratio (M-H, Random, 95% CI) 2.58 [1.01, 6.60]
5 Number of smokers receiving
nicotine gum/replacement
therapy
9 5073 Odds Ratio (M-H, Random, 95% CI) 1.57 [0.72, 3.42]
5.1 Single session 3 2445 Odds Ratio (M-H, Random, 95% CI) 4.33 [3.18, 5.89]
5.2 Multiple sessions 6 2628 Odds Ratio (M-H, Random, 95% CI) 0.97 [0.74, 1.27]
Comparison 4. Sub-group: treatment intensity - Total exposure
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient asked to set a quit date 8 4332 Odds Ratio (M-H, Random, 95% CI) 4.98 [1.79, 13.88]
1.1 Duration 40 minutes to 2
hours
5 2979 Odds Ratio (M-H, Random, 95% CI) 5.63 [0.71, 44.43]
1.2 Duration >2 to 4 hours 2 1102 Odds Ratio (M-H, Random, 95% CI) 4.70 [3.08, 7.16]
1.3 Duration >4 hours 1 251 Odds Ratio (M-H, Random, 95% CI) 3.76 [0.65, 21.65]
2 Patient asked to make a
follow-up appointment
6 Odds Ratio (M-H, Random, 95% CI) Totals not selected
2.1 Duration 40 minutes to 2
hours
4 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.2 Duration >2 to 4 hours 2 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3 Number of smokers counselled 14 8531 Odds Ratio (M-H, Random, 95% CI) 2.28 [1.41, 3.67]
3.1 Duration 40 minutes to 2
hours
8 4220 Odds Ratio (M-H, Random, 95% CI) 3.25 [1.67, 6.33]
3.2 Duration >2 to 4 hours 3 2482 Odds Ratio (M-H, Random, 95% CI) 1.57 [0.86, 2.86]
3.3 Duration >4 hours 3 1829 Odds Ratio (M-H, Random, 95% CI) 1.29 [0.99, 1.68]
4 Number of smokers receiving
self-help material
9 4925 Odds Ratio (M-H, Random, 95% CI) 3.52 [1.56, 7.91]
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4.1 Duration 40 minutes to 2
hours
5 2192 Odds Ratio (M-H, Random, 95% CI) 3.16 [0.77, 13.07]
4.2 Duration >2 to 4 hours 3 2482 Odds Ratio (M-H, Random, 95% CI) 3.54 [1.84, 6.83]
4.3 Duration >4 hours 1 251 Odds Ratio (M-H, Random, 95% CI) 21.82 [1.50, 317.23]
5 Number of smokers receiving
nicotine gum/replacement
therapy
9 5073 Odds Ratio (M-H, Random, 95% CI) 1.57 [0.72, 3.42]
5.1 Duration 40 minutes to 2
hours
5 3164 Odds Ratio (M-H, Random, 95% CI) 2.33 [0.73, 7.43]
5.2 Duration >2 to 4 hours 3 1334 Odds Ratio (M-H, Random, 95% CI) 0.87 [0.52, 1.45]
5.3 Duration >4 hours 1 575 Odds Ratio (M-H, Random, 95% CI) 1.14 [0.67, 1.95]
Comparison 5. Sub-group: mode of intervention delivery
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient asked to set a quit date 8 Odds Ratio (M-H, Random, 95% CI) Subtotals only
1.1 One-on-one 4 2353 Odds Ratio (M-H, Random, 95% CI) 7.52 [2.17, 26.12]
1.2 Group sessions 8 4332 Odds Ratio (M-H, Random, 95% CI) 4.98 [1.79, 13.88]
2 Patient asked to make a
follow-up appointment
7 Odds Ratio (M-H, Random, 95% CI) Subtotals only
2.1 One-on-one 3 1135 Odds Ratio (M-H, Random, 95% CI) 3.60 [0.86, 15.08]
2.2 Group sessions 6 2596 Odds Ratio (M-H, Random, 95% CI) 2.74 [1.06, 7.08]
3 Number of smokers counselled 14 Odds Ratio (M-H, Random, 95% CI) Subtotals only
3.1 One-on-one 6 3762 Odds Ratio (M-H, Random, 95% CI) 2.76 [1.27, 6.01]
3.2 Group sessions 12 7438 Odds Ratio (M-H, Random, 95% CI) 2.47 [1.41, 4.30]
4 Number of smokers receiving
self-help material
9 Odds Ratio (M-H, Random, 95% CI) Subtotals only
4.1 One-on-one 3 1451 Odds Ratio (M-H, Random, 95% CI) 6.09 [3.93, 9.44]
4.2 Group sessions 8 4407 Odds Ratio (M-H, Random, 95% CI) 3.22 [1.36, 7.65]
5 Number of smokers receiving
nicotine gum/replacement
therapy
9 Odds Ratio (IV, Random, 95% CI) Subtotals only
5.1 One-on-one 2 941 Odds Ratio (IV, Random, 95% CI) 0.88 [0.41, 1.87]
5.2 Group sessions 8 4498 Odds Ratio (IV, Random, 95% CI) 1.65 [0.68, 4.01]
Comparison 6. Sub-group: behavioural change technique used
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient asked to set a quit date 5 2997 Odds Ratio (M-H, Random, 95% CI) 4.19 [0.63, 28.09]
1.1 Prompting 3 1939 Odds Ratio (M-H, Random, 95% CI) 6.99 [0.90, 54.02]
1.2 Provide feedback 2 1058 Odds Ratio (M-H, Random, 95% CI) 1.76 [0.43, 7.17]
2 Patient asked to make a
follow-up appointment
4 Odds Ratio (M-H, Random, 95% CI) Totals not selected
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2.1 Prompting 1 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.2 Provide feedback 3 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3 Number of smokers counselled 8 4322 Odds Ratio (M-H, Random, 95% CI) 2.32 [1.13, 4.74]
3.1 Prompting 4 2171 Odds Ratio (M-H, Random, 95% CI) 3.27 [1.23, 8.68]
3.2 Provide feedback 4 2151 Odds Ratio (M-H, Random, 95% CI) 1.67 [0.99, 2.85]
4 Number of smokers receiving
self-help material
5 2011 Odds Ratio (M-H, Random, 95% CI) 2.51 [0.74, 8.58]
4.1 Prompting 2 435 Odds Ratio (M-H, Random, 95% CI) 1.48 [0.64, 3.42]
4.2 Provide feedback 3 1576 Odds Ratio (M-H, Random, 95% CI) 4.33 [0.51, 36.60]
5 Number of smokers receiving
nicotine gum/replacement
therapy
4 1526 Odds Ratio (M-H, Fixed, 95% CI) 1.05 [0.76, 1.45]
5.1 Provide feedback 2 1091 Odds Ratio (M-H, Fixed, 95% CI) 1.00 [0.71, 1.41]
5.2 Prompting 2 435 Odds Ratio (M-H, Fixed, 95% CI) 1.47 [0.57, 3.76]
Comparison 7. Sub-group: type of professional being trained
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient asked to set a quit date 8 4332 Odds Ratio (M-H, Random, 95% CI) 4.98 [1.79, 13.88]
1.1 Doctor 6 2878 Odds Ratio (M-H, Random, 95% CI) 6.35 [2.49, 16.19]
1.2 Dentist 1 647 Odds Ratio (M-H, Random, 95% CI) 6.43 [1.91, 21.56]
1.3 Healthcare worker 1 807 Odds Ratio (M-H, Random, 95% CI) 1.19 [0.74, 1.91]
2 Patient asked to make a
follow-up appointment
7 Odds Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Doctor 7 3114 Odds Ratio (M-H, Random, 95% CI) 3.34 [1.18, 9.46]
2.2 Healthcare worker 1 807 Odds Ratio (M-H, Random, 95% CI) 1.06 [0.73, 1.54]
3 Number of smokers counselled 14 10916 Odds Ratio (IV, Random, 95% CI) 2.05 [1.38, 3.05]
3.1 Doctor 12 7592 Odds Ratio (IV, Random, 95% CI) 2.09 [1.25, 3.49]
3.2 Dentist 1 647 Odds Ratio (IV, Random, 95% CI) 4.33 [2.64, 7.10]
3.3 Healthcare worker 4 2677 Odds Ratio (IV, Random, 95% CI) 1.55 [0.99, 2.42]
4 Number of smokers receiving
self-help material
9 Odds Ratio (IV, Random, 95% CI) Subtotals only
4.1 Doctor 9 4925 Odds Ratio (IV, Random, 95% CI) 3.51 [1.57, 7.85]
4.2 Healthcare worker 1 807 Odds Ratio (IV, Random, 95% CI) 1.07 [0.73, 1.55]
5 Number of smokers receiving
nicotine gum/replacement
therapy
9 Odds Ratio (IV, Random, 95% CI) Subtotals only
5.1 Doctor 8 4581 Odds Ratio (IV, Random, 95% CI) 1.44 [0.63, 3.30]
5.2 Healthcare worker 3 1583 Odds Ratio (IV, Random, 95% CI) 1.27 [0.64, 2.53]
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Comparison 8. Sub-group: length of follow-up
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient asked to set a quit date 8 Odds Ratio (IV, Random, 95% CI) Subtotals only
1.1 From 6 months up to and
including 9 months
3 1939 Odds Ratio (IV, Random, 95% CI) 7.02 [0.98, 50.34]
1.2 From greater than 9
months up to and including 12
months
7 4129 Odds Ratio (IV, Random, 95% CI) 5.67 [1.96, 16.42]
2 Patient asked to make a
follow-up appointment
7 3114 Odds Ratio (IV, Random, 95% CI) 3.34 [1.19, 9.34]
2.1 From 6 months up to and
including 9 months
2 721 Odds Ratio (IV, Random, 95% CI) 3.82 [0.48, 30.51]
2.2 From greater than 9
months up to and including 12
months
5 2393 Odds Ratio (IV, Random, 95% CI) 3.10 [0.98, 9.75]
3 Number of smokers counselled 14 Odds Ratio (IV, Random, 95% CI) Subtotals only
3.1 From 6 months up to and
including 9 months
6 3752 Odds Ratio (IV, Random, 95% CI) 3.13 [1.38, 7.09]
3.2 From greater than 9
months up to and including 12
months
10 6575 Odds Ratio (IV, Random, 95% CI) 2.50 [1.34, 4.64]
3.3 From greater than 12
months up to 24 months
2 1235 Odds Ratio (IV, Random, 95% CI) 1.30 [0.91, 1.86]
4 Number of smokers receiving
self-help material
9 4925 Odds Ratio (IV, Random, 95% CI) 3.51 [1.57, 7.85]
4.1 From 6 months up to and
including 9 months
2 721 Odds Ratio (IV, Random, 95% CI) 2.59 [0.22, 30.56]
4.2 From greater than 9
months up to and including 12
months
6 3972 Odds Ratio (IV, Random, 95% CI) 4.42 [1.53, 12.70]
4.3 From greater than 12
months up to 24 months
1 232 Odds Ratio (IV, Random, 95% CI) 1.88 [0.80, 4.42]
5 Number of smokers receiving
nicotine gum/replacement
therapy
9 5073 Odds Ratio (IV, Random, 95% CI) 1.57 [0.72, 3.41]
5.1 From 6 months up to and
including 9 months
2 695 Odds Ratio (IV, Random, 95% CI) 2.27 [0.75, 6.85]
5.2 From greater than 9
months up to and including 12
months
6 4146 Odds Ratio (IV, Random, 95% CI) 1.44 [0.54, 3.81]
5.3 From greater than 12
months up to 24 months
1 232 Odds Ratio (IV, Random, 95% CI) 1.43 [0.34, 5.99]
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Comparison 9. Sub-group: risk of bias in the studies
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient asked to set a quit date 8 4332 Odds Ratio (IV, Random, 95% CI) 4.97 [1.85, 13.30]
1.1 Up to and including 2
domains
7 4129 Odds Ratio (IV, Random, 95% CI) 5.67 [1.96, 16.42]
1.2 From 3 to 5 domains 1 203 Odds Ratio (IV, Random, 95% CI) 1.68 [0.31, 9.00]
2 Patient asked to make a
follow-up appointment
7 3114 Odds Ratio (IV, Random, 95% CI) 3.34 [1.19, 9.34]
2.1 Up to and including 2
domains
6 2911 Odds Ratio (IV, Random, 95% CI) 3.79 [1.14, 12.55]
2.2 From 3 to 5 domains 1 203 Odds Ratio (IV, Random, 95% CI) 1.68 [0.69, 4.06]
3 Number of smokers counselled 14 8531 Odds Ratio (IV, Random, 95% CI) 2.28 [1.41, 3.67]
3.1 Up to and including 2
domains
11 7804 Odds Ratio (IV, Random, 95% CI) 2.32 [1.34, 4.02]
3.2 From 3 to 5 domains 2 435 Odds Ratio (IV, Random, 95% CI) 1.64 [0.87, 3.10]
3.3 From 6 to 8 domains 1 292 Odds Ratio (IV, Random, 95% CI) 3.42 [1.61, 7.28]
4 Number of smokers receiving
self-help material
9 5157 Odds Ratio (IV, Random, 95% CI) 3.26 [1.57, 6.77]
4.1 Up to and including 2
domains
8 4722 Odds Ratio (IV, Random, 95% CI) 4.08 [1.75, 9.55]
4.2 From 3 to 5 domains 2 435 Odds Ratio (IV, Random, 95% CI) 1.48 [0.64, 3.42]
5 Number of smokers receiving
nicotine gum/replacement
therapy
9 5073 Odds Ratio (IV, Random, 95% CI) 1.57 [0.72, 3.41]
5.1 Up to and including 2
domains
6 4146 Odds Ratio (IV, Random, 95% CI) 1.44 [0.54, 3.81]
5.2 From 3 to 5 domains 2 435 Odds Ratio (IV, Random, 95% CI) 1.47 [0.57, 3.76]
5.3 From 6 to 8 domains 1 492 Odds Ratio (IV, Random, 95% CI) 3.53 [0.95, 13.09]
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Analysis 1.1. Comparison 1 The effect of training health professionals on patient smoking cessation,
Outcome 1 Smoking cessation at longest follow-up.
Review: Training health professionals in smoking cessation
Comparison: 1 The effect of training health professionals on patient smoking cessation
Outcome: 1 Smoking cessation at longest follow-up
Study or subgroup Favours control Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Point prevalence
Cohen (Dent) 1989 39/771 8/256 2.8 % 1.65 [ 0.76, 3.58 ]
Cohen (Doc) 1989 63/1065 5/355 1.7 % 4.40 [ 1.76, 11.03 ]
Cornuz 2002 15/115 7/136 1.4 % 2.76 [ 1.09, 7.04 ]
Cummings (Priv) 1989 26/386 30/364 7.0 % 0.80 [ 0.47, 1.39 ]
Cummings 1989 67/837 60/840 13.4 % 1.13 [ 0.79, 1.63 ]
Gordon 2010 158/1394 79/1155 18.7 % 1.74 [ 1.31, 2.31 ]
Joseph 2004 32/280 39/295 8.2 % 0.85 [ 0.51, 1.40 ]
Lennox 1998 100/1381 93/1207 22.5 % 0.94 [ 0.70, 1.25 ]
Sinclair 1998 55/187 51/223 8.0 % 1.41 [ 0.90, 2.19 ]
Swartz 2002 61/413 42/394 8.9 % 1.45 [ 0.95, 2.21 ]
Twardella 2007 69/503 3/74 1.1 % 3.76 [ 1.15, 12.28 ]
Unrod 2007 32/270 20/248 4.5 % 1.53 [ 0.85, 2.76 ]
Wang 1994 10/54 1/23 0.3 % 5.00 [ 0.60, 41.59 ]
Wilson 1988 15/158 5/75 1.5 % 1.47 [ 0.51, 4.20 ]
Subtotal (95% CI) 7814 5645 100.0 % 1.36 [ 1.20, 1.55 ]
Total events: 742 (Favours control), 443 (Control)
Heterogeneity: Chi2 = 30.55, df = 13 (P = 0.004); I2 =57%
Test for overall effect: Z = 4.72 (P < 0.00001)
2 Continuous abstinence
Cummings (Priv) 1989 12/386 9/364 8.0 % 1.27 [ 0.53, 3.04 ]
Cummings 1989 22/837 13/840 11.2 % 1.72 [ 0.86, 3.43 ]
Gordon 2010 74/1394 22/1155 20.2 % 2.89 [ 1.78, 4.68 ]
Lennox 1998 32/1381 37/1207 34.2 % 0.75 [ 0.46, 1.21 ]
Sinclair 1998 22/187 16/223 11.4 % 1.73 [ 0.88, 3.39 ]
Strecher 1991 33/502 8/157 10.1 % 1.31 [ 0.59, 2.90 ]
Twardella 2007 32/503 1/74 1.4 % 4.96 [ 0.67, 36.85 ]
0.02 0.1 1 10 50
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(. . . Continued)
Study or subgroup Favours control Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wilson 1988 12/158 3/75 3.3 % 1.97 [ 0.54, 7.21 ]
Subtotal (95% CI) 5348 4095 100.0 % 1.60 [ 1.26, 2.03 ]
Total events: 239 (Favours control), 109 (Control)
Heterogeneity: Chi2 = 17.27, df = 7 (P = 0.02); I2 =59%
Test for overall effect: Z = 3.88 (P = 0.00010)
Test for subgroup differences: Chi2 = 1.40, df = 1 (P = 0.24), I2 =28%
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Analysis 1.2. Comparison 1 The effect of training health professionals on patient smoking cessation,
Outcome 2 Patient asked to set a quit date.
Review: Training health professionals in smoking cessation
Comparison: 1 The effect of training health professionals on patient smoking cessation
Outcome: 2 Patient asked to set a quit date
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Swartz 2002 343/413 317/394 14.7 % 1.19 [ 0.83, 1.70 ]
Strecher 1991 16/156 3/47 10.8 % 1.68 [ 0.47, 6.02 ]
Cornuz 2002 9/115 3/136 10.5 % 3.76 [ 0.99, 14.25 ]
Cummings (Priv) 1989 84/218 18/148 14.1 % 4.53 [ 2.58, 7.95 ]
Cummings 1989 146/388 39/348 14.6 % 4.78 [ 3.23, 7.07 ]
Cohen (Dent) 1989 83/486 5/161 12.5 % 6.43 [ 2.56, 16.14 ]
Wilson 1988 53/158 2/75 10.0 % 18.42 [ 4.35, 78.00 ]
Cohen (Doc) 1989 275/816 5/273 12.7 % 27.25 [ 11.12, 66.78 ]
Total (95% CI) 2750 1582 100.0 % 4.98 [ 2.29, 10.86 ]
Total events: 1009 (Experimental), 392 (Control)
Heterogeneity: Tau2 = 1.04; Chi2 = 71.38, df = 7 (P<0.00001); I2 =90%
Test for overall effect: Z = 4.04 (P = 0.000054)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 The effect of training health professionals on patient smoking cessation,
Outcome 3 Patient asked to make a follow-up appointment.
Review: Training health professionals in smoking cessation
Comparison: 1 The effect of training health professionals on patient smoking cessation
Outcome: 3 Patient asked to make a follow-up appointment
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cornuz 2002 8/115 4/136 11.8 % 2.47 [ 0.72, 8.42 ]
Cummings (Priv) 1989 42/218 16/148 14.9 % 1.97 [ 1.06, 3.65 ]
Cummings 1989 59/388 17/348 15.2 % 3.49 [ 1.99, 6.12 ]
Strecher 1991 76/156 17/47 14.7 % 1.68 [ 0.86, 3.29 ]
Swartz 2002 164/413 151/394 16.1 % 1.06 [ 0.80, 1.41 ]
Unrod 2007 128/270 24/248 15.5 % 8.41 [ 5.19, 13.65 ]
Wilson 1988 84/158 3/75 11.9 % 27.24 [ 8.23, 90.13 ]
Total (95% CI) 1718 1396 100.0 % 3.34 [ 1.51, 7.37 ]
Total events: 561 (Experimental), 232 (Control)
Heterogeneity: Tau2 = 0.99; Chi2 = 77.02, df = 6 (P<0.00001); I2 =92%
Test for overall effect: Z = 2.98 (P = 0.0028)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 The effect of training health professionals on patient smoking cessation,
Outcome 4 Number of smokers counselled.
Review: Training health professionals in smoking cessation
Comparison: 1 The effect of training health professionals on patient smoking cessation
Outcome: 4 Number of smokers counselled
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cohen (Dent) 1989 350/486 60/161 7.4 % 4.33 [ 2.97, 6.31 ]
Cohen (Doc) 1989 691/816 112/273 7.6 % 7.95 [ 5.84, 10.81 ]
Cornuz 2002 45/115 39/136 6.9 % 1.60 [ 0.94, 2.71 ]
Cummings (Priv) 1989 221/343 151/339 7.6 % 2.26 [ 1.66, 3.07 ]
Cummings 1989 392/783 352/785 7.9 % 1.23 [ 1.01, 1.50 ]
Hymowitz 2007 30/142 15/90 6.3 % 1.34 [ 0.67, 2.66 ]
Joseph 2004 165/280 162/295 7.5 % 1.18 [ 0.85, 1.64 ]
Lennox 1998 420/529 355/474 7.6 % 1.29 [ 0.96, 1.74 ]
Sinclair 1998 113/133 99/159 6.7 % 3.42 [ 1.93, 6.08 ]
Strecher 1991 114/156 27/47 6.3 % 2.01 [ 1.02, 3.96 ]
Swartz 2002 114/413 82/394 7.6 % 1.45 [ 1.05, 2.01 ]
Twardella 2007 257/377 32/54 6.7 % 1.47 [ 0.82, 2.64 ]
Unrod 2007 207/270 131/248 7.4 % 2.93 [ 2.01, 4.28 ]
Wilson 1988 123/158 23/75 6.5 % 7.95 [ 4.28, 14.74 ]
Total (95% CI) 5001 3530 100.0 % 2.28 [ 1.58, 3.27 ]
Total events: 3242 (Experimental), 1640 (Control)
Heterogeneity: Tau2 = 0.43; Chi2 = 168.50, df = 13 (P<0.00001); I2 =92%
Test for overall effect: Z = 4.44 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 The effect of training health professionals on patient smoking cessation,
Outcome 5 Number of smokers receiving self-help material.
Review: Training health professionals in smoking cessation
Comparison: 1 The effect of training health professionals on patient smoking cessation
Outcome: 5 Number of smokers receiving self-help material
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cornuz 2002 16/115 1/136 5.5 % 21.82 [ 2.85, 167.27 ]
Cummings (Priv) 1989 126/343 32/339 13.1 % 5.57 [ 3.64, 8.52 ]
Cummings 1989 195/783 66/785 13.5 % 3.61 [ 2.68, 4.87 ]
Hymowitz 2007 41/142 16/90 12.1 % 1.88 [ 0.98, 3.60 ]
Strecher 1991 19/156 6/47 10.3 % 0.95 [ 0.35, 2.53 ]
Swartz 2002 155/413 142/394 13.6 % 1.07 [ 0.80, 1.42 ]
Twardella 2007 107/377 8/54 11.4 % 2.28 [ 1.04, 4.99 ]
Unrod 2007 87/270 17/248 12.6 % 6.46 [ 3.71, 11.25 ]
Wilson 1988 77/158 2/75 7.9 % 34.70 [ 8.23, 146.30 ]
Total (95% CI) 2757 2168 100.0 % 3.52 [ 1.90, 6.52 ]
Total events: 823 (Experimental), 290 (Control)
Heterogeneity: Tau2 = 0.71; Chi2 = 87.72, df = 8 (P<0.00001); I2 =91%
Test for overall effect: Z = 4.00 (P = 0.000063)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 The effect of training health professionals on patient smoking cessation,
Outcome 6 Number of smokers receiving nicotine gum/replacement therapy.
Review: Training health professionals in smoking cessation
Comparison: 1 The effect of training health professionals on patient smoking cessation
Outcome: 6 Number of smokers receiving nicotine gum/replacement therapy
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cummings (Priv) 1989 29/218 29/148 11.8 % 0.63 [ 0.36, 1.11 ]
Cummings 1989 40/388 36/348 12.2 % 1.00 [ 0.62, 1.60 ]
Hymowitz 2007 11/142 5/90 9.1 % 1.43 [ 0.48, 4.25 ]
Joseph 2004 59/280 56/295 12.4 % 1.14 [ 0.76, 1.71 ]
Sinclair 1998 219/224 248/268 9.6 % 3.53 [ 1.30, 9.57 ]
Strecher 1991 28/156 6/47 9.9 % 1.49 [ 0.58, 3.86 ]
Swartz 2002 127/275 117/241 12.7 % 0.91 [ 0.64, 1.29 ]
Twardella 2007 82/377 4/54 9.4 % 3.47 [ 1.22, 9.90 ]
Wilson 1988 615/1064 108/458 12.9 % 4.44 [ 3.47, 5.69 ]
Total (95% CI) 3124 1949 100.0 % 1.57 [ 0.87, 2.84 ]
Total events: 1210 (Experimental), 609 (Control)
Heterogeneity: Tau2 = 0.69; Chi2 = 93.68, df = 8 (P<0.00001); I2 =91%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 The effect of training health professionals on patient smoking cessation,
Outcome 7 Number of smokers prescribed a quit date.
Review: Training health professionals in smoking cessation
Comparison: 1 The effect of training health professionals on patient smoking cessation
Outcome: 7 Number of smokers prescribed a quit date
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cummings 1989 63/388 4/348 52.1 % 16.67 [ 6.00, 46.32 ]
Strecher 1991 9/156 1/47 21.4 % 2.82 [ 0.35, 22.82 ]
Wilson 1988 53/158 2/75 26.6 % 18.42 [ 4.35, 78.00 ]
Total (95% CI) 702 470 100.0 % 14.18 [ 6.57, 30.61 ]
Total events: 125 (Experimental), 7 (Control)
Heterogeneity: Chi2 = 2.52, df = 2 (P = 0.28); I2 =20%
Test for overall effect: Z = 6.75 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Sub-group: treatment type, Outcome 1 Patient asked to set a quit date.
Review: Training health professionals in smoking cessation
Comparison: 2 Sub-group: treatment type
Outcome: 1 Patient asked to set a quit date
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling plus NRT
Cohen (Dent) 1989 83/486 5/161 12.5 % 6.43 [ 2.56, 16.14 ]
Cohen (Doc) 1989 275/816 5/273 12.7 % 27.25 [ 11.12, 66.78 ]
Cornuz 2002 9/115 3/136 10.5 % 3.76 [ 0.99, 14.25 ]
Cummings (Priv) 1989 84/218 18/148 14.1 % 4.53 [ 2.58, 7.95 ]
Cummings 1989 146/388 39/348 14.6 % 4.78 [ 3.23, 7.07 ]
Wilson 1988 53/158 2/75 10.0 % 18.42 [ 4.35, 78.00 ]
Subtotal (99% CI) 2181 1141 74.5 % 7.45 [ 3.30, 16.85 ]
Total events: 650 (Experimental), 72 (Control)
Heterogeneity: Tau2 = 0.39; Chi2 = 18.35, df = 5 (P = 0.003); I2 =73%
Test for overall effect: Z = 6.35 (P < 0.00001)
2 Counselling alone
Strecher 1991 16/156 3/47 10.8 % 1.68 [ 0.47, 6.02 ]
Swartz 2002 343/413 317/394 14.7 % 1.19 [ 0.83, 1.70 ]
Subtotal (99% CI) 569 441 25.5 % 1.22 [ 0.78, 1.92 ]
Total events: 359 (Experimental), 320 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.26, df = 1 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 1.13 (P = 0.26)
Total (99% CI) 2750 1582 100.0 % 4.98 [ 1.79, 13.88 ]
Total events: 1009 (Experimental), 392 (Control)
Heterogeneity: Tau2 = 1.04; Chi2 = 71.38, df = 7 (P<0.00001); I2 =90%
Test for overall effect: Z = 4.04 (P = 0.000054)
Test for subgroup differences: Chi2 = 24.97, df = 1 (P = 0.00), I2 =96%
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Analysis 2.2. Comparison 2 Sub-group: treatment type, Outcome 2 Patient asked to make a follow-up
appointment.
Review: Training health professionals in smoking cessation
Comparison: 2 Sub-group: treatment type
Outcome: 2 Patient asked to make a follow-up appointment
Study or subgroup Experimental Control Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling plus NRT
Cornuz 2002 8/115 4/136 2.47 [ 0.72, 8.42 ]
Cummings (Priv) 1989 42/218 16/148 1.97 [ 1.06, 3.65 ]
Cummings 1989 59/388 17/348 3.49 [ 1.99, 6.12 ]
Wilson 1988 84/158 3/75 27.24 [ 8.23, 90.13 ]
2 Counselling alone
Strecher 1991 76/156 17/47 1.68 [ 0.86, 3.29 ]
Swartz 2002 164/413 151/394 1.06 [ 0.80, 1.41 ]
Unrod 2007 128/270 24/248 8.41 [ 5.19, 13.65 ]
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Analysis 2.3. Comparison 2 Sub-group: treatment type, Outcome 3 Number of smokers counselled.
Review: Training health professionals in smoking cessation
Comparison: 2 Sub-group: treatment type
Outcome: 3 Number of smokers counselled
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling plus NRT
Cohen (Dent) 1989 350/486 60/161 7.4 % 4.33 [ 2.97, 6.31 ]
Cohen (Doc) 1989 691/816 112/273 7.6 % 7.95 [ 5.84, 10.81 ]
Cornuz 2002 45/115 39/136 6.9 % 1.60 [ 0.94, 2.71 ]
Cummings (Priv) 1989 221/343 151/339 7.6 % 2.26 [ 1.66, 3.07 ]
Cummings 1989 392/783 352/785 7.9 % 1.23 [ 1.01, 1.50 ]
Joseph 2004 165/280 162/295 7.5 % 1.18 [ 0.85, 1.64 ]
Sinclair 1998 113/133 99/159 6.7 % 3.42 [ 1.93, 6.08 ]
Twardella 2007 257/377 32/54 6.7 % 1.47 [ 0.82, 2.64 ]
Wilson 1988 123/158 23/75 6.5 % 7.95 [ 4.28, 14.74 ]
Subtotal (99% CI) 3491 2277 64.8 % 2.66 [ 1.33, 5.32 ]
Total events: 2357 (Experimental), 1030 (Control)
Heterogeneity: Tau2 = 0.60; Chi2 = 148.06, df = 8 (P<0.00001); I2 =95%
Test for overall effect: Z = 3.65 (P = 0.00026)
2 Counselling alone
Hymowitz 2007 30/142 15/90 6.3 % 1.34 [ 0.67, 2.66 ]
Lennox 1998 420/529 355/474 7.6 % 1.29 [ 0.96, 1.74 ]
Strecher 1991 114/156 27/47 6.3 % 2.01 [ 1.02, 3.96 ]
Swartz 2002 114/413 82/394 7.6 % 1.45 [ 1.05, 2.01 ]
Unrod 2007 207/270 131/248 7.4 % 2.93 [ 2.01, 4.28 ]
Subtotal (99% CI) 1510 1253 35.2 % 1.71 [ 1.09, 2.68 ]
Total events: 885 (Experimental), 610 (Control)
Heterogeneity: Tau2 = 0.10; Chi2 = 12.91, df = 4 (P = 0.01); I2 =69%
Test for overall effect: Z = 3.07 (P = 0.0021)
Total (99% CI) 5001 3530 100.0 % 2.28 [ 1.41, 3.67 ]
Total events: 3242 (Experimental), 1640 (Control)
Heterogeneity: Tau2 = 0.43; Chi2 = 168.50, df = 13 (P<0.00001); I2 =92%
Test for overall effect: Z = 4.44 (P < 0.00001)
Test for subgroup differences: Chi2 = 1.91, df = 1 (P = 0.17), I2 =48%
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Analysis 2.4. Comparison 2 Sub-group: treatment type, Outcome 4 Number of smokers receiving self-help
material.
Review: Training health professionals in smoking cessation
Comparison: 2 Sub-group: treatment type
Outcome: 4 Number of smokers receiving self-help material
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling plus NRT
Cornuz 2002 16/115 1/136 5.5 % 21.82 [ 2.85, 167.27 ]
Cummings (Priv) 1989 126/343 32/339 13.1 % 5.57 [ 3.64, 8.52 ]
Cummings 1989 195/783 66/785 13.5 % 3.61 [ 2.68, 4.87 ]
Twardella 2007 107/377 8/54 11.4 % 2.28 [ 1.04, 4.99 ]
Wilson 1988 77/158 2/75 7.9 % 34.70 [ 8.23, 146.30 ]
Subtotal (99% CI) 1776 1389 51.5 % 5.50 [ 2.45, 12.36 ]
Total events: 521 (Experimental), 109 (Control)
Heterogeneity: Tau2 = 0.30; Chi2 = 16.28, df = 4 (P = 0.003); I2 =75%
Test for overall effect: Z = 5.43 (P < 0.00001)
2 Counselling alone
Hymowitz 2007 41/142 16/90 12.1 % 1.88 [ 0.98, 3.60 ]
Strecher 1991 19/156 6/47 10.3 % 0.95 [ 0.35, 2.53 ]
Swartz 2002 155/413 142/394 13.6 % 1.07 [ 0.80, 1.42 ]
Unrod 2007 87/270 17/248 12.6 % 6.46 [ 3.71, 11.25 ]
Subtotal (99% CI) 981 779 48.5 % 1.91 [ 0.56, 6.48 ]
Total events: 302 (Experimental), 181 (Control)
Heterogeneity: Tau2 = 0.80; Chi2 = 33.67, df = 3 (P<0.00001); I2 =91%
Test for overall effect: Z = 1.36 (P = 0.18)
Total (99% CI) 2757 2168 100.0 % 3.52 [ 1.56, 7.91 ]
Total events: 823 (Experimental), 290 (Control)
Heterogeneity: Tau2 = 0.71; Chi2 = 87.72, df = 8 (P<0.00001); I2 =91%
Test for overall effect: Z = 4.00 (P = 0.000063)
Test for subgroup differences: Chi2 = 3.46, df = 1 (P = 0.06), I2 =71%
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Analysis 2.5. Comparison 2 Sub-group: treatment type, Outcome 5 Number of smokers receiving nicotine
gum/replacement therapy.
Review: Training health professionals in smoking cessation
Comparison: 2 Sub-group: treatment type
Outcome: 5 Number of smokers receiving nicotine gum/replacement therapy
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling plus NRT
Cummings (Priv) 1989 29/218 29/148 11.8 % 0.63 [ 0.36, 1.11 ]
Cummings 1989 40/388 36/348 12.2 % 1.00 [ 0.62, 1.60 ]
Joseph 2004 59/280 56/295 12.4 % 1.14 [ 0.76, 1.71 ]
Sinclair 1998 219/224 248/268 9.6 % 3.53 [ 1.30, 9.57 ]
Twardella 2007 82/377 4/54 9.4 % 3.47 [ 1.22, 9.90 ]
Wilson 1988 615/1064 108/458 12.9 % 4.44 [ 3.47, 5.69 ]
Subtotal (99% CI) 2551 1571 68.4 % 1.78 [ 0.65, 4.91 ]
Total events: 1044 (Experimental), 481 (Control)
Heterogeneity: Tau2 = 0.82; Chi2 = 71.97, df = 5 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.47 (P = 0.14)
2 Counselling alone
Hymowitz 2007 11/142 5/90 9.1 % 1.43 [ 0.48, 4.25 ]
Strecher 1991 28/156 6/47 9.9 % 1.49 [ 0.58, 3.86 ]
Swartz 2002 127/275 117/241 12.7 % 0.91 [ 0.64, 1.29 ]
Subtotal (99% CI) 573 378 31.6 % 1.00 [ 0.66, 1.50 ]
Total events: 166 (Experimental), 128 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.39, df = 2 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 0.03 (P = 0.98)
Total (99% CI) 3124 1949 100.0 % 1.57 [ 0.72, 3.42 ]
Total events: 1210 (Experimental), 609 (Control)
Heterogeneity: Tau2 = 0.69; Chi2 = 93.68, df = 8 (P<0.00001); I2 =91%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Chi2 = 1.88, df = 1 (P = 0.17), I2 =47%
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Analysis 3.1. Comparison 3 Sub-group: treatment intensity - Number of sessions, Outcome 1 Patient asked
to set a quit date.
Review: Training health professionals in smoking cessation
Comparison: 3 Sub-group: treatment intensity - Number of sessions
Outcome: 1 Patient asked to set a quit date
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single session
Cohen (Dent) 1989 83/486 5/161 12.5 % 6.43 [ 2.56, 16.14 ]
Cohen (Doc) 1989 275/816 5/273 12.7 % 27.25 [ 11.12, 66.78 ]
Wilson 1988 53/158 2/75 10.0 % 18.42 [ 4.35, 78.00 ]
Subtotal (99% CI) 1460 509 35.2 % 14.45 [ 3.98, 52.48 ]
Total events: 411 (Experimental), 12 (Control)
Heterogeneity: Tau2 = 0.45; Chi2 = 5.17, df = 2 (P = 0.08); I2 =61%
Test for overall effect: Z = 5.33 (P < 0.00001)
2 Multiple sessions
Cornuz 2002 9/115 3/136 10.5 % 3.76 [ 0.99, 14.25 ]
Cummings (Priv) 1989 84/218 18/148 14.1 % 4.53 [ 2.58, 7.95 ]
Cummings 1989 146/388 39/348 14.6 % 4.78 [ 3.23, 7.07 ]
Strecher 1991 16/156 3/47 10.8 % 1.68 [ 0.47, 6.02 ]
Swartz 2002 343/413 317/394 14.7 % 1.19 [ 0.83, 1.70 ]
Subtotal (99% CI) 1290 1073 64.8 % 2.79 [ 1.03, 7.55 ]
Total events: 598 (Experimental), 380 (Control)
Heterogeneity: Tau2 = 0.58; Chi2 = 32.13, df = 4 (P<0.00001); I2 =88%
Test for overall effect: Z = 2.65 (P = 0.0081)
Total (99% CI) 2750 1582 100.0 % 4.98 [ 1.79, 13.88 ]
Total events: 1009 (Experimental), 392 (Control)
Heterogeneity: Tau2 = 1.04; Chi2 = 71.38, df = 7 (P<0.00001); I2 =90%
Test for overall effect: Z = 4.04 (P = 0.000054)
Test for subgroup differences: Chi2 = 6.76, df = 1 (P = 0.01), I2 =85%
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Analysis 3.2. Comparison 3 Sub-group: treatment intensity - Number of sessions, Outcome 2 Patient asked
to make a follow-up appointment.
Review: Training health professionals in smoking cessation
Comparison: 3 Sub-group: treatment intensity - Number of sessions
Outcome: 2 Patient asked to make a follow-up appointment
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single session
Unrod 2007 128/270 24/248 15.5 % 8.41 [ 5.19, 13.65 ]
Wilson 1988 84/158 3/75 11.9 % 27.24 [ 8.23, 90.13 ]
Subtotal (99% CI) 428 323 27.4 % 13.33 [ 2.95, 60.24 ]
Total events: 212 (Experimental), 27 (Control)
Heterogeneity: Tau2 = 0.50; Chi2 = 3.32, df = 1 (P = 0.07); I2 =70%
Test for overall effect: Z = 4.42 (P < 0.00001)
2 Multiple sessions
Cornuz 2002 8/115 4/136 11.8 % 2.47 [ 0.72, 8.42 ]
Cummings (Priv) 1989 42/218 16/148 14.9 % 1.97 [ 1.06, 3.65 ]
Cummings 1989 59/388 17/348 15.2 % 3.49 [ 1.99, 6.12 ]
Strecher 1991 76/156 17/47 14.7 % 1.68 [ 0.86, 3.29 ]
Swartz 2002 164/413 151/394 16.1 % 1.06 [ 0.80, 1.41 ]
Subtotal (99% CI) 1290 1073 72.6 % 1.88 [ 0.94, 3.74 ]
Total events: 349 (Experimental), 205 (Control)
Heterogeneity: Tau2 = 0.25; Chi2 = 16.02, df = 4 (P = 0.003); I2 =75%
Test for overall effect: Z = 2.36 (P = 0.018)
Total (99% CI) 1718 1396 100.0 % 3.34 [ 1.18, 9.46 ]
Total events: 561 (Experimental), 232 (Control)
Heterogeneity: Tau2 = 0.99; Chi2 = 77.02, df = 6 (P<0.00001); I2 =92%
Test for overall effect: Z = 2.98 (P = 0.0028)
Test for subgroup differences: Chi2 = 9.27, df = 1 (P = 0.00), I2 =89%
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Analysis 3.3. Comparison 3 Sub-group: treatment intensity - Number of sessions, Outcome 3 Number of
smokers counselled.
Review: Training health professionals in smoking cessation
Comparison: 3 Sub-group: treatment intensity - Number of sessions
Outcome: 3 Number of smokers counselled
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single session
Cohen (Dent) 1989 350/486 60/161 7.4 % 4.33 [ 2.97, 6.31 ]
Cohen (Doc) 1989 691/816 112/273 7.6 % 7.95 [ 5.84, 10.81 ]
Lennox 1998 420/529 355/474 7.6 % 1.29 [ 0.96, 1.74 ]
Sinclair 1998 113/133 99/159 6.7 % 3.42 [ 1.93, 6.08 ]
Twardella 2007 257/377 32/54 6.7 % 1.47 [ 0.82, 2.64 ]
Unrod 2007 207/270 131/248 7.4 % 2.93 [ 2.01, 4.28 ]
Wilson 1988 123/158 23/75 6.5 % 7.95 [ 4.28, 14.74 ]
Subtotal (99% CI) 2769 1444 50.0 % 3.39 [ 1.56, 7.37 ]
Total events: 2161 (Experimental), 812 (Control)
Heterogeneity: Tau2 = 0.58; Chi2 = 87.64, df = 6 (P<0.00001); I2 =93%
Test for overall effect: Z = 4.05 (P = 0.000052)
2 Multiple sessions
Cornuz 2002 45/115 39/136 6.9 % 1.60 [ 0.94, 2.71 ]
Cummings (Priv) 1989 221/343 151/339 7.6 % 2.26 [ 1.66, 3.07 ]
Cummings 1989 392/783 352/785 7.9 % 1.23 [ 1.01, 1.50 ]
Hymowitz 2007 30/142 15/90 6.3 % 1.34 [ 0.67, 2.66 ]
Joseph 2004 165/280 162/295 7.5 % 1.18 [ 0.85, 1.64 ]
Strecher 1991 114/156 27/47 6.3 % 2.01 [ 1.02, 3.96 ]
Swartz 2002 114/413 82/394 7.6 % 1.45 [ 1.05, 2.01 ]
Subtotal (99% CI) 2232 2086 50.0 % 1.50 [ 1.14, 1.98 ]
Total events: 1081 (Experimental), 828 (Control)
Heterogeneity: Tau2 = 0.04; Chi2 = 13.05, df = 6 (P = 0.04); I2 =54%
Test for overall effect: Z = 3.80 (P = 0.00015)
Total (99% CI) 5001 3530 100.0 % 2.28 [ 1.41, 3.67 ]
Total events: 3242 (Experimental), 1640 (Control)
Heterogeneity: Tau2 = 0.43; Chi2 = 168.50, df = 13 (P<0.00001); I2 =92%
Test for overall effect: Z = 4.44 (P < 0.00001)
Test for subgroup differences: Chi2 = 6.47, df = 1 (P = 0.01), I2 =85%
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Analysis 3.4. Comparison 3 Sub-group: treatment intensity - Number of sessions, Outcome 4 Number of
smokers receiving self-help material.
Review: Training health professionals in smoking cessation
Comparison: 3 Sub-group: treatment intensity - Number of sessions
Outcome: 4 Number of smokers receiving self-help material
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single session
Twardella 2007 107/377 8/54 11.4 % 2.28 [ 1.04, 4.99 ]
Unrod 2007 87/270 17/248 12.6 % 6.46 [ 3.71, 11.25 ]
Wilson 1988 77/158 2/75 7.9 % 34.70 [ 8.23, 146.30 ]
Subtotal (99% CI) 805 377 31.9 % 6.93 [ 1.42, 33.76 ]
Total events: 271 (Experimental), 27 (Control)
Heterogeneity: Tau2 = 0.91; Chi2 = 11.92, df = 2 (P = 0.003); I2 =83%
Test for overall effect: Z = 3.15 (P = 0.0016)
2 Multiple sessions
Cornuz 2002 16/115 1/136 5.5 % 21.82 [ 2.85, 167.27 ]
Cummings (Priv) 1989 126/343 32/339 13.1 % 5.57 [ 3.64, 8.52 ]
Cummings 1989 195/783 66/785 13.5 % 3.61 [ 2.68, 4.87 ]
Hymowitz 2007 41/142 16/90 12.1 % 1.88 [ 0.98, 3.60 ]
Strecher 1991 19/156 6/47 10.3 % 0.95 [ 0.35, 2.53 ]
Swartz 2002 155/413 142/394 13.6 % 1.07 [ 0.80, 1.42 ]
Subtotal (99% CI) 1952 1791 68.1 % 2.58 [ 1.01, 6.60 ]
Total events: 552 (Experimental), 263 (Control)
Heterogeneity: Tau2 = 0.64; Chi2 = 61.57, df = 5 (P<0.00001); I2 =92%
Test for overall effect: Z = 2.59 (P = 0.0096)
Total (99% CI) 2757 2168 100.0 % 3.52 [ 1.56, 7.91 ]
Total events: 823 (Experimental), 290 (Control)
Heterogeneity: Tau2 = 0.71; Chi2 = 87.72, df = 8 (P<0.00001); I2 =91%
Test for overall effect: Z = 4.00 (P = 0.000063)
Test for subgroup differences: Chi2 = 1.92, df = 1 (P = 0.17), I2 =48%
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Analysis 3.5. Comparison 3 Sub-group: treatment intensity - Number of sessions, Outcome 5 Number of
smokers receiving nicotine gum/replacement therapy.
Review: Training health professionals in smoking cessation
Comparison: 3 Sub-group: treatment intensity - Number of sessions
Outcome: 5 Number of smokers receiving nicotine gum/replacement therapy
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single session
Sinclair 1998 219/224 248/268 9.6 % 3.53 [ 1.30, 9.57 ]
Twardella 2007 82/377 4/54 9.4 % 3.47 [ 1.22, 9.90 ]
Wilson 1988 615/1064 108/458 12.9 % 4.44 [ 3.47, 5.69 ]
Subtotal (99% CI) 1665 780 31.9 % 4.33 [ 3.18, 5.89 ]
Total events: 916 (Experimental), 360 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.37, df = 2 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 12.26 (P < 0.00001)
2 Multiple sessions
Cummings (Priv) 1989 29/218 29/148 11.8 % 0.63 [ 0.36, 1.11 ]
Cummings 1989 40/388 36/348 12.2 % 1.00 [ 0.62, 1.60 ]
Hymowitz 2007 11/142 5/90 9.1 % 1.43 [ 0.48, 4.25 ]
Joseph 2004 59/280 56/295 12.4 % 1.14 [ 0.76, 1.71 ]
Strecher 1991 28/156 6/47 9.9 % 1.49 [ 0.58, 3.86 ]
Swartz 2002 127/275 117/241 12.7 % 0.91 [ 0.64, 1.29 ]
Subtotal (99% CI) 1459 1169 68.1 % 0.97 [ 0.74, 1.27 ]
Total events: 294 (Experimental), 249 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 4.28, df = 5 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 0.30 (P = 0.77)
Total (99% CI) 3124 1949 100.0 % 1.57 [ 0.72, 3.42 ]
Total events: 1210 (Experimental), 609 (Control)
Heterogeneity: Tau2 = 0.69; Chi2 = 93.68, df = 8 (P<0.00001); I2 =91%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Chi2 = 88.84, df = 1 (P = 0.00), I2 =99%
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Analysis 4.1. Comparison 4 Sub-group: treatment intensity - Total exposure, Outcome 1 Patient asked to
set a quit date.
Review: Training health professionals in smoking cessation
Comparison: 4 Sub-group: treatment intensity - Total exposure
Outcome: 1 Patient asked to set a quit date
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Duration 40 minutes to 2 hours
Cohen (Dent) 1989 83/486 5/161 12.5 % 6.43 [ 2.56, 16.14 ]
Cohen (Doc) 1989 275/816 5/273 12.7 % 27.25 [ 11.12, 66.78 ]
Strecher 1991 16/156 3/47 10.8 % 1.68 [ 0.47, 6.02 ]
Swartz 2002 343/413 317/394 14.7 % 1.19 [ 0.83, 1.70 ]
Wilson 1988 53/158 2/75 10.0 % 18.42 [ 4.35, 78.00 ]
Subtotal (99% CI) 2029 950 60.7 % 5.63 [ 0.71, 44.43 ]
Total events: 770 (Experimental), 332 (Control)
Heterogeneity: Tau2 = 2.94; Chi2 = 67.50, df = 4 (P<0.00001); I2 =94%
Test for overall effect: Z = 2.16 (P = 0.031)
2 Duration >2 to 4 hours
Cummings (Priv) 1989 84/218 18/148 14.1 % 4.53 [ 2.58, 7.95 ]
Cummings 1989 146/388 39/348 14.6 % 4.78 [ 3.23, 7.07 ]
Subtotal (99% CI) 606 496 28.7 % 4.70 [ 3.08, 7.16 ]
Total events: 230 (Experimental), 57 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 9.43 (P < 0.00001)
3 Duration >4 hours
Cornuz 2002 9/115 3/136 10.5 % 3.76 [ 0.99, 14.25 ]
Subtotal (99% CI) 115 136 10.5 % 3.76 [ 0.65, 21.65 ]
Total events: 9 (Experimental), 3 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.95 (P = 0.051)
Total (99% CI) 2750 1582 100.0 % 4.98 [ 1.79, 13.88 ]
Total events: 1009 (Experimental), 392 (Control)
Heterogeneity: Tau2 = 1.04; Chi2 = 71.38, df = 7 (P<0.00001); I2 =90%
Test for overall effect: Z = 4.04 (P = 0.000054)
Test for subgroup differences: Chi2 = 0.16, df = 2 (P = 0.92), I2 =0.0%
0.02 0.1 1 10 50
Favours control Favours experimental
95Training health professionals in smoking cessation (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.2. Comparison 4 Sub-group: treatment intensity - Total exposure, Outcome 2 Patient asked to
make a follow-up appointment.
Review: Training health professionals in smoking cessation
Comparison: 4 Sub-group: treatment intensity - Total exposure
Outcome: 2 Patient asked to make a follow-up appointment
Study or subgroup Experimental Control Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Duration 40 minutes to 2 hours
Strecher 1991 76/156 17/47 1.68 [ 0.86, 3.29 ]
Swartz 2002 164/413 151/394 1.06 [ 0.80, 1.41 ]
Unrod 2007 128/270 24/248 8.41 [ 5.19, 13.65 ]
Wilson 1988 84/158 3/75 27.24 [ 8.23, 90.13 ]
2 Duration >2 to 4 hours
Cummings (Priv) 1989 42/218 16/148 1.97 [ 1.06, 3.65 ]
Cummings 1989 59/388 17/348 3.49 [ 1.99, 6.12 ]
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Analysis 4.3. Comparison 4 Sub-group: treatment intensity - Total exposure, Outcome 3 Number of
smokers counselled.
Review: Training health professionals in smoking cessation
Comparison: 4 Sub-group: treatment intensity - Total exposure
Outcome: 3 Number of smokers counselled
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Duration 40 minutes to 2 hours
Cohen (Dent) 1989 350/486 60/161 7.4 % 4.33 [ 2.97, 6.31 ]
Cohen (Doc) 1989 691/816 112/273 7.6 % 7.95 [ 5.84, 10.81 ]
Sinclair 1998 113/133 99/159 6.7 % 3.42 [ 1.93, 6.08 ]
Strecher 1991 114/156 27/47 6.3 % 2.01 [ 1.02, 3.96 ]
Swartz 2002 114/413 82/394 7.6 % 1.45 [ 1.05, 2.01 ]
Twardella 2007 257/377 32/54 6.7 % 1.47 [ 0.82, 2.64 ]
Unrod 2007 207/270 131/248 7.4 % 2.93 [ 2.01, 4.28 ]
Wilson 1988 123/158 23/75 6.5 % 7.95 [ 4.28, 14.74 ]
Subtotal (99% CI) 2809 1411 56.2 % 3.25 [ 1.67, 6.33 ]
Total events: 1969 (Experimental), 566 (Control)
Heterogeneity: Tau2 = 0.47; Chi2 = 75.38, df = 7 (P<0.00001); I2 =91%
Test for overall effect: Z = 4.55 (P < 0.00001)
2 Duration >2 to 4 hours
Cummings (Priv) 1989 221/343 151/339 7.6 % 2.26 [ 1.66, 3.07 ]
Cummings 1989 392/783 352/785 7.9 % 1.23 [ 1.01, 1.50 ]
Hymowitz 2007 30/142 15/90 6.3 % 1.34 [ 0.67, 2.66 ]
Subtotal (99% CI) 1268 1214 21.7 % 1.57 [ 0.86, 2.86 ]
Total events: 643 (Experimental), 518 (Control)
Heterogeneity: Tau2 = 0.12; Chi2 = 10.50, df = 2 (P = 0.01); I2 =81%
Test for overall effect: Z = 1.94 (P = 0.053)
3 Duration >4 hours
Cornuz 2002 45/115 39/136 6.9 % 1.60 [ 0.94, 2.71 ]
Joseph 2004 165/280 162/295 7.5 % 1.18 [ 0.85, 1.64 ]
Lennox 1998 420/529 355/474 7.6 % 1.29 [ 0.96, 1.74 ]
Subtotal (99% CI) 924 905 22.1 % 1.29 [ 0.99, 1.68 ]
Total events: 630 (Experimental), 556 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.93, df = 2 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 2.44 (P = 0.015)
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(. . . Continued)
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Total (99% CI) 5001 3530 100.0 % 2.28 [ 1.41, 3.67 ]
Total events: 3242 (Experimental), 1640 (Control)
Heterogeneity: Tau2 = 0.43; Chi2 = 168.50, df = 13 (P<0.00001); I2 =92%
Test for overall effect: Z = 4.44 (P < 0.00001)
Test for subgroup differences: Chi2 = 11.07, df = 2 (P = 0.00), I2 =82%
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Analysis 4.4. Comparison 4 Sub-group: treatment intensity - Total exposure, Outcome 4 Number of
smokers receiving self-help material.
Review: Training health professionals in smoking cessation
Comparison: 4 Sub-group: treatment intensity - Total exposure
Outcome: 4 Number of smokers receiving self-help material
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Duration 40 minutes to 2 hours
Strecher 1991 19/156 6/47 10.3 % 0.95 [ 0.35, 2.53 ]
Swartz 2002 155/413 142/394 13.6 % 1.07 [ 0.80, 1.42 ]
Twardella 2007 107/377 8/54 11.4 % 2.28 [ 1.04, 4.99 ]
Unrod 2007 87/270 17/248 12.6 % 6.46 [ 3.71, 11.25 ]
Wilson 1988 77/158 2/75 7.9 % 34.70 [ 8.23, 146.30 ]
Subtotal (99% CI) 1374 818 55.8 % 3.16 [ 0.77, 13.07 ]
Total events: 445 (Experimental), 175 (Control)
Heterogeneity: Tau2 = 1.33; Chi2 = 54.03, df = 4 (P<0.00001); I2 =93%
Test for overall effect: Z = 2.09 (P = 0.037)
2 Duration >2 to 4 hours
Cummings (Priv) 1989 126/343 32/339 13.1 % 5.57 [ 3.64, 8.52 ]
Cummings 1989 195/783 66/785 13.5 % 3.61 [ 2.68, 4.87 ]
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(. . . Continued)
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Hymowitz 2007 41/142 16/90 12.1 % 1.88 [ 0.98, 3.60 ]
Subtotal (99% CI) 1268 1214 38.7 % 3.54 [ 1.84, 6.83 ]
Total events: 362 (Experimental), 114 (Control)
Heterogeneity: Tau2 = 0.14; Chi2 = 7.73, df = 2 (P = 0.02); I2 =74%
Test for overall effect: Z = 4.97 (P < 0.00001)
3 Duration >4 hours
Cornuz 2002 16/115 1/136 5.5 % 21.82 [ 2.85, 167.27 ]
Subtotal (99% CI) 115 136 5.5 % 21.82 [ 1.50, 317.23 ]
Total events: 16 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.97 (P = 0.0030)
Total (99% CI) 2757 2168 100.0 % 3.52 [ 1.56, 7.91 ]
Total events: 823 (Experimental), 290 (Control)
Heterogeneity: Tau2 = 0.71; Chi2 = 87.72, df = 8 (P<0.00001); I2 =91%
Test for overall effect: Z = 4.00 (P = 0.000063)
Test for subgroup differences: Chi2 = 3.01, df = 2 (P = 0.22), I2 =34%
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Analysis 4.5. Comparison 4 Sub-group: treatment intensity - Total exposure, Outcome 5 Number of
smokers receiving nicotine gum/replacement therapy.
Review: Training health professionals in smoking cessation
Comparison: 4 Sub-group: treatment intensity - Total exposure
Outcome: 5 Number of smokers receiving nicotine gum/replacement therapy
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Duration 40 minutes to 2 hours
Sinclair 1998 219/224 248/268 9.6 % 3.53 [ 1.30, 9.57 ]
Strecher 1991 28/156 6/47 9.9 % 1.49 [ 0.58, 3.86 ]
Swartz 2002 127/275 117/241 12.7 % 0.91 [ 0.64, 1.29 ]
Twardella 2007 82/377 4/54 9.4 % 3.47 [ 1.22, 9.90 ]
Wilson 1988 615/1064 108/458 12.9 % 4.44 [ 3.47, 5.69 ]
Subtotal (99% CI) 2096 1068 54.4 % 2.33 [ 0.73, 7.43 ]
Total events: 1071 (Experimental), 483 (Control)
Heterogeneity: Tau2 = 0.86; Chi2 = 55.22, df = 4 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.88 (P = 0.061)
2 Duration >2 to 4 hours
Cummings (Priv) 1989 29/218 29/148 11.8 % 0.63 [ 0.36, 1.11 ]
Cummings 1989 40/388 36/348 12.2 % 1.00 [ 0.62, 1.60 ]
Hymowitz 2007 11/142 5/90 9.1 % 1.43 [ 0.48, 4.25 ]
Subtotal (99% CI) 748 586 33.1 % 0.87 [ 0.52, 1.45 ]
Total events: 80 (Experimental), 70 (Control)
Heterogeneity: Tau2 = 0.02; Chi2 = 2.37, df = 2 (P = 0.31); I2 =16%
Test for overall effect: Z = 0.69 (P = 0.49)
3 Duration >4 hours
Joseph 2004 59/280 56/295 12.4 % 1.14 [ 0.76, 1.71 ]
Subtotal (99% CI) 280 295 12.4 % 1.14 [ 0.67, 1.95 ]
Total events: 59 (Experimental), 56 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.63 (P = 0.53)
Total (99% CI) 3124 1949 100.0 % 1.57 [ 0.72, 3.42 ]
Total events: 1210 (Experimental), 609 (Control)
Heterogeneity: Tau2 = 0.69; Chi2 = 93.68, df = 8 (P<0.00001); I2 =91%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Chi2 = 4.13, df = 2 (P = 0.13), I2 =52%
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Analysis 5.1. Comparison 5 Sub-group: mode of intervention delivery, Outcome 1 Patient asked to set a
quit date.
Review: Training health professionals in smoking cessation
Comparison: 5 Sub-group: mode of intervention delivery
Outcome: 1 Patient asked to set a quit date
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 One-on-one
Cohen (Dent) 1989 83/486 5/161 25.1 % 6.43 [ 2.56, 16.14 ]
Cohen (Doc) 1989 275/816 5/273 25.4 % 27.25 [ 11.12, 66.78 ]
Cornuz 2002 9/115 3/136 20.0 % 3.76 [ 0.99, 14.25 ]
Cummings (Priv) 1989 84/218 18/148 29.5 % 4.53 [ 2.58, 7.95 ]
Subtotal (99% CI) 1635 718 100.0 % 7.52 [ 2.17, 26.12 ]
Total events: 451 (Experimental), 31 (Control)
Heterogeneity: Tau2 = 0.71; Chi2 = 13.87, df = 3 (P = 0.003); I2 =78%
Test for overall effect: Z = 4.18 (P = 0.000030)
2 Group sessions
Cohen (Dent) 1989 83/486 5/161 12.5 % 6.43 [ 2.56, 16.14 ]
Cohen (Doc) 1989 275/816 5/273 12.7 % 27.25 [ 11.12, 66.78 ]
Cornuz 2002 9/115 3/136 10.5 % 3.76 [ 0.99, 14.25 ]
Cummings (Priv) 1989 84/218 18/148 14.1 % 4.53 [ 2.58, 7.95 ]
Cummings 1989 146/388 39/348 14.6 % 4.78 [ 3.23, 7.07 ]
Strecher 1991 16/156 3/47 10.8 % 1.68 [ 0.47, 6.02 ]
Swartz 2002 343/413 317/394 14.7 % 1.19 [ 0.83, 1.70 ]
Wilson 1988 53/158 2/75 10.0 % 18.42 [ 4.35, 78.00 ]
Subtotal (99% CI) 2750 1582 100.0 % 4.98 [ 1.79, 13.88 ]
Total events: 1009 (Experimental), 392 (Control)
Heterogeneity: Tau2 = 1.04; Chi2 = 71.38, df = 7 (P<0.00001); I2 =90%
Test for overall effect: Z = 4.04 (P = 0.000054)
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Analysis 5.2. Comparison 5 Sub-group: mode of intervention delivery, Outcome 2 Patient asked to make a
follow-up appointment.
Review: Training health professionals in smoking cessation
Comparison: 5 Sub-group: mode of intervention delivery
Outcome: 2 Patient asked to make a follow-up appointment
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 One-on-one
Cornuz 2002 8/115 4/136 26.7 % 2.47 [ 0.72, 8.42 ]
Cummings (Priv) 1989 42/218 16/148 35.8 % 1.97 [ 1.06, 3.65 ]
Unrod 2007 128/270 24/248 37.5 % 8.41 [ 5.19, 13.65 ]
Subtotal (99% CI) 603 532 100.0 % 3.60 [ 0.86, 15.08 ]
Total events: 178 (Experimental), 44 (Control)
Heterogeneity: Tau2 = 0.76; Chi2 = 14.22, df = 2 (P = 0.00082); I2 =86%
Test for overall effect: Z = 2.31 (P = 0.021)
2 Group sessions
Cornuz 2002 8/115 4/136 13.0 % 2.47 [ 0.72, 8.42 ]
Cummings (Priv) 1989 42/218 16/148 17.9 % 1.97 [ 1.06, 3.65 ]
Cummings 1989 59/388 17/348 18.4 % 3.49 [ 1.99, 6.12 ]
Strecher 1991 76/156 17/47 17.5 % 1.68 [ 0.86, 3.29 ]
Swartz 2002 164/413 151/394 20.0 % 1.06 [ 0.80, 1.41 ]
Wilson 1988 84/158 3/75 13.2 % 27.24 [ 8.23, 90.13 ]
Subtotal (99% CI) 1448 1148 100.0 % 2.74 [ 1.06, 7.08 ]
Total events: 433 (Experimental), 208 (Control)
Heterogeneity: Tau2 = 0.66; Chi2 = 39.67, df = 5 (P<0.00001); I2 =87%
Test for overall effect: Z = 2.73 (P = 0.0064)
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Analysis 5.3. Comparison 5 Sub-group: mode of intervention delivery, Outcome 3 Number of smokers
counselled.
Review: Training health professionals in smoking cessation
Comparison: 5 Sub-group: mode of intervention delivery
Outcome: 3 Number of smokers counselled
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 One-on-one
Cohen (Dent) 1989 350/486 60/161 16.7 % 4.33 [ 2.97, 6.31 ]
Cohen (Doc) 1989 691/816 112/273 17.0 % 7.95 [ 5.84, 10.81 ]
Cornuz 2002 45/115 39/136 15.6 % 1.60 [ 0.94, 2.71 ]
Cummings (Priv) 1989 221/343 151/339 17.0 % 2.26 [ 1.66, 3.07 ]
Joseph 2004 165/280 162/295 16.9 % 1.18 [ 0.85, 1.64 ]
Unrod 2007 207/270 131/248 16.7 % 2.93 [ 2.01, 4.28 ]
Subtotal (99% CI) 2310 1452 100.0 % 2.76 [ 1.27, 6.01 ]
Total events: 1679 (Experimental), 655 (Control)
Heterogeneity: Tau2 = 0.51; Chi2 = 81.78, df = 5 (P<0.00001); I2 =94%
Test for overall effect: Z = 3.37 (P = 0.00075)
2 Group sessions
Cohen (Dent) 1989 350/486 60/161 8.8 % 4.33 [ 2.97, 6.31 ]
Cohen (Doc) 1989 691/816 112/273 9.0 % 7.95 [ 5.84, 10.81 ]
Cornuz 2002 17/115 8/136 6.7 % 2.78 [ 1.15, 6.70 ]
Cummings (Priv) 1989 221/343 151/339 9.0 % 2.26 [ 1.66, 3.07 ]
Cummings 1989 392/783 352/785 9.3 % 1.23 [ 1.01, 1.50 ]
Hymowitz 2007 30/142 15/90 7.6 % 1.34 [ 0.67, 2.66 ]
Lennox 1998 420/529 355/474 9.0 % 1.29 [ 0.96, 1.74 ]
Sinclair 1998 113/133 99/159 8.1 % 3.42 [ 1.93, 6.08 ]
Strecher 1991 114/156 27/47 7.6 % 2.01 [ 1.02, 3.96 ]
Swartz 2002 114/413 82/394 9.0 % 1.45 [ 1.05, 2.01 ]
Twardella 2007 257/377 32/54 8.0 % 1.47 [ 0.82, 2.64 ]
Wilson 1988 123/158 23/75 7.9 % 7.95 [ 4.28, 14.74 ]
Subtotal (99% CI) 4451 2987 100.0 % 2.47 [ 1.41, 4.30 ]
Total events: 2842 (Experimental), 1316 (Control)
Heterogeneity: Tau2 = 0.49; Chi2 = 153.53, df = 11 (P<0.00001); I2 =93%
Test for overall effect: Z = 4.18 (P = 0.000029)
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Analysis 5.4. Comparison 5 Sub-group: mode of intervention delivery, Outcome 4 Number of smokers
receiving self-help material.
Review: Training health professionals in smoking cessation
Comparison: 5 Sub-group: mode of intervention delivery
Outcome: 4 Number of smokers receiving self-help material
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 One-on-one
Cornuz 2002 16/115 1/136 2.7 % 21.82 [ 2.85, 167.27 ]
Cummings (Priv) 1989 126/343 32/339 61.3 % 5.57 [ 3.64, 8.52 ]
Unrod 2007 87/270 17/248 36.0 % 6.46 [ 3.71, 11.25 ]
Subtotal (99% CI) 728 723 100.0 % 6.09 [ 3.93, 9.44 ]
Total events: 229 (Experimental), 50 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.75, df = 2 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 10.64 (P < 0.00001)
2 Group sessions
Cornuz 2002 16/115 1/136 6.3 % 21.82 [ 2.85, 167.27 ]
Cummings (Priv) 1989 126/343 32/339 15.0 % 5.57 [ 3.64, 8.52 ]
Cummings 1989 195/783 66/785 15.5 % 3.61 [ 2.68, 4.87 ]
Hymowitz 2007 41/142 16/90 13.8 % 1.88 [ 0.98, 3.60 ]
Strecher 1991 19/156 6/47 11.8 % 0.95 [ 0.35, 2.53 ]
Swartz 2002 155/413 142/394 15.5 % 1.07 [ 0.80, 1.42 ]
Twardella 2007 107/377 8/54 13.0 % 2.28 [ 1.04, 4.99 ]
Wilson 1988 77/158 2/75 9.1 % 34.70 [ 8.23, 146.30 ]
Subtotal (99% CI) 2487 1920 100.0 % 3.22 [ 1.36, 7.65 ]
Total events: 736 (Experimental), 273 (Control)
Heterogeneity: Tau2 = 0.70; Chi2 = 76.22, df = 7 (P<0.00001); I2 =91%
Test for overall effect: Z = 3.49 (P = 0.00049)
0.01 0.1 1 10 100
Favours control Favours experimental
104Training health professionals in smoking cessation (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 5.5. Comparison 5 Sub-group: mode of intervention delivery, Outcome 5 Number of smokers
receiving nicotine gum/replacement therapy.
Review: Training health professionals in smoking cessation
Comparison: 5 Sub-group: mode of intervention delivery
Outcome: 5 Number of smokers receiving nicotine gum/replacement therapy
Study or subgroup Favours control Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 One-on-one
Cummings (Priv) 1989 29/218 29/148 44.4 % 0.63 [ 0.36, 1.11 ]
Joseph 2004 59/280 56/295 55.6 % 1.14 [ 0.76, 1.71 ]
Subtotal (99% CI) 498 443 100.0 % 0.88 [ 0.41, 1.87 ]
Total events: 88 (Favours control), 85 (Control)
Heterogeneity: Tau2 = 0.11; Chi2 = 2.79, df = 1 (P = 0.09); I2 =64%
Test for overall effect: Z = 0.45 (P = 0.65)
2 Group sessions
Cummings (Priv) 1989 29/218 29/148 13.4 % 0.63 [ 0.36, 1.11 ]
Cummings 1989 40/388 36/348 13.8 % 1.00 [ 0.62, 1.60 ]
Hymowitz 2007 11/142 5/90 10.7 % 1.43 [ 0.48, 4.25 ]
Sinclair 1998 219/224 248/268 11.2 % 3.53 [ 1.30, 9.57 ]
Strecher 1991 28/156 6/47 11.4 % 1.49 [ 0.58, 3.86 ]
Swartz 2002 127/275 117/241 14.2 % 0.91 [ 0.64, 1.29 ]
Twardella 2007 82/377 4/54 10.9 % 3.47 [ 1.22, 9.90 ]
Wilson 1988 615/1064 108/458 14.5 % 4.44 [ 3.47, 5.69 ]
Subtotal (99% CI) 2844 1654 100.0 % 1.65 [ 0.68, 4.01 ]
Total events: 1151 (Favours control), 553 (Control)
Heterogeneity: Tau2 = 0.81; Chi2 = 87.14, df = 7 (P<0.00001); I2 =92%
Test for overall effect: Z = 1.45 (P = 0.15)
Test for subgroup differences: Chi2 = 1.95, df = 1 (P = 0.16), I2 =49%
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Analysis 6.1. Comparison 6 Sub-group: behavioural change technique used, Outcome 1 Patient asked to set
a quit date.
Review: Training health professionals in smoking cessation
Comparison: 6 Sub-group: behavioural change technique used
Outcome: 1 Patient asked to set a quit date
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Prompting
Cohen (Dent) 1989 83/486 5/161 20.3 % 6.43 [ 2.56, 16.14 ]
Cohen (Doc) 1989 275/816 5/273 20.4 % 27.25 [ 11.12, 66.78 ]
Strecher 1991 16/156 3/47 18.9 % 1.68 [ 0.47, 6.02 ]
Subtotal (99% CI) 1458 481 59.5 % 6.99 [ 0.90, 54.02 ]
Total events: 374 (Experimental), 13 (Control)
Heterogeneity: Tau2 = 1.61; Chi2 = 14.02, df = 2 (P = 0.00090); I2 =86%
Test for overall effect: Z = 2.45 (P = 0.014)
2 Provide feedback
Cornuz 2002 9/115 3/136 18.6 % 3.76 [ 0.99, 14.25 ]
Swartz 2002 343/413 317/394 21.8 % 1.19 [ 0.83, 1.70 ]
Subtotal (99% CI) 528 530 40.5 % 1.76 [ 0.43, 7.17 ]
Total events: 352 (Experimental), 320 (Control)
Heterogeneity: Tau2 = 0.42; Chi2 = 2.69, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 1.03 (P = 0.30)
Total (99% CI) 1986 1011 100.0 % 4.19 [ 0.63, 28.09 ]
Total events: 726 (Experimental), 333 (Control)
Heterogeneity: Tau2 = 2.46; Chi2 = 58.36, df = 4 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.94 (P = 0.052)
Test for subgroup differences: Chi2 = 2.05, df = 1 (P = 0.15), I2 =51%
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Analysis 6.2. Comparison 6 Sub-group: behavioural change technique used, Outcome 2 Patient asked to
make a follow-up appointment.
Review: Training health professionals in smoking cessation
Comparison: 6 Sub-group: behavioural change technique used
Outcome: 2 Patient asked to make a follow-up appointment
Study or subgroup Experimental Control Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Prompting
Strecher 1991 76/156 17/47 1.68 [ 0.86, 3.29 ]
2 Provide feedback
Cornuz 2002 8/115 4/136 2.47 [ 0.72, 8.42 ]
Swartz 2002 164/413 151/394 1.06 [ 0.80, 1.41 ]
Unrod 2007 128/270 24/248 8.41 [ 5.19, 13.65 ]
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Analysis 6.3. Comparison 6 Sub-group: behavioural change technique used, Outcome 3 Number of smokers
counselled.
Review: Training health professionals in smoking cessation
Comparison: 6 Sub-group: behavioural change technique used
Outcome: 3 Number of smokers counselled
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Prompting
Cohen (Dent) 1989 350/486 60/161 12.9 % 4.33 [ 2.97, 6.31 ]
Cohen (Doc) 1989 691/816 112/273 13.2 % 7.95 [ 5.84, 10.81 ]
Hymowitz 2007 30/142 15/90 11.3 % 1.34 [ 0.67, 2.66 ]
Strecher 1991 114/156 27/47 11.3 % 2.01 [ 1.02, 3.96 ]
Subtotal (99% CI) 1600 571 48.7 % 3.27 [ 1.23, 8.68 ]
Total events: 1185 (Experimental), 214 (Control)
Heterogeneity: Tau2 = 0.50; Chi2 = 30.38, df = 3 (P<0.00001); I2 =90%
Test for overall effect: Z = 3.12 (P = 0.0018)
2 Provide feedback
Cornuz 2002 45/115 39/136 12.2 % 1.60 [ 0.94, 2.71 ]
Joseph 2004 165/280 162/295 13.1 % 1.18 [ 0.85, 1.64 ]
Swartz 2002 114/413 82/394 13.1 % 1.45 [ 1.05, 2.01 ]
Unrod 2007 207/270 131/248 12.9 % 2.93 [ 2.01, 4.28 ]
Subtotal (99% CI) 1078 1073 51.3 % 1.67 [ 0.99, 2.85 ]
Total events: 531 (Experimental), 414 (Control)
Heterogeneity: Tau2 = 0.13; Chi2 = 13.58, df = 3 (P = 0.004); I2 =78%
Test for overall effect: Z = 2.50 (P = 0.012)
Total (99% CI) 2678 1644 100.0 % 2.32 [ 1.13, 4.74 ]
Total events: 1716 (Experimental), 628 (Control)
Heterogeneity: Tau2 = 0.56; Chi2 = 100.16, df = 7 (P<0.00001); I2 =93%
Test for overall effect: Z = 3.03 (P = 0.0025)
Test for subgroup differences: Chi2 = 2.40, df = 1 (P = 0.12), I2 =58%
0.1 0.2 0.5 1 2 5 10
Favours control Favours experimental
108Training health professionals in smoking cessation (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 6.4. Comparison 6 Sub-group: behavioural change technique used, Outcome 4 Number of smokers
receiving self-help material.
Review: Training health professionals in smoking cessation
Comparison: 6 Sub-group: behavioural change technique used
Outcome: 4 Number of smokers receiving self-help material
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Prompting
Hymowitz 2007 41/142 16/90 22.1 % 1.88 [ 0.98, 3.60 ]
Strecher 1991 19/156 6/47 19.5 % 0.95 [ 0.35, 2.53 ]
Subtotal (99% CI) 298 137 41.6 % 1.48 [ 0.64, 3.42 ]
Total events: 60 (Experimental), 22 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 1.29, df = 1 (P = 0.26); I2 =23%
Test for overall effect: Z = 1.20 (P = 0.23)
2 Provide feedback
Cornuz 2002 16/115 1/136 11.4 % 21.82 [ 2.85, 167.27 ]
Swartz 2002 155/413 142/394 24.2 % 1.07 [ 0.80, 1.42 ]
Unrod 2007 87/270 17/248 22.8 % 6.46 [ 3.71, 11.25 ]
Subtotal (99% CI) 798 778 58.4 % 4.33 [ 0.51, 36.60 ]
Total events: 258 (Experimental), 160 (Control)
Heterogeneity: Tau2 = 1.76; Chi2 = 39.39, df = 2 (P<0.00001); I2 =95%
Test for overall effect: Z = 1.77 (P = 0.077)
Total (99% CI) 1096 915 100.0 % 2.51 [ 0.74, 8.58 ]
Total events: 318 (Experimental), 182 (Control)
Heterogeneity: Tau2 = 0.92; Chi2 = 40.61, df = 4 (P<0.00001); I2 =90%
Test for overall effect: Z = 1.93 (P = 0.054)
Test for subgroup differences: Chi2 = 1.46, df = 1 (P = 0.23), I2 =31%
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Analysis 6.5. Comparison 6 Sub-group: behavioural change technique used, Outcome 5 Number of smokers
receiving nicotine gum/replacement therapy.
Review: Training health professionals in smoking cessation
Comparison: 6 Sub-group: behavioural change technique used
Outcome: 5 Number of smokers receiving nicotine gum/replacement therapy
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Provide feedback
Joseph 2004 59/280 56/295 34.9 % 1.14 [ 0.76, 1.71 ]
Swartz 2002 127/275 117/241 54.4 % 0.91 [ 0.64, 1.29 ]
Subtotal (99% CI) 555 536 89.3 % 1.00 [ 0.71, 1.41 ]
Total events: 186 (Experimental), 173 (Control)
Heterogeneity: Chi2 = 0.68, df = 1 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 1.0)
2 Prompting
Hymowitz 2007 11/142 5/90 4.6 % 1.43 [ 0.48, 4.25 ]
Strecher 1991 28/156 6/47 6.1 % 1.49 [ 0.58, 3.86 ]
Subtotal (99% CI) 298 137 10.7 % 1.47 [ 0.57, 3.76 ]
Total events: 39 (Experimental), 11 (Control)
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 1.05 (P = 0.30)
Total (99% CI) 853 673 100.0 % 1.05 [ 0.76, 1.45 ]
Total events: 225 (Experimental), 184 (Control)
Heterogeneity: Chi2 = 1.65, df = 3 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 0.38 (P = 0.70)
Test for subgroup differences: Chi2 = 0.97, df = 1 (P = 0.33), I2 =0.0%
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Analysis 7.1. Comparison 7 Sub-group: type of professional being trained, Outcome 1 Patient asked to set a
quit date.
Review: Training health professionals in smoking cessation
Comparison: 7 Sub-group: type of professional being trained
Outcome: 1 Patient asked to set a quit date
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Doctor
Cohen (Doc) 1989 275/816 5/273 12.7 % 27.25 [ 11.12, 66.78 ]
Cornuz 2002 9/115 3/136 10.5 % 3.76 [ 0.99, 14.25 ]
Cummings (Priv) 1989 84/218 18/148 14.1 % 4.53 [ 2.58, 7.95 ]
Cummings 1989 146/388 39/348 14.6 % 4.78 [ 3.23, 7.07 ]
Strecher 1991 16/156 3/47 10.8 % 1.68 [ 0.47, 6.02 ]
Wilson 1988 53/158 2/75 10.0 % 18.42 [ 4.35, 78.00 ]
Subtotal (99% CI) 1851 1027 72.7 % 6.35 [ 2.49, 16.19 ]
Total events: 583 (Experimental), 70 (Control)
Heterogeneity: Tau2 = 0.55; Chi2 = 22.23, df = 5 (P = 0.00047); I2 =78%
Test for overall effect: Z = 5.08 (P < 0.00001)
2 Dentist
Cohen (Dent) 1989 83/486 5/161 12.5 % 6.43 [ 2.56, 16.14 ]
Subtotal (99% CI) 486 161 12.5 % 6.43 [ 1.91, 21.56 ]
Total events: 83 (Experimental), 5 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 3.96 (P = 0.000076)
3 Healthcare worker
Swartz 2002 343/413 317/394 14.7 % 1.19 [ 0.83, 1.70 ]
Subtotal (99% CI) 413 394 14.7 % 1.19 [ 0.74, 1.91 ]
Total events: 343 (Experimental), 317 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.95 (P = 0.34)
Total (99% CI) 2750 1582 100.0 % 4.98 [ 1.79, 13.88 ]
Total events: 1009 (Experimental), 392 (Control)
Heterogeneity: Tau2 = 1.04; Chi2 = 71.38, df = 7 (P<0.00001); I2 =90%
Test for overall effect: Z = 4.04 (P = 0.000054)
Test for subgroup differences: Chi2 = 24.26, df = 2 (P = 0.00), I2 =92%
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Analysis 7.2. Comparison 7 Sub-group: type of professional being trained, Outcome 2 Patient asked to
make a follow-up appointment.
Review: Training health professionals in smoking cessation
Comparison: 7 Sub-group: type of professional being trained
Outcome: 2 Patient asked to make a follow-up appointment
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Doctor
Cornuz 2002 8/115 4/136 11.8 % 2.47 [ 0.72, 8.42 ]
Cummings (Priv) 1989 42/218 16/148 14.9 % 1.97 [ 1.06, 3.65 ]
Cummings 1989 59/388 17/348 15.2 % 3.49 [ 1.99, 6.12 ]
Strecher 1991 76/156 17/47 14.7 % 1.68 [ 0.86, 3.29 ]
Swartz 2002 164/413 151/394 16.1 % 1.06 [ 0.80, 1.41 ]
Unrod 2007 128/270 24/248 15.5 % 8.41 [ 5.19, 13.65 ]
Wilson 1988 84/158 3/75 11.9 % 27.24 [ 8.23, 90.13 ]
Subtotal (99% CI) 1718 1396 100.0 % 3.34 [ 1.18, 9.46 ]
Total events: 561 (Experimental), 232 (Control)
Heterogeneity: Tau2 = 0.99; Chi2 = 77.02, df = 6 (P<0.00001); I2 =92%
Test for overall effect: Z = 2.98 (P = 0.0028)
2 Healthcare worker
Swartz 2002 164/413 151/394 100.0 % 1.06 [ 0.80, 1.41 ]
Subtotal (99% CI) 413 394 100.0 % 1.06 [ 0.73, 1.54 ]
Total events: 164 (Experimental), 151 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.40 (P = 0.69)
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Analysis 7.3. Comparison 7 Sub-group: type of professional being trained, Outcome 3 Number of smokers
counselled.
Review: Training health professionals in smoking cessation
Comparison: 7 Sub-group: type of professional being trained
Outcome: 3 Number of smokers counselled
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Doctor
Cohen (Doc) 1989 691/816 112/273 6.3 % 7.95 [ 5.84, 10.81 ]
Cornuz 2002 45/115 39/136 5.6 % 1.60 [ 0.94, 2.71 ]
Cummings (Priv) 1989 221/343 151/339 6.3 % 2.26 [ 1.66, 3.07 ]
Cummings 1989 392/783 352/785 6.5 % 1.23 [ 1.01, 1.50 ]
Hymowitz 2007 30/142 15/90 5.0 % 1.34 [ 0.67, 2.66 ]
Joseph 2004 165/280 162/295 6.2 % 1.18 [ 0.85, 1.64 ]
Lennox 1998 420/529 355/474 6.3 % 1.29 [ 0.96, 1.74 ]
Strecher 1991 114/156 27/47 5.0 % 2.01 [ 1.02, 3.96 ]
Swartz 2002 114/413 82/394 6.2 % 1.45 [ 1.05, 2.01 ]
Twardella 2007 257/377 32/54 5.3 % 1.47 [ 0.82, 2.64 ]
Unrod 2007 207/270 131/248 6.1 % 2.93 [ 2.01, 4.28 ]
Wilson 1988 123/158 23/75 5.2 % 7.95 [ 4.28, 14.74 ]
Subtotal (99% CI) 4382 3210 69.9 % 2.09 [ 1.25, 3.49 ]
Total events: 2779 (Experimental), 1481 (Control)
Heterogeneity: Tau2 = 0.42; Chi2 = 147.76, df = 11 (P<0.00001); I2 =93%
Test for overall effect: Z = 3.69 (P = 0.00022)
2 Dentist
Cohen (Dent) 1989 350/486 60/161 6.1 % 4.33 [ 2.97, 6.31 ]
Subtotal (99% CI) 486 161 6.1 % 4.33 [ 2.64, 7.10 ]
Total events: 350 (Experimental), 60 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 7.64 (P < 0.00001)
3 Healthcare worker
Joseph 2004 165/280 162/295 6.2 % 1.18 [ 0.85, 1.64 ]
Lennox 1998 420/529 355/474 6.3 % 1.29 [ 0.96, 1.74 ]
Sinclair 1998 113/133 99/159 5.4 % 3.42 [ 1.93, 6.08 ]
Swartz 2002 114/413 82/394 6.2 % 1.45 [ 1.05, 2.01 ]
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(. . . Continued)
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (99% CI) 1355 1322 24.1 % 1.55 [ 0.99, 2.42 ]
Total events: 812 (Experimental), 698 (Control)
Heterogeneity: Tau2 = 0.08; Chi2 = 10.69, df = 3 (P = 0.01); I2 =72%
Test for overall effect: Z = 2.50 (P = 0.012)
Total (99% CI) 6223 4693 100.0 % 2.05 [ 1.38, 3.05 ]
Total events: 3941 (Experimental), 2239 (Control)
Heterogeneity: Tau2 = 0.36; Chi2 = 187.02, df = 16 (P<0.00001); I2 =91%
Test for overall effect: Z = 4.66 (P < 0.00001)
Test for subgroup differences: Chi2 = 16.28, df = 2 (P = 0.00), I2 =88%
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Analysis 7.4. Comparison 7 Sub-group: type of professional being trained, Outcome 4 Number of smokers
receiving self-help material.
Review: Training health professionals in smoking cessation
Comparison: 7 Sub-group: type of professional being trained
Outcome: 4 Number of smokers receiving self-help material
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Doctor
Cornuz 2002 16/115 1/136 5.5 % 21.82 [ 2.85, 167.27 ]
Cummings (Priv) 1989 126/343 32/339 13.1 % 5.57 [ 3.64, 8.52 ]
Cummings 1989 195/783 66/785 13.6 % 3.61 [ 2.68, 4.87 ]
Hymowitz 2007 41/142 16/90 12.1 % 1.88 [ 0.98, 3.60 ]
Strecher 1991 19/156 6/47 10.3 % 0.95 [ 0.35, 2.53 ]
Swartz 2002 155/413 142/394 13.6 % 1.07 [ 0.80, 1.42 ]
Twardella 2007 107/377 8/54 11.4 % 2.28 [ 1.04, 4.99 ]
Unrod 2007 87/270 17/248 12.6 % 6.46 [ 3.71, 11.25 ]
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(. . . Continued)
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Wilson 1988 77/158 2/75 7.9 % 34.70 [ 8.23, 146.30 ]
Subtotal (99% CI) 2757 2168 100.0 % 3.51 [ 1.57, 7.85 ]
Total events: 823 (Experimental), 290 (Control)
Heterogeneity: Tau2 = 0.70; Chi2 = 86.32, df = 8 (P<0.00001); I2 =91%
Test for overall effect: Z = 4.02 (P = 0.000057)
2 Healthcare worker
Swartz 2002 155/413 142/394 100.0 % 1.07 [ 0.80, 1.42 ]
Subtotal (99% CI) 413 394 100.0 % 1.07 [ 0.73, 1.55 ]
Total events: 155 (Experimental), 142 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.44 (P = 0.66)
Test for subgroup differences: Chi2 = 11.97, df = 1 (P = 0.00), I2 =92%
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Analysis 7.5. Comparison 7 Sub-group: type of professional being trained, Outcome 5 Number of smokers
receiving nicotine gum/replacement therapy.
Review: Training health professionals in smoking cessation
Comparison: 7 Sub-group: type of professional being trained
Outcome: 5 Number of smokers receiving nicotine gum/replacement therapy
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Doctor
Cummings (Priv) 1989 29/218 29/148 13.1 % 0.63 [ 0.36, 1.11 ]
Cummings 1989 40/388 36/348 13.5 % 1.00 [ 0.62, 1.60 ]
Hymowitz 2007 11/142 5/90 10.1 % 1.43 [ 0.48, 4.25 ]
Joseph 2004 59/280 56/295 13.7 % 1.14 [ 0.76, 1.71 ]
Strecher 1991 28/156 6/47 11.0 % 1.49 [ 0.58, 3.86 ]
Swartz 2002 127/275 117/241 14.0 % 0.91 [ 0.64, 1.29 ]
Twardella 2007 82/377 4/54 10.4 % 3.47 [ 1.22, 9.90 ]
Wilson 1988 615/1064 108/458 14.3 % 4.44 [ 3.47, 5.69 ]
Subtotal (99% CI) 2900 1681 100.0 % 1.44 [ 0.63, 3.30 ]
Total events: 991 (Experimental), 361 (Control)
Heterogeneity: Tau2 = 0.71; Chi2 = 91.84, df = 7 (P<0.00001); I2 =92%
Test for overall effect: Z = 1.14 (P = 0.25)
2 Healthcare worker
Joseph 2004 59/280 56/295 39.5 % 1.14 [ 0.76, 1.71 ]
Sinclair 1998 219/224 248/268 18.1 % 3.53 [ 1.30, 9.57 ]
Swartz 2002 127/275 117/241 42.4 % 0.91 [ 0.64, 1.29 ]
Subtotal (99% CI) 779 804 100.0 % 1.27 [ 0.64, 2.53 ]
Total events: 405 (Experimental), 421 (Control)
Heterogeneity: Tau2 = 0.14; Chi2 = 6.44, df = 2 (P = 0.04); I2 =69%
Test for overall effect: Z = 0.89 (P = 0.37)
Test for subgroup differences: Chi2 = 0.09, df = 1 (P = 0.76), I2 =0.0%
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Analysis 8.1. Comparison 8 Sub-group: length of follow-up, Outcome 1 Patient asked to set a quit date.
Review: Training health professionals in smoking cessation
Comparison: 8 Sub-group: length of follow-up
Outcome: 1 Patient asked to set a quit date
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 From 6 months up to and including 9 months
Cohen (Dent) 1989 83/486 5/161 34.5 % 6.43 [ 2.56, 16.14 ]
Cohen (Doc) 1989 275/816 5/273 34.7 % 27.25 [ 11.12, 66.78 ]
Strecher 1991 16/156 3/47 30.8 % 1.68 [ 0.47, 6.02 ]
Subtotal (99% CI) 1458 481 100.0 % 7.02 [ 0.98, 50.34 ]
Total events: 374 (Experimental), 13 (Control)
Heterogeneity: Tau2 = 1.48; Chi2 = 13.01, df = 2 (P = 0.001); I2 =85%
Test for overall effect: Z = 2.55 (P = 0.011)
2 From greater than 9 months up to and including 12 months
Cohen (Dent) 1989 83/486 5/161 14.0 % 6.43 [ 2.56, 16.14 ]
Cohen (Doc) 1989 275/816 5/273 14.2 % 27.25 [ 11.12, 66.78 ]
Cornuz 2002 9/115 3/136 11.7 % 3.76 [ 0.99, 14.25 ]
Cummings (Priv) 1989 84/218 18/148 15.8 % 4.53 [ 2.58, 7.95 ]
Cummings 1989 146/388 39/348 16.5 % 4.78 [ 3.23, 7.07 ]
Swartz 2002 343/413 317/394 16.6 % 1.19 [ 0.83, 1.70 ]
Wilson 1988 53/158 2/75 11.1 % 18.42 [ 4.35, 78.00 ]
Subtotal (99% CI) 2594 1535 100.0 % 5.67 [ 1.96, 16.42 ]
Total events: 993 (Experimental), 389 (Control)
Heterogeneity: Tau2 = 0.99; Chi2 = 64.64, df = 6 (P<0.00001); I2 =91%
Test for overall effect: Z = 4.20 (P = 0.000026)
Test for subgroup differences: Chi2 = 0.06, df = 1 (P = 0.81), I2 =0.0%
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Analysis 8.2. Comparison 8 Sub-group: length of follow-up, Outcome 2 Patient asked to make a follow-up
appointment.
Review: Training health professionals in smoking cessation
Comparison: 8 Sub-group: length of follow-up
Outcome: 2 Patient asked to make a follow-up appointment
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 From 6 months up to and including 9 months
Strecher 1991 76/156 17/47 14.7 % 1.68 [ 0.86, 3.29 ]
Unrod 2007 128/270 24/248 15.5 % 8.41 [ 5.19, 13.65 ]
Subtotal (99% CI) 426 295 30.2 % 3.82 [ 0.48, 30.51 ]
Total events: 204 (Experimental), 41 (Control)
Heterogeneity: Tau2 = 1.21; Chi2 = 14.55, df = 1 (P = 0.00014); I2 =93%
Test for overall effect: Z = 1.66 (P = 0.096)
2 From greater than 9 months up to and including 12 months
Cornuz 2002 8/115 4/136 11.7 % 2.47 [ 0.72, 8.42 ]
Cummings (Priv) 1989 42/218 16/148 14.9 % 1.97 [ 1.06, 3.65 ]
Cummings 1989 59/388 17/348 15.2 % 3.49 [ 1.99, 6.12 ]
Swartz 2002 164/413 151/394 16.1 % 1.06 [ 0.80, 1.41 ]
Wilson 1988 84/158 3/75 11.9 % 27.24 [ 8.23, 90.13 ]
Subtotal (99% CI) 1292 1101 69.8 % 3.10 [ 0.98, 9.75 ]
Total events: 357 (Experimental), 191 (Control)
Heterogeneity: Tau2 = 0.82; Chi2 = 38.05, df = 4 (P<0.00001); I2 =89%
Test for overall effect: Z = 2.54 (P = 0.011)
Total (99% CI) 1718 1396 100.0 % 3.34 [ 1.19, 9.34 ]
Total events: 561 (Experimental), 232 (Control)
Heterogeneity: Tau2 = 0.97; Chi2 = 75.32, df = 6 (P<0.00001); I2 =92%
Test for overall effect: Z = 3.01 (P = 0.0026)
Test for subgroup differences: Chi2 = 0.05, df = 1 (P = 0.82), I2 =0.0%
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Analysis 8.3. Comparison 8 Sub-group: length of follow-up, Outcome 3 Number of smokers counselled.
Review: Training health professionals in smoking cessation
Comparison: 8 Sub-group: length of follow-up
Outcome: 3 Number of smokers counselled
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 From 6 months up to and including 9 months
Cohen (Dent) 1989 350/486 60/161 17.1 % 4.33 [ 2.97, 6.31 ]
Cohen (Doc) 1989 691/816 112/273 17.5 % 7.95 [ 5.84, 10.81 ]
Lennox 1998 420/529 355/474 17.5 % 1.29 [ 0.96, 1.74 ]
Sinclair 1998 113/133 99/159 15.8 % 3.42 [ 1.93, 6.08 ]
Strecher 1991 114/156 27/47 15.0 % 2.01 [ 1.02, 3.96 ]
Unrod 2007 207/270 131/248 17.1 % 2.93 [ 2.01, 4.28 ]
Subtotal (99% CI) 2390 1362 100.0 % 3.13 [ 1.38, 7.09 ]
Total events: 1895 (Experimental), 784 (Control)
Heterogeneity: Tau2 = 0.55; Chi2 = 74.35, df = 5 (P<0.00001); I2 =93%
Test for overall effect: Z = 3.60 (P = 0.00032)
2 From greater than 9 months up to and including 12 months
Cohen (Dent) 1989 350/486 60/161 10.2 % 4.33 [ 2.97, 6.31 ]
Cohen (Doc) 1989 691/816 112/273 10.4 % 7.95 [ 5.84, 10.81 ]
Cornuz 2002 45/115 39/136 9.6 % 1.60 [ 0.94, 2.71 ]
Cummings (Priv) 1989 221/343 151/339 10.4 % 2.26 [ 1.66, 3.07 ]
Cummings 1989 392/783 352/785 10.7 % 1.23 [ 1.01, 1.50 ]
Joseph 2004 165/280 162/295 10.4 % 1.18 [ 0.85, 1.64 ]
Sinclair 1998 113/133 99/159 9.4 % 3.42 [ 1.93, 6.08 ]
Swartz 2002 114/413 82/394 10.4 % 1.45 [ 1.05, 2.01 ]
Twardella 2007 257/377 32/54 9.3 % 1.47 [ 0.82, 2.64 ]
Wilson 1988 123/158 23/75 9.2 % 7.95 [ 4.28, 14.74 ]
Subtotal (99% CI) 3904 2671 100.0 % 2.50 [ 1.34, 4.64 ]
Total events: 2471 (Experimental), 1112 (Control)
Heterogeneity: Tau2 = 0.53; Chi2 = 153.86, df = 9 (P<0.00001); I2 =94%
Test for overall effect: Z = 3.80 (P = 0.00014)
3 From greater than 12 months up to 24 months
Hymowitz 2007 30/142 15/90 15.7 % 1.34 [ 0.67, 2.66 ]
Lennox 1998 420/529 355/474 84.3 % 1.29 [ 0.96, 1.74 ]
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(. . . Continued)
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (99% CI) 671 564 100.0 % 1.30 [ 0.91, 1.86 ]
Total events: 450 (Experimental), 370 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 1 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 1.89 (P = 0.059)
Test for subgroup differences: Chi2 = 10.01, df = 2 (P = 0.01), I2 =80%
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Analysis 8.4. Comparison 8 Sub-group: length of follow-up, Outcome 4 Number of smokers receiving self-
help material.
Review: Training health professionals in smoking cessation
Comparison: 8 Sub-group: length of follow-up
Outcome: 4 Number of smokers receiving self-help material
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 From 6 months up to and including 9 months
Strecher 1991 19/156 6/47 10.3 % 0.95 [ 0.35, 2.53 ]
Unrod 2007 87/270 17/248 12.6 % 6.46 [ 3.71, 11.25 ]
Subtotal (99% CI) 426 295 22.9 % 2.59 [ 0.22, 30.56 ]
Total events: 106 (Experimental), 23 (Control)
Heterogeneity: Tau2 = 1.68; Chi2 = 11.13, df = 1 (P = 0.00085); I2 =91%
Test for overall effect: Z = 0.99 (P = 0.32)
2 From greater than 9 months up to and including 12 months
Cornuz 2002 16/115 1/136 5.5 % 21.82 [ 2.85, 167.27 ]
Cummings (Priv) 1989 126/343 32/339 13.1 % 5.57 [ 3.64, 8.52 ]
Cummings 1989 195/783 66/785 13.6 % 3.61 [ 2.68, 4.87 ]
Swartz 2002 155/413 142/394 13.6 % 1.07 [ 0.80, 1.42 ]
Twardella 2007 107/377 8/54 11.4 % 2.28 [ 1.04, 4.99 ]
Wilson 1988 77/158 2/75 7.9 % 34.70 [ 8.23, 146.30 ]
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Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (99% CI) 2189 1783 65.0 % 4.42 [ 1.53, 12.70 ]
Total events: 676 (Experimental), 251 (Control)
Heterogeneity: Tau2 = 0.80; Chi2 = 70.71, df = 5 (P<0.00001); I2 =93%
Test for overall effect: Z = 3.62 (P = 0.00030)
3 From greater than 12 months up to 24 months
Hymowitz 2007 41/142 16/90 12.1 % 1.88 [ 0.98, 3.60 ]
Subtotal (99% CI) 142 90 12.1 % 1.88 [ 0.80, 4.42 ]
Total events: 41 (Experimental), 16 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.90 (P = 0.058)
Total (99% CI) 2757 2168 100.0 % 3.51 [ 1.57, 7.85 ]
Total events: 823 (Experimental), 290 (Control)
Heterogeneity: Tau2 = 0.70; Chi2 = 86.32, df = 8 (P<0.00001); I2 =91%
Test for overall effect: Z = 4.02 (P = 0.000057)
Test for subgroup differences: Chi2 = 2.62, df = 2 (P = 0.27), I2 =24%
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Analysis 8.5. Comparison 8 Sub-group: length of follow-up, Outcome 5 Number of smokers receiving
nicotine gum/replacement therapy.
Review: Training health professionals in smoking cessation
Comparison: 8 Sub-group: length of follow-up
Outcome: 5 Number of smokers receiving nicotine gum/replacement therapy
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 From 6 months up to and including 9 months
Sinclair 1998 219/224 248/268 9.6 % 3.53 [ 1.30, 9.57 ]
Strecher 1991 28/156 6/47 9.9 % 1.49 [ 0.58, 3.86 ]
Subtotal (99% CI) 380 315 19.5 % 2.27 [ 0.75, 6.85 ]
Total events: 247 (Experimental), 254 (Control)
Heterogeneity: Tau2 = 0.12; Chi2 = 1.50, df = 1 (P = 0.22); I2 =33%
Test for overall effect: Z = 1.90 (P = 0.057)
2 From greater than 9 months up to and including 12 months
Cummings (Priv) 1989 29/218 29/148 11.8 % 0.63 [ 0.36, 1.11 ]
Cummings 1989 40/388 36/348 12.2 % 1.00 [ 0.62, 1.60 ]
Joseph 2004 59/280 56/295 12.4 % 1.14 [ 0.76, 1.71 ]
Swartz 2002 127/275 117/241 12.7 % 0.91 [ 0.64, 1.29 ]
Twardella 2007 82/377 4/54 9.3 % 3.47 [ 1.22, 9.90 ]
Wilson 1988 615/1064 108/458 12.9 % 4.44 [ 3.47, 5.69 ]
Subtotal (99% CI) 2602 1544 71.4 % 1.44 [ 0.54, 3.81 ]
Total events: 952 (Experimental), 350 (Control)
Heterogeneity: Tau2 = 0.78; Chi2 = 91.46, df = 5 (P<0.00001); I2 =95%
Test for overall effect: Z = 0.96 (P = 0.34)
3 From greater than 12 months up to 24 months
Hymowitz 2007 11/142 5/90 9.1 % 1.43 [ 0.48, 4.25 ]
Subtotal (99% CI) 142 90 9.1 % 1.43 [ 0.34, 5.99 ]
Total events: 11 (Experimental), 5 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
Total (99% CI) 3124 1949 100.0 % 1.57 [ 0.72, 3.41 ]
Total events: 1210 (Experimental), 609 (Control)
Heterogeneity: Tau2 = 0.69; Chi2 = 93.49, df = 8 (P<0.00001); I2 =91%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Chi2 = 0.74, df = 2 (P = 0.69), I2 =0.0%
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Analysis 9.1. Comparison 9 Sub-group: risk of bias in the studies, Outcome 1 Patient asked to set a quit date.
Review: Training health professionals in smoking cessation
Comparison: 9 Sub-group: risk of bias in the studies
Outcome: 1 Patient asked to set a quit date
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Up to and including 2 domains
Cohen (Dent) 1989 83/486 5/161 12.5 % 6.43 [ 2.56, 16.14 ]
Cohen (Doc) 1989 275/816 5/273 12.7 % 27.25 [ 11.12, 66.78 ]
Cornuz 2002 9/115 3/136 10.4 % 3.76 [ 0.99, 14.25 ]
Cummings (Priv) 1989 84/218 18/148 14.2 % 4.53 [ 2.58, 7.95 ]
Cummings 1989 146/388 39/348 14.8 % 4.78 [ 3.23, 7.07 ]
Swartz 2002 343/413 317/394 14.9 % 1.19 [ 0.83, 1.70 ]
Wilson 1988 53/158 2/75 9.8 % 18.42 [ 4.35, 78.00 ]
Subtotal (99% CI) 2594 1535 89.3 % 5.67 [ 1.96, 16.42 ]
Total events: 993 (Experimental), 389 (Control)
Heterogeneity: Tau2 = 0.99; Chi2 = 64.64, df = 6 (P<0.00001); I2 =91%
Test for overall effect: Z = 4.20 (P = 0.000026)
2 From 3 to 5 domains
Strecher 1991 16/156 3/47 10.7 % 1.68 [ 0.47, 6.02 ]
Subtotal (99% CI) 156 47 10.7 % 1.68 [ 0.31, 9.00 ]
Total events: 16 (Experimental), 3 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.79 (P = 0.43)
Total (99% CI) 2750 1582 100.0 % 4.97 [ 1.85, 13.30 ]
Total events: 1009 (Experimental), 392 (Control)
Heterogeneity: Tau2 = 0.95; Chi2 = 65.65, df = 7 (P<0.00001); I2 =89%
Test for overall effect: Z = 4.19 (P = 0.000028)
Test for subgroup differences: Chi2 = 2.49, df = 1 (P = 0.11), I2 =60%
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Analysis 9.2. Comparison 9 Sub-group: risk of bias in the studies, Outcome 2 Patient asked to make a
follow-up appointment.
Review: Training health professionals in smoking cessation
Comparison: 9 Sub-group: risk of bias in the studies
Outcome: 2 Patient asked to make a follow-up appointment
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Up to and including 2 domains
Cornuz 2002 8/115 4/136 11.7 % 2.47 [ 0.72, 8.42 ]
Cummings (Priv) 1989 42/218 16/148 14.9 % 1.97 [ 1.06, 3.65 ]
Cummings 1989 59/388 17/348 15.2 % 3.49 [ 1.99, 6.12 ]
Swartz 2002 164/413 151/394 16.1 % 1.06 [ 0.80, 1.41 ]
Unrod 2007 128/270 24/248 15.5 % 8.41 [ 5.19, 13.65 ]
Wilson 1988 84/158 3/75 11.9 % 27.24 [ 8.23, 90.13 ]
Subtotal (99% CI) 1562 1349 85.3 % 3.79 [ 1.14, 12.55 ]
Total events: 485 (Experimental), 215 (Control)
Heterogeneity: Tau2 = 1.14; Chi2 = 74.81, df = 5 (P<0.00001); I2 =93%
Test for overall effect: Z = 2.86 (P = 0.0042)
2 From 3 to 5 domains
Strecher 1991 76/156 17/47 14.7 % 1.68 [ 0.86, 3.29 ]
Subtotal (99% CI) 156 47 14.7 % 1.68 [ 0.69, 4.06 ]
Total events: 76 (Experimental), 17 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.51 (P = 0.13)
Total (99% CI) 1718 1396 100.0 % 3.34 [ 1.19, 9.34 ]
Total events: 561 (Experimental), 232 (Control)
Heterogeneity: Tau2 = 0.97; Chi2 = 75.32, df = 6 (P<0.00001); I2 =92%
Test for overall effect: Z = 3.01 (P = 0.0026)
Test for subgroup differences: Chi2 = 1.99, df = 1 (P = 0.16), I2 =50%
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Analysis 9.3. Comparison 9 Sub-group: risk of bias in the studies, Outcome 3 Number of smokers
counselled.
Review: Training health professionals in smoking cessation
Comparison: 9 Sub-group: risk of bias in the studies
Outcome: 3 Number of smokers counselled
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Up to and including 2 domains
Cohen (Dent) 1989 350/486 60/161 7.4 % 4.33 [ 2.97, 6.31 ]
Cohen (Doc) 1989 691/816 112/273 7.6 % 7.95 [ 5.84, 10.81 ]
Cornuz 2002 45/115 39/136 6.9 % 1.60 [ 0.94, 2.71 ]
Cummings (Priv) 1989 221/343 151/339 7.6 % 2.26 [ 1.66, 3.07 ]
Cummings 1989 392/783 352/785 7.9 % 1.23 [ 1.01, 1.50 ]
Joseph 2004 165/280 162/295 7.5 % 1.18 [ 0.85, 1.64 ]
Lennox 1998 420/529 355/474 7.6 % 1.29 [ 0.96, 1.74 ]
Swartz 2002 114/413 82/394 7.6 % 1.45 [ 1.05, 2.01 ]
Twardella 2007 257/377 32/54 6.7 % 1.47 [ 0.82, 2.64 ]
Unrod 2007 207/270 131/248 7.4 % 2.93 [ 2.01, 4.28 ]
Wilson 1988 123/158 23/75 6.5 % 7.95 [ 4.28, 14.74 ]
Subtotal (99% CI) 4570 3234 80.7 % 2.32 [ 1.34, 4.02 ]
Total events: 2985 (Experimental), 1499 (Control)
Heterogeneity: Tau2 = 0.46; Chi2 = 163.86, df = 10 (P<0.00001); I2 =94%
Test for overall effect: Z = 3.93 (P = 0.000084)
2 From 3 to 5 domains
Hymowitz 2007 30/142 15/90 6.3 % 1.34 [ 0.67, 2.66 ]
Strecher 1991 114/156 27/47 6.3 % 2.01 [ 1.02, 3.96 ]
Subtotal (99% CI) 298 137 12.5 % 1.64 [ 0.87, 3.10 ]
Total events: 144 (Experimental), 42 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.68, df = 1 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 2.02 (P = 0.043)
3 From 6 to 8 domains
Sinclair 1998 113/133 99/159 6.7 % 3.42 [ 1.93, 6.08 ]
Subtotal (99% CI) 133 159 6.7 % 3.42 [ 1.61, 7.28 ]
Total events: 113 (Experimental), 99 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 4.21 (P = 0.000026)
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(. . . Continued)
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Total (99% CI) 5001 3530 100.0 % 2.28 [ 1.41, 3.67 ]
Total events: 3242 (Experimental), 1640 (Control)
Heterogeneity: Tau2 = 0.43; Chi2 = 168.49, df = 13 (P<0.00001); I2 =92%
Test for overall effect: Z = 4.44 (P < 0.00001)
Test for subgroup differences: Chi2 = 3.70, df = 2 (P = 0.16), I2 =46%
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Analysis 9.4. Comparison 9 Sub-group: risk of bias in the studies, Outcome 4 Number of smokers receiving
self-help material.
Review: Training health professionals in smoking cessation
Comparison: 9 Sub-group: risk of bias in the studies
Outcome: 4 Number of smokers receiving self-help material
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Up to and including 2 domains
Cornuz 2002 16/115 1/136 4.7 % 21.82 [ 2.85, 167.27 ]
Cummings (Priv) 1989 126/343 32/339 11.8 % 5.57 [ 3.64, 8.52 ]
Cummings 1989 195/783 66/785 12.2 % 3.61 [ 2.68, 4.87 ]
Hymowitz 2007 41/142 16/90 10.8 % 1.88 [ 0.98, 3.60 ]
Swartz 2002 155/413 142/394 12.3 % 1.07 [ 0.80, 1.42 ]
Twardella 2007 107/377 8/54 10.1 % 2.28 [ 1.04, 4.99 ]
Unrod 2007 87/270 17/248 11.3 % 6.46 [ 3.71, 11.25 ]
Wilson 1988 77/158 2/75 6.9 % 34.70 [ 8.23, 146.30 ]
Subtotal (99% CI) 2601 2121 80.1 % 4.08 [ 1.75, 9.55 ]
Total events: 804 (Experimental), 284 (Control)
Heterogeneity: Tau2 = 0.70; Chi2 = 82.21, df = 7 (P<0.00001); I2 =91%
Test for overall effect: Z = 4.26 (P = 0.000020)
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(. . . Continued)
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
2 From 3 to 5 domains
Hymowitz 2007 41/142 16/90 10.8 % 1.88 [ 0.98, 3.60 ]
Strecher 1991 19/156 6/47 9.1 % 0.95 [ 0.35, 2.53 ]
Subtotal (99% CI) 298 137 19.9 % 1.48 [ 0.64, 3.42 ]
Total events: 60 (Experimental), 22 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 1.29, df = 1 (P = 0.26); I2 =23%
Test for overall effect: Z = 1.20 (P = 0.23)
Total (99% CI) 2899 2258 100.0 % 3.26 [ 1.57, 6.77 ]
Total events: 864 (Experimental), 306 (Control)
Heterogeneity: Tau2 = 0.64; Chi2 = 87.18, df = 9 (P<0.00001); I2 =90%
Test for overall effect: Z = 4.16 (P = 0.000032)
Test for subgroup differences: Chi2 = 4.80, df = 1 (P = 0.03), I2 =79%
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Analysis 9.5. Comparison 9 Sub-group: risk of bias in the studies, Outcome 5 Number of smokers receiving
nicotine gum/replacement therapy.
Review: Training health professionals in smoking cessation
Comparison: 9 Sub-group: risk of bias in the studies
Outcome: 5 Number of smokers receiving nicotine gum/replacement therapy
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Up to and including 2 domains
Cummings (Priv) 1989 29/218 29/148 11.8 % 0.63 [ 0.36, 1.11 ]
Cummings 1989 40/388 36/348 12.2 % 1.00 [ 0.62, 1.60 ]
Joseph 2004 59/280 56/295 12.4 % 1.14 [ 0.76, 1.71 ]
Swartz 2002 127/275 117/241 12.7 % 0.91 [ 0.64, 1.29 ]
Twardella 2007 82/377 4/54 9.3 % 3.47 [ 1.22, 9.90 ]
Wilson 1988 615/1064 108/458 12.9 % 4.44 [ 3.47, 5.69 ]
Subtotal (99% CI) 2602 1544 71.4 % 1.44 [ 0.54, 3.81 ]
Total events: 952 (Experimental), 350 (Control)
Heterogeneity: Tau2 = 0.78; Chi2 = 91.46, df = 5 (P<0.00001); I2 =95%
Test for overall effect: Z = 0.96 (P = 0.34)
2 From 3 to 5 domains
Hymowitz 2007 11/142 5/90 9.1 % 1.43 [ 0.48, 4.25 ]
Strecher 1991 28/156 6/47 9.9 % 1.49 [ 0.58, 3.86 ]
Subtotal (99% CI) 298 137 19.0 % 1.47 [ 0.57, 3.76 ]
Total events: 39 (Experimental), 11 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 1.05 (P = 0.30)
3 From 6 to 8 domains
Sinclair 1998 219/224 248/268 9.6 % 3.53 [ 1.30, 9.57 ]
Subtotal (99% CI) 224 268 9.6 % 3.53 [ 0.95, 13.09 ]
Total events: 219 (Experimental), 248 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.48 (P = 0.013)
Total (99% CI) 3124 1949 100.0 % 1.57 [ 0.72, 3.41 ]
Total events: 1210 (Experimental), 609 (Control)
Heterogeneity: Tau2 = 0.69; Chi2 = 93.49, df = 8 (P<0.00001); I2 =91%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Chi2 = 2.41, df = 2 (P = 0.30), I2 =17%
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A D D I T I O N A L T A B L E S
Table 1. Summary of individual study outcomes
Study ID/sub-headings: Detailed synthesis of intervention effectiveness:
Cohen (Dent) 1989
Point prevalence/ continuous abstinence
One year follow-up: At 12 month follow-up there was a signifi-
cant interaction between subjects receiving the gum compared to
control (7.7% and 3.1% for gum and control groups respectively,
p< 0.05). When the three intervention groups were combined to-
gether as per themethods outlined in this review, point prevalence
of smoking at 12 month follow-up was 5.1%, compared to the
control of 3.1%, which failed to reach statistical significance
Six months follow-up: At 6 month follow-up the coefficient for
the reminder effect was negative, which authors state is likely to
be caused by high cessation in the gum group coupled with the
lower percentages in the gum and reminders group (9% for gum
only, 3.2% for reminder only, 3% for gum and reminder and 3.
1% for control)
Cohen (Dent) 1989
Secondary outcomes
Patient asked to set a quit date: Prompted dentists were more
likely to ask patients to set a quit date (6% for gum only, 14%
for reminder only, 31% for both reminder and gum and 3% for
control)
Number of smokers counselled: Prompted conditions increased
the likelihood of dentists advising their patients to quit (72% for
gum only, 59% for reminder only, 85% for both reminder and
gum and 37% for controls)
Cohen (Doc) 1989
Point prevalence/ continuous abstinence
One year follow-up: The combination of gum and reminders
did not increase the percent of patients who quit smoking com-
pared to either condition alone. At 1 year follow-up significant
negative interaction between gum and reminders were found (p<
0.05). Pair-wise comparisons among the groups showed that the
three intervention groups were not significantly different from
each other (reminder 15%, gum 8.8%, both 9.6%), however, each
of them were significantly different from the control for analyses
based on returnees and on all patients (control 2.7%, p< 0.05)
. Twelve month quit percentages for point prevalence were sig-
nificantly higher for the reminders group (7.9%), compared to
those using gum (4.7%), those using a combination of the two (5.
2%) and control (1.5%), p< 0.05. When the three intervention
groups were combined together as per the methods outlined in
this review, point prevalence of smoking at 12 months follow-up
was 5.9%, compared to the control of 1.5%, which statistically
favoured the intervention, p= 0.002
Cohen (Doc) 1989
Secondary outcomes
Patient asked to set a quit date: Prompted doctors were more
likely to ask patients to set a quit date (10% for gum only, 33%
for reminder only, 58% for both reminder and gum and 2% for
control)
Number of smokers counselled: Both the gum and prompted
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Table 1. Summary of individual study outcomes (Continued)
conditions increased the likelihood of doctors advising patients to
quit (84% for gum only, 75% for reminder only, 95% for both
reminder and gum and 41% for control)
Cornuz 2002
Point prevalence/ continuous abstinence
One year follow-up: At 12 month follow-up, 7 day point preva-
lence was significantly higher in the intervention group (15 of 115
patients [13%, 95% CI 7% to 12%]) compared to the control
group (7 of 136 patients [5%, 95% CI 1% to 9%]). The eight-
percentage point difference between groups translates to a resident
needing to counsel 13 patients to gain 1 additional former smoker
Cornuz 2002
Secondary outcomes
Patient asked to set a quit date: The short-term effect of the train-
ing program performed by the resident was statistically significant
in favour of the intervention with 8% compared to 2% for the
intervention and control groups respectively
Patient asked to make follow-up appointment: Short-term effect
was not significantly different between groups with 7% of the
intervention and 3% of the control population asked by their
physician to make a follow-up appointment
Number of smokers counselled: Not statistically significant with
39% of intervention patients and 29% of control patients coun-
selled not to smoke
Number of smokers receiving self-help materials: Short-term ef-
fects were statistically significant between groups with 14% of in-
tervention subjects provided with a brochure compared to 1% of
control
Cummings (Priv) 1989
Point prevalence/ continuous abstinence
One year follow-up: There was no statistical significance on 7
day point prevalence for validated smoking cessation at one year
follow-up, with 6.7% for trained group patients quit compared to
8.2% for control. Biochemically validated continuous abstinence
(defined as > 9 months abstinence) results were similar with 3.2%
for intervention subjects and 2.5% for control (95% CI for the 0.
7% difference= -1.7 to +3.1%)
Cummings (Priv) 1989
Secondary outcomes
Patient asked to set a quit date: Physicians in the experimental
group asked more smokers to set quit dates with 100 out of 261
for intervention and 22 out of 177 for control
Patient asked tomake follow-up appointment: Trained physicians
were significantly more likely to arrange a follow-up appointment
to discuss smoking with 50 out of 261 for the intervention and
19 out of 177 for control
Number of smokers counselled: Trained physicians were signif-
icantly more likely to discuss smoking (64%) compared to the
control (44%)
Number of smokers receiving self-help materials: Physicians in
the experimental group gave self-help booklets to more smokers
with 151 out of 411 for intervention compared to 38 out of 407
for control
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Table 1. Summary of individual study outcomes (Continued)
Number of smokers receiving nicotine gum/replacement therapy:
There was no significant difference in the prescription of nicotine
gum; Control group patients with whom smoking was discussed
were more likely to be prescribed it (19%) than the trained group
(13%)
Cummings 1989
Point prevalence/ continuous abstinence
One year follow-up:There was no significant effect on validated
abstinence at one year follow-up, with 8.0% of trained group
patients quitting versus 7.1% of control
Cummings 1989
Secondary outcomes
Patient asked to set a quit date: Trained physicians were signifi-
cantly more likely to ask patients to set a quit date with 37.6% of
intervention subjects and 11.1% of control subjects asked
Patient asked to make follow-up appointment: Significantly more
subjects in the intervention group had a follow-up appointment
arranged with 15.2% compared to 5% in the control population
Number of smokers counselled: Trained and control physicians
were similar in terms of asking patients to discuss smoking (50.
1% vs 44.9% respectively)
Number of smokers receiving self-helpmaterials: Physicians in the
intervention arm were more likely to provide patients with self-
help materials with 24.9% compared to control physicians with
8.4%
Number of smokers receiving nicotine gum/replacement therapy:
There was no significant difference in the prescription of nicotine
gum; Approximately 10% of patients with whom smoking was
discussed were prescribed gum
Number of smokers prescribed a quit date: Trained physicians
were significantly more likely to prescribe patients with a quit date
(16.1%) compared to control physicians (1.2%)
Gordon 2010
Point prevalence/ continuous abstinence
Six months follow-up:Significantly higher abstinence levelswere
reported for both continuous abstinence and point prevalence at
7.5month (sixmonths post-enrolment plus six week grace period)
follow-up (continuous abstinence: 74 out of 1394 for intervention
and 22 out of 1155 control, p< 0.01; Point prevalence: 158 out
of 1394 for intervention and 79 out of 1155 for control, p< 0.05)
Gordon 2010
Secondary outcomes
No secondary outcomes reported across both groups, however two
outcomes reported for intervention group only:
Number of smokers receiving self-help materials: Among inter-
vention patients, 66.5% reported receiving the self-help reading
materials and 96.7% reported reading them
Number of smokers receiving nicotine gum/replacement therapy:
Of the intervention subjects 16.9% reported using nicotine re-
placement therapy
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Table 1. Summary of individual study outcomes (Continued)
Hymowitz 2007
Point prevalence/ continuous abstinence
One year follow-up: There was an increase in the special train-
ing condition of reported quitting during the past year of 3.8%
(an 8.5% increase over baseline levels), however the change from
baseline failed to achieve statistical significance. Among parents
associated with standard training, the change was only 0.8%
Hymowitz 2007
Secondary outcomes
Number of smokers counselled: There was a significant increase
in the percentage of parents counselled at both intervention and
control training sites from baseline, however absolute levels of this
activity for residents in each conditions was low (intervention 21.
4% (OR 2.08, 95% CI 1.12 to 3.87), control 16.7% (OR 1.
84, 95% CI 0.84 to 4.02)). There was no significant difference
between groups
Number of smokers receiving self-helpmaterials: Provision of ces-
sation materials increased significantly across both groups over the
four year period when compared to baseline values (intervention
28.8% (OR 1.95, 95% CI 1.10 to 3.46), control 17.6% (OR 1.
76, 95% CI 0.76 to 4.08)). There was no significant difference
between groups
Number of smokers receiving nicotine gum/replacement therapy:
Few parents in either condition reported that residents prescribed
nicotine replacement therapy (intervention n= 7.6%, control n=
5.9%)
Joseph 2004
Point prevalence/ continuous abstinence
One year follow-up: At follow-up the point prevalence of smok-
ing cessation did not significantly improve for the intervention
subjects, over that of control (intervention 11.4%, control 13.2%
(p= 0.51 for Pearson Chi² test))
Joseph 2004
Secondary outcomes
Number of smokers counselled: During the intervention period,
59% of subjects in the intervention arm received behavioural sup-
port to stop smoking in comparison to 55% in the control (p=
NS)
Number of smokers receiving nicotine gum/replacement therapy:
Twenty-one percent of subjects reported receivingmedications for
smoking cessation in the intervention arm whilst 19% received
medication in the control group (p= NS)
Kottke 1989
Point prevalence/ continuous abstinence
One year follow-up:Almost half of the participants in each group
who were smoking at baseline reported quit attempts for at least
24 hours during the previous year, with a mean duration of cessa-
tion of 2-months. No differences between the three groups were
identified
Kottke 1989
Secondary outcomes
Patient asked to set a quit date: Almost 20% of patients seen in the
workshop group reported being asked to set a quit date, compared
to 10% in the materials group and 5% in the no-assistance group
(p< 0.005)
Patient asked to make follow-up appointment: Greater propor-
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Table 1. Summary of individual study outcomes (Continued)
tions of patients in the workshop group were asked to make a fol-
low-up appointment compared to the other two groups but this
was not significant
Number of smokers counselled: Slightly over half of the patients
interviewed reported that they had been ‘asked if they smoked’
when visiting their physicians during the campaign (p< 0.025);
This did not differ significantly between intervention groups
Number of smokers receiving self-helpmaterials: One third of pa-
tients in the workshop group reported receiving self-helpmaterial
compared to 11% in the no-assistance group (p< 0.001)
Lennox 1998
Point prevalence/ continuous abstinence
Fourteen months follow-up:There was no significant difference
in sustained abstinence at 14 months between intervention (3.
6%) and control (4.7%)
Eight months follow-up:No significant difference was observed
between intervention and control groups as to whether an attempt
was made to give up smoking at any time during the study period
Lennox 1998
Secondary outcomes
Number of smokers counselled: No significant difference in dis-
cussion of smoking with doctors, nurses or health visitors, how-
ever results in both groups were above 70%; Intervention subjects
who smoked were more likely than control subjects who smoked
to recall smoking having beenmentioned in a consultation during
the 14-month follow-up period (significant for GP consultations
at the 10 percent level, but not for consultations with practice
nurses or health visitors
Sinclair 1998
Point prevalence/ continuous abstinence
Nine month follow-up: There was no significant difference in
nine month continuous abstinence with Intervention group 12%,
control 7.4%, and no difference in one month point prevalence
Sinclair 1998
Secondary outcomes
Number of smokers counselled: Patients consulting training phar-
macistswere significantlymore likely to report discussion of smok-
ing (85% vs 62.3%)
Number of smokers receiving nicotine gum/replacement therapy:
Anti-smoking products were bought by most subjects following
enrolment, however, intervention subjects were significantly more
likely to make a purchase (p = 0.0085); There was a significantly
greater use of nicotine patches relative to nicotine gum in the inter-
vention group comparedwith the control group (p =0.029).Over-
all, approximately three-quarters of the customers used patches
compared with a quarter using gum
Stretcher 1991
Point prevalence/ continuous abstinence
Six months follow-up: There were no significant differences be-
tween 6 month validated abstinence rates, which ranged from 1.
7% to 5.7%
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Stretcher 1991
Secondary outcomes
Patient asked to set a quit date: Trained physicians were signifi-
cantly more likely to advise smokers to quit (73% vs 58%) based
on physician reported outcomes, however patient reports of this
outcome are not significant
Patient asked to make follow-up appointment: Overall there were
no significant differences in scheduling follow-up appointments;
According to patient outcomes however, more tutorial physicians
asked to schedule follow-up appointments compared to non-tu-
torial physicians (p< 0.05)
Number of smokers counselled: A prompt alone achieved simi-
lar counselling levels compared to control (75% vs 70% respec-
tively) and there was no significant interaction between tutorial
and prompt; After adjusting for pre-test scores and speciality,
physicians receiving the tutorial reported a significantly greater
number of patients advised to quit (76%) compared to non-tuto-
rial physicians (69%) (p< 0.05)
Number of smokers receiving self-help materials: All physicians
were equally likely to give self help materials
Number of smokers receiving nicotine gum/replacement therapy:
There were no differences in the proportion of physicians who
prescribed nicotine gum
Number of smokers prescribed a quit date: There were no differ-
ences in advice to set a quit day, but the trained group was signif-
icantly more likely to write a quit day prescription according to
physicians; Patients reported that significantlymore tutorial physi-
cians prescribed a quit date than non-tutorial physicians, however
when groups were combined (tutorial and prompt, prompt only
and tutorial only) this was not significant
Swartz 2002
Point prevalence/ continuous abstinence
One year follow-up: Intervention subjects were more likely to
quit at follow-up (14.8% quit percentage) compared to control
subjects (10.7%). Although this result was not statistically signif-
icant (p= 0.08), authors of the study report long-term clinically
important reductions
Swartz 2002
Secondary outcomes
Patient asked to set a quit date: There was no significant differ-
ence between intervention and control groups for patients being
advised to quit smoking (OR 1.22, 95% CI 0.81 to 1.83)
Patient asked to make follow-up appointment: No significant dif-
ference was observed between intervention and control groups for
patients asked to make a follow-up appointment (OR 1.08, 95%
CI 0.77 to 1.51)
Number of smokers counselled: Providers discussed counselling
more in the intervention group compared to control (27.7% vs.
20.8%; OR 1.39, 95% CI 0.96 to 2.02)
Number of smokers receiving self-help materials: There was no
statistically significant difference between groups for the prevision
of self-help materials (OR 1.04, 95% CI 0.76 to 1.43)
Number of smokers receiving nicotine gum/replacement therapy:
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Subjects in both intervention and control groups had similar offers
for the provision of nicotine replacement therapy (intervention
46.2%, control 18.6%, OR 0.89, 95% CI 0.63 to 1.25)
Twardella 2007
Point prevalence/ continuous abstinence
One year follow-up: Point prevalence of smoking abstinence was
3%, 3%, 12% and 15% for the control, treatment plus incen-
tive (TI), treatment plus medication (TM) and treatment plus
incentive and medication (TI+TM) arms respectively. There were
statistically significant differences between the TM, TI+TM and
control arms (p= 0.046 and p= 0.02, respectively). Continuous
abstinence (for at least 6-months) was higher in the TM arm (13/
140, 9%) and TI+TM arm (17/219, 8%) compared to the control
arm (1/74, 1%) and TI arm (2/144, 1%), however this difference
was not statistically significant
Twardella 2007
Secondary outcomes
Number of smokers counselled: No significant differences were
observed for number of smokers counselled between the four
groups (control 59%, TI 73%, TM 67%, TI+TM 65%)
Number of smokers receiving self-help materials: A significant
difference was observed when comparing TM group to control
group (p=0.03), however no other between group difference were
observed (control 15%, TI 32%, TM 31%, TI+TM 24%)
Number of smokers receiving nicotine gum/replacement therapy:
There was a significant difference between groups for prescription
of nicotine replacement therapy, particularly for those provided
with reimbursement for costs of themedication (TMandTI+TM)
(control 7%, TI 13%, TM 30%, TI+TM 22%)
Unrod 2007
Point prevalence/ continuous abstinence
Six months follow-up: Seven day point prevalence of abstinence
results were higher in the intervention group (12%) than the con-
trol group (8%), however this difference approached but did not
reach significance (OR 1.77, 95% CI 0.94 to 3.34, p= 0.078)
Unrod 2007
Secondary outcomes
Patient asked tomake follow-up appointment:Intervention physi-
cians were five times more likely to arrange a follow-up appoint-
ment (47.5%) compared to control (9.7%) (OR 8.14, 95% CI 3.
98 to 16.68, p< 0.0001)
Number of smokers counselled: Significantly more intervention
physicians provided quit smoking assistance to their patients (55.
1%) compared to control physicians (20.2%) (OR 4.31, 95% CI
2.59 to 7.16, p< 0.0001)
Number of smokers receiving self-helpmaterials: Physicians in the
intervention group were more than three times as likely to pro-
vide self-help materials to patients (32.3%) compared to control
physicians (6.9%) (OR 5.14, 95% CI 2.60 to 10.14, p< 0.0001)
Wang 1994
Point prevalence/ continuous abstinence
Six months follow-up: Statistically significant difference favour-
ing the lesson intervention over the control (p=0.02) and signifi-
cant difference (p=0.054) between lessons (G1) and poster (G2),
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however there was no significant difference between group 2 and
control. When group 1 and group 2 were combined in meta-anal-
yses and adjusted for potential clustering effects, no significant
differences were observed
Wang 1994
Secondary outcomes
No secondary outcomes were reported
Wilson 1988
Point prevalence/ continuous abstinence
One year follow-up: Differences between the training arm and
the other two arms were significant for sustained abstinence at one
year and for 2 point prevalence, but not for one year point preva-
lence. Results were similar when mean cessation percentages were
adjusted for baseline values. Twelve month sustained abstinence
results were 8.8% for the intervention group, compared to 6.1%
and 4.4% in the two comparison arms. However, when the two
intervention groups were combined and adjustments for potential
clustering effects taken into account, these results were no longer
significant for point prevalence or continuous abstinence
Wilson 1988
Secondary outcomes
Patient asked to make follow-up appointment: Training groups
more likely to ask for a quit date (54%) and arrange follow-up
(12%) than gum only (12%/22%) or usual care (2%/4%)
Number of smokers counselled: Training (85%) and gum (70%)
groups more likely to mention smoking than usual care (31%)
Number of smokers receiving nicotine gum/replacement therapy:
Training (63%) and gum (59%) groups more likely to suggest use
of gum than usual care (9%)
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1 RANDOMIZED-CONTROLLED-TRIAL.pt. (223948)
2 CONTROLLED-CLINICAL-TRIAL.pt. (38083)
3 CLINICAL-TRIAL.pt. (265615)
4 Meta analysis.pt. (29188)
5 exp Clinical Trial/ (457811)
6 Random-Allocation/ (38507)
7 randomized-controlled trials/ (69081)
8 double-blind-method/ (68631)
9 single-blind-method/ (13151)
10 placebos/ (12338)
11 Research-Design/ (43437)
12 ((clin$ adj$ trial$) or placebo$ or random$).ti,ab. (530665)
13 ((singl$ or doubl$ or trebl$ or tripl$) adj5 (blind$ or mask$)).ti,ab. (67270)
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14 (volunteer$ or prospectiv$).ti,ab. (340629)
15 exp Follow-Up-Studies/ (269958)
16 exp Retrospective-Studies/ (314812)
17 exp Prospective-Studies/ (233927)
18 exp Evaluation-Studies/ or Program-Evaluation.mp. [mp=title, abstract, original title, name of substance word, subject heading
word, protocol supplementary concept, rare disease supplementary concept, unique identifier] (187044)
19 exp Cross-Sectional-Studies/ (115024)
20 exp Behavior-therapy/ (25130)
21 exp Health-Promotion/ (34021)
22 exp Community-Health-Services/ (246874)
23 exp Health-Education/ (69098)
24 exp Health-Behavior/ (59981)
25 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24
(1995011)
26 smoking cessation.mp. or exp Smoking Cessation/ (17529)
27 “Tobacco-Use-Cessation”/ (545)
28 “Tobacco-Use-Disorder”/ (5569)
29 Tobacco-Smokeless/ (1457)
30 exp Tobacco-Smoke-Pollution/ (6538)
31 exp Tobacco-/ (13929)
32 exp Nicotine-/ (10241)
33 ((quit$ or stop$ or ceas$ or giv$) adj5 smoking).ti,ab. (6469)
34 exp Smoking/pc, th [Prevention & Control, Therapy] (8740)
35 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 [A category smoking terms] (50315)
36 1 or 2 or 3 [Likely CT design terms; RCTs, CCTs, Clinical trials] (384162)
37 (animals not humans).sh. [used with ’not’ to exclude animal studies for each subset] (1521160)
38 (35 and 36) not 37 [Set 1: A smoking terms, likely CT design terms, human only] (3290)
39 Education, Premedical/ (192)
40 exp Education, Professional/ (102079)
41 exp Inservice Training/ (13162)
42 Physician’s Practice Patterns/ (30147)
43 Dentist’s Practice Patterns/ (1382)
44 exp Delivery of Health Care/ (479118)
45 exp Comprehensive Health Care/ (120957)
46 Critical Pathways/ (3744)
47 Disease Management/ (8035)
48 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 (622105)
49 (training or trained).ti,ab. (152010)
50 48 not 49 [MeSH without training text terms] (575357)
51 38 and 49 [training text terms with smoking trials] (224)
52 38 and 50 [sensitive MeSH terms, no mention of training in text] (600)
Records retrieved by this strategy that matched records in the Tobacco Addiction Group Specialised Register were screened for potential
relevance. Records not already in the Register were not checked because they would previously have been retrieved during regular
searches, and excluded for not being reports of controlled trials or other potentially eligible evaluations of tobacco control interventions.
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Appendix 2. Glossary of tobacco-specific terms
Term Definition
Abstinence A period of being quit, i.e. stopping the use of cigarettes or other tobacco products,
May be defined in various ways; see also:
point prevalence abstinence; prolonged abstinence; continuous/sustained abstinence
Biochemical verification Also called ’biochemical validation’ or ’biochemical confirmation’:
A procedure for checking a tobacco user’s report that he or she has not smoked or used
tobacco. It can be measured by testing levels of nicotine or cotinine or other chemicals
in blood, urine, or saliva, or by measuring levels of carbon monoxide in exhaled breath
or in blood
Bupropion A pharmaceutical drug originally developed as an antidepressant, but now also licensed
for smoking cessation; trade names Zyban, Wellbutrin (when prescribed as an antide-
pressant)
Carbon monoxide (CO) A colourless, odourless highly poisonous gas found in tobacco smoke and in the lungs
of people who have recently smoked, or (in smaller amounts) in people who have been
exposed to tobacco smoke. May be used for biochemical verification of abstinence
Cessation Also called ’quitting’
The goal of treatment to help people achieve abstinence from smoking or other tobacco
use, also used to describe the process of changing the behaviour
Continuous abstinence Also called ’sustained abstinence’
A measure of cessation often used in clinical trials involving avoidance of all tobacco
use since the quit day until the time the assessment is made. The definition occasionally
allows for lapses. This is the most rigorous measure of abstinence
’Cold Turkey’ Quitting abruptly, and/or quitting without behavioural or pharmaceutical support
Craving A very intense urge or desire [to smoke].
See: Shiffman et al ’Recommendations for the assessment of tobacco craving and with-
drawal in smoking cessation trials’
Nicotine & Tobacco Research 2004: 6(4): 599-614
Dopamine A neurotransmitter in the brain which regulates mood, attention, pleasure, reward,
motivation and movement
Efficacy Also called ’treatment effect’ or ’effect size’:
The difference in outcome between the experimental and control groups
Harm reduction Strategies to reduce harm caused by continued tobacco/nicotine use, such as reducing
the number of cigarettes smoked, or switching to different brands or products, e.g.
potentially reduced exposure products (PREPs), smokeless tobacco
138Training health professionals in smoking cessation (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Lapse/slip Terms sometimes used for a return to tobacco use after a period of abstinence. A
lapse or slip might be defined as a puff or two on a cigarette. This may proceed to
relapse, or abstinence may be regained. Some definitions of continuous, sustained or
prolonged abstinence require complete abstinence, but some allow for a limited number
or duration of slips. People who lapse are very likely to relapse, but some treatments
may have their effect by helping people recover from a lapse
nAChR [neural nicotinic acetylcholine receptors]: Areas in the brain which are thought to
respond to nicotine, forming the basis of nicotine addiction by stimulating the overflow
of dopamine
Nicotine An alkaloid derived from tobacco, responsible for the psychoactive and addictive effects
of smoking
Nicotine Replacement Therapy (NRT) A smoking cessation treatment in which nicotine from tobacco is replaced for a limited
period by pharmaceutical nicotine. This reduces the craving and withdrawal experi-
enced during the initial period of abstinence while users are learning to be tobacco-free
The nicotine dose can be taken through the skin, using patches, by inhaling a spray, or
by mouth using gum or lozenges
Outcome Often used to describe the result being measured in trials that is of relevance to the
review. For example smoking cessation is the outcome used in reviews of ways to help
smokers quit. The exact outcome in terms of the definition of abstinence and the length
of time that has elapsed since the quit attempt was made may vary from trial to trial
Pharmacotherapy A treatment using pharmaceutical drugs, e.g. NRT, bupropion
Point prevalence abstinence (PPA) A measure of cessation based on behaviour at a particular point in time, or during a
relatively brief specified period, e.g. 24 hours, 7 days. It may include a mixture of recent
and long-term quitters. cf. prolonged abstinence, continuous abstinence
Prolonged abstinence A measure of cessation which typically allows a ’grace period’ following the quit date
(usually of about two weeks), to allow for slips/lapses during the first few days when
the effect of treatment may still be emerging.
See:Hughes et al ’Measures of abstinence in clinical trials: issues and recommendations’;
Nicotine & Tobacco Research, 2003: 5 (1); 13-25
Relapse A return to regular smoking after a period of abstinence
Secondhand smoke Also called passive smoking or environmental tobacco smoke [ETS]
A mixture of smoke exhaled by smokers and smoke released from smouldering
cigarettes, cigars, pipes, bidis, etc. The smoke mixture contains gases and particulates,
including nicotine, carcinogens and toxins
Self-efficacy The belief that one will be able to change one’s behaviour, e.g. to quit smoking
SPC [Summary of Product Characteristics] Advice from the manufacturers of a drug, agreed with the relevant licensing authority,
to enable health professionals to prescribe and use the treatment safely and effectively
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Tapering A gradual decrease in dose at the end of treatment, as an alternative to abruptly stopping
treatment
Titration A technique of dosing at low levels at the beginning of treatment, and gradually in-
creasing to full dose over a few days, to allow the body to get used to the drug. It is
designed to limit side effects
Withdrawal A variety of behavioural, affective, cognitive and physiological symptoms, usually tran-
sient, which occur after use of an addictive drug is reduced or stopped.
See: Shiffman et al ’Recommendations for the assessment of tobacco craving and with-
drawal in smoking cessation trials’
Nicotine & Tobacco Research 2004: 6(4): 599-614
WH A T ’ S N E W
Last assessed as up-to-date: 13 April 2012.
Date Event Description
5 December 2013 Amended Correction to Summary of Findings Table (confidence interval for continuous abstinence)
H I S T O R Y
Protocol first published: Issue 2, 1996
Review first published: Issue 2, 1996
Date Event Description
30 March 2012 New search has been performed Seven new studies added; SOF table, meta-analyses and
summary of individual study effectiveness table added
30 March 2012 New citation required and conclusions have changed Structure of review changed, body of text updated and re-
written; Conclusions changed
4 August 2008 Amended Converted to new review format
31 May 2000 New citation required and conclusions have changed Substantive amendment
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C O N T R I B U T I O N S O F A U T H O R S
Kristin Carson updated the protocol, reviewed the literature, identified studies for inclusion, extracted data, entered and analysed data
and updated the text of the manuscript.
Marjolein Verbiest updated the protocol, reviewed the literature, identified studies for inclusion, extracted data and updated the text
of the manuscript.
Mathilde Crone updated the protocol, identified studies for inclusion and updated the text of the manuscript.
Malcolm Brinn extracted data, entered and analysed data and updated the text of the manuscript.
Adrian Esterman updated the protocol, analysed data and updated the text of the manuscript.
Willem Assendelft assisted in updating the protocol and updating the text of the manuscript.
Brian Smith assisted in updating the protocol and updating the text of the manuscript.
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• The Respiratory Medicine Unit, The Queen Elizabeth Hospital, Australia.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
RevMan version 5.1 was upgraded to version 5.1.2 during the review update, as such risk of bias domain categories were altered from
’yes’, ’no’ and ’unclear’ to ’high risk’, ’low risk’ and ’unclear risk’.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Health Personnel [∗education]; Outcome Assessment (Health Care); Program Evaluation; Randomized Controlled Trials as Topic;
Smoking Cessation [∗methods]
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MeSH check words
Humans
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